PubMed Identification:

Starting with   __   _1   _2   _3   _4   _5   _6   _7   _8   _9   10   11   12   13   14   15   16   17   18   19   20   21   22   23   24   25   26   27   28   29   30   31   32   33   34   35   36   37

PMID
Article Title
Citation
Organization
Download
View Data
P2'-truncated BACE-1 inhibitors with a novel hydroxethylene-like core.EBI
Eur J Med Chem 45: 542-54 (2010)
Stockholm University
Selective Inhibition of DNA Replicase Assembly by a Non-natural Nucleotide: Exploiting the Structural Diversity of ATP-Binding SitesBDB
ACS Chem Biol 5: 183-94 (2010)
Case Western Reserve University
Synthesis and antiproliferative activity of 7-azaindirubin-3'-oxime, a 7-aza isostere of the natural indirubin pharmacophore.EBI
J Nat Prod 72: 2199-202 (2009)
University of Athens
Identification of triazinoindol-benzimidazolones as nanomolar inhibitors of the Mycobacterium tuberculosis enzyme TDP-6-deoxy-d-xylo-4-hexopyranosid-4-ulose 3,5-epimerase (RmlC).EBI
Bioorg Med Chem 18: 896-908 (2010)
University of Pennsylvania
Enhancement of EGFR tyrosine kinase inhibition by C-C multiple bonds-containing anilinoquinazolines.EBI
Bioorg Med Chem 18: 870-9 (2010)
Gakushuin University
Design, synthesis and primary activity assay of bi- or tri-peptide analogues with the scaffold l-arginine as amino-peptidase N/CD13 inhibitors.EBI
Bioorg Med Chem 18: 887-95 (2010)
Shandong University
Continued exploration of the triazolopyridine scaffold as a platform for p38 MAP kinase inhibition.EBI
Bioorg Med Chem Lett 20: 469-73 (2010)
Pfizer
Evaluation of pyrrolin-2-one derivatives synthesized by a new practical method as inhibitors of plasminogen activator inhibitor-1 (PAI-1).EBI
Bioorg Med Chem Lett 20: 546-8 (2010)
Mitsubishi Tanabe Pharma
Structure-guided design of alpha-amino acid-derived Pin1 inhibitors.EBI
Bioorg Med Chem Lett 20: 586-90 (2010)
Vernalis (R&D)
Novel purine and pyrazolo[3,4-d]pyrimidine inhibitors of PI3 kinase-alpha: Hit to lead studies.EBI
Bioorg Med Chem Lett 20: 636-9 (2010)
Wyeth Research
Proposed structural basis of interaction of piperine and related compounds with monoamine oxidases.EBI
Bioorg Med Chem Lett 20: 537-40 (2010)
University of Cambridge
Optimization of piperidyl-ureas as inhibitors of soluble epoxide hydrolase.EBI
Bioorg Med Chem Lett 20: 571-5 (2010)
Boehringer Ingelheim Pharmaceuticals
Sulfonylureido thiazoles as fructose-1,6-bisphosphatase inhibitors for the treatment of type-2 diabetes.EBI
Bioorg Med Chem Lett 20: 594-9 (2010)
F. Hoffmann-La Roche
5-Substituted [1]pyrindine derivatives with antiproliferative activity.EBI
Eur J Med Chem 45: 896-901 (2010)
University of Paris
3D-QSAR, molecular docking studies, and binding mode prediction of thiolactomycin analogs as mtFabH inhibitors.BDB
J Enzyme Inhib Med Chem 25: 240-9 (2010)
China Pharmaceutical University
Design and synthesis of 5,5'-disubstituted aminohydantoins as potent and selective human beta-secretase (BACE1) inhibitors.EBI
J Med Chem 53: 1146-58 (2010)
Wyeth Research
Lead optimization of N-3-substituted 7-morpholinotriazolopyrimidines as dual phosphoinositide 3-kinase/mammalian target of rapamycin inhibitors: discovery of PKI-402.EBI
J Med Chem 53: 798-810 (2010)
Wyeth Research
Reduced histone deacetylase 7 activity restores function to misfolded CFTR in cystic fibrosis.EBI
Nat Chem Biol 6: 25-33 (2009)
The Scripps Research Institute
Inhibitors of human tyrosyl-DNA phospodiesterase (hTdp1) developed by virtual screening using ligand-based pharmacophores.EBI
Bioorg Med Chem 18: 182-9 (2010)
National Cancer Institute-Frederick
Discovery of 3,6-dihydro-2H-pyran as a morpholine replacement in 6-aryl-1H-pyrazolo[3,4-d]pyrimidines and 2-arylthieno[3,2-d]pyrimidines: ATP-competitive inhibitors of the mammalian target of rapamycin (mTOR).EBI
Bioorg Med Chem Lett 20: 640-3 (2010)
Wyeth Research
Design, synthesis and prostate cancer cell-based studies of analogs of the Rho/MKL1 transcriptional pathway inhibitor, CCG-1423.EBI
Bioorg Med Chem Lett 20: 665-72 (2010)
University of Michigan Medical School
Potent and selective neuronal nitric oxide synthase inhibitors with improved cellular permeability.EBI
Bioorg Med Chem Lett 20: 554-7 (2010)
Northwestern University
Synthetic studies and pharmacological evaluations on the MDMA ('Ecstasy') antagonist nantenine.EBI
Bioorg Med Chem Lett 20: 628-31 (2010)
Hunter College and The Graduate Center of The City University of New York
Synthesis and pharmacological characterization of constrained analogues of Vestipitant as in vitro potent and orally active NK(1) receptor antagonists.EBI
Bioorg Med Chem Lett 20: 623-7 (2010)
Glaxosmithkline
Macrocyclic BACE-1 inhibitors acutely reduce Abeta in brain after po application.EBI
Bioorg Med Chem Lett 20: 603-7 (2010)
Novartis Institutes For Biomedical Research
Triazole oxytocin antagonists: Identification of an aryloxyazetidine replacement for a biaryl substituent.EBI
Bioorg Med Chem Lett 20: 516-20 (2010)
Pfizer
Synthesis, pharmacological studies and molecular modeling of some tetracyclic 1,3-diazepinium chlorides.EBI
Bioorg Med Chem 18: 909-21 (2010)
University of The West Indies
The comparative antimalarial properties of weak base and neutral synthetic ozonides.EBI
Bioorg Med Chem Lett 20: 563-6 (2010)
University of Nebraska Medical Center
Quinoline-3-carboxamide containing sulfones as liver X receptor (LXR) agonists with binding selectivity for LXRbeta and low blood-brain penetration.EBI
Bioorg Med Chem Lett 20: 689-93 (2010)
Wyeth Pharmaceuticals
3D QSAR studies on ketoamides of human cathepsin K inhibitors based on two different alignment methods.EBI
Eur J Med Chem 45: 667-81 (2010)
Chinese Academy of Sciences
Synthesis and biological evaluation of [1,2,4]triazino[4,3-a] benzimidazole acetic acid derivatives as selective aldose reductase inhibitors.EBI
Eur J Med Chem 45: 909-14 (2010)
Institute of Pharmaceutical Sciences
Application of a novel [3+2] cycloaddition reaction to prepare substituted imidazoles and their use in the design of potent DFG-out allosteric B-Raf inhibitors.EBI
Bioorg Med Chem 18: 292-304 (2010)
The University of Arizona
Drug design and synthesis of a novel kappa opioid receptor agonist with an oxabicyclo[2.2.2]octane skeleton and its pharmacology.EBI
Bioorg Med Chem Lett 20: 121-4 (2010)
Kitasato University
HIV-1 protease inhibitors with a transition-state mimic comprising a tertiary alcohol: improved antiviral activity in cells.EBI
J Med Chem 53: 607-15 (2010)
Uppsala University
Synthesis of 3-[(N-carboalkoxy)ethylamino]-indazole-dione derivatives and their biological activities on human liver carbonyl reductase.EBI
Bioorg Med Chem 18: 134-41 (2010)
Howard University
Novel enoyl-ACP reductase (FabI) potential inhibitors of Escherichia coli from Chinese medicine monomers.EBI
Bioorg Med Chem Lett 20: 56-9 (2010)
Huazhong Agricultural University
SAR of N-phenyl piperidine based oral integrin alpha5beta1 antagonists.EBI
Bioorg Med Chem Lett 20: 65-8 (2010)
Jerini
Discovery and initial optimization of 5,5'-disubstituted aminohydantoins as potent beta-secretase (BACE1) inhibitors.EBI
Bioorg Med Chem Lett 20: 632-5 (2010)
Wyeth Research
Optimization of orally bioavailable alkyl amine renin inhibitors.EBI
Bioorg Med Chem Lett 20: 694-9 (2010)
Vitae Pharmaceuticals
Enhancing the intestinal absorption of molecules containing the polar guanidino functionality: a double-targeted prodrug approach.EBI
J Med Chem 53: 624-32 (2010)
University of Michigan
Novel ester and acid derivatives of the 1,5-diarylpyrrole scaffold as anti-inflammatory and analgesic agents. Synthesis and in vitro and in vivo biological evaluation.EBI
J Med Chem 53: 723-33 (2010)
Sapienza University of Rome
Structure-activity relationship studies leading to the identification of (2E)-3-[l-[(2,4-dichlorophenyl)methyl]-5-fluoro-3-methyl-lH-indol-7-yl]-N-[(4,5-dichloro-2-thienyl)sulfonyl]-2-propenamide (DG-041), a potent and selective prostanoid EP3 receptor antagonist, as a novel antiplatelet agent thatEBI
J Med Chem 53: 18-36 (2010)
Decode Chemistry
Identification of a novel ligand binding motif in the transthyretin channel.EBI
Bioorg Med Chem 18: 100-10 (2010)
Universidade Federal Do Rio De Janeiro
Exploring SAR features in diverse library of 4-cyanomethyl-pyrazole-3-carboxamides suitable for further elaborations as CB1 antagonists.EBI
Bioorg Med Chem Lett 20: 26-30 (2010)
7Tm Pharma
Pyrazole derived from (+)-3-carene; a novel potent, selective scaffold for sphingosine-1-phosphate (S1P(1)) receptor agonists.EBI
Bioorg Med Chem Lett 20: 35-7 (2010)
Novartis Institutes For Biomedical Research
Structure-activity relationships of N-substituted ligands for the alpha7 nicotinic acetylcholine receptor.EBI
Bioorg Med Chem Lett 20: 104-7 (2010)
Abbott Laboratories
Oxygenated analogues of UK-396082 as inhibitors of activated thrombin activatable fibrinolysis inhibitor.EBI
Bioorg Med Chem Lett 20: 92-6 (2010)
Pfizer
Oxo-bridged isomers of aza-trishomocubane sigma (sigma) receptor ligands: Synthesis, in vitro binding, and molecular modeling.EBI
Bioorg Med Chem Lett 20: 145-8 (2010)
University of Sydney
Coumarins as novel 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for potential treatment of prostate cancer.EBI
Bioorg Med Chem Lett 20: 272-5 (2010)
Sumitomo Chemical
Novel imidazolopyrimidines as dual PI3-Kinase/mTOR inhibitors.EBI
Bioorg Med Chem Lett 20: 653-6 (2010)
Wyeth Research
Radiosynthesis and radiopharmacological evaluation of cyclin-dependent kinase 4 (Cdk4) inhibitors.EBI
Eur J Med Chem 45: 727-37 (2010)
Institute of Radiopharmacy
Efficient microwave combinatorial synthesis of novel indolic arylpiperazine derivatives as serotoninergic ligands.EBI
Eur J Med Chem 45: 752-9 (2010)
Universit£
Synthesis and AChE inhibitory activity of new chiral tetrahydroacridine analogues from terpenic cyclanones.EBI
Eur J Med Chem 45: 526-35 (2010)
Universidade Federal Do Rio Grande Do Sul
Heme oxygenase inhibition by 2-oxy-substituted 1-azolyl-4-phenylbutanes: effect of variation of the azole moiety. X-ray crystal structure of human heme oxygenase-1 in complex with 4-phenyl-1-(1H-1,2,4-triazol-1-yl)-2-butanone.BDB
Chem Biol Drug Des 75: 68-90 (2010)
Queen'S University
Increasing selectivity of CC chemokine receptor 8 antagonists by engineering nondesolvation related interactions with the intended and off-target binding sites.EBI
J Med Chem 52: 7706-23 (2009)
Astrazeneca
A strategy to minimize reactive metabolite formation: discovery of (S)-4-(1-cyclopropyl-2-methoxyethyl)-6-[6-(difluoromethoxy)-2,5-dimethylpyridin-3-ylamino]-5-oxo-4,5-dihydropyrazine-2-carbonitrile as a potent, orally bioavailable corticotropin-releasing factor-1 receptor antagonist.EBI
J Med Chem 52: 7653-68 (2009)
Bristol-Myers Squibb
Small-sized human immunodeficiency virus type-1 protease inhibitors containing allophenylnorstatine to explore the S2' pocket.EBI
J Med Chem 52: 7604-17 (2009)
Kyoto Pharmaceutical University
Design, synthesis, and 3D-QSAR analysis of novel 1,3,4-oxadiazol-2(3H)-ones as protoporphyrinogen oxidase inhibitors.EBI
J Agric Food Chem 58: 2643-51 (2010)
Central China Normal University
Structure-activity relationships of the ultrapotent vanilloid resiniferatoxin (RTX): The side chain benzylic methylene.EBI
Bioorg Med Chem Lett 20: 97-9 (2010)
Universit£
3D QSAR studies on 3,4-dihydroquinazolines as T-type calcium channel blocker by comparative molecular similarity indices analysis (CoMSIA).EBI
Bioorg Med Chem Lett 20: 38-41 (2010)
Kyung Hee University
Selective p38alpha inhibitors clinically evaluated for the treatment of chronic inflammatory disorders.EBI
J Med Chem 53: 2345-53 (2010)
Roche Palo Alto
Discovery of 4-[(2S)-2-{[4-(4-chlorophenoxy)phenoxy]methyl}-1-pyrrolidinyl]butanoic acid (DG-051) as a novel leukotriene A4 hydrolase inhibitor of leukotriene B4 biosynthesis.EBI
J Med Chem 53: 573-85 (2010)
Decode Chemistry
Blockade of X4-tropic HIV-1 cellular entry by GSK812397, a potent noncompetitive CXCR4 receptor antagonist.EBI
Antimicrob Agents Chemother 54: 817-24 (2010)
Glaxosmithkline
Synthesis and anticancer activities of ageladine A and structural analogs.EBI
Bioorg Med Chem Lett 20: 83-6 (2010)
Beckman Research Institute At City of Hope
Synthesis, biological evaluation, X-ray structure, and pharmacokinetics of aminopyrimidine c-jun-N-terminal kinase (JNK) inhibitors.EBI
J Med Chem 53: 419-31 (2010)
Translational Research Institute
Synthesis and biological activity of 5-styryl and 5-phenethyl-substituted 2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indoles.EBI
Bioorg Med Chem Lett 20: 78-82 (2010)
Chemical Diversity Research Institute
The discovery of tetrahydro-beta-carbolines as inhibitors of the kinesin Eg5.EBI
Bioorg Med Chem Lett 20: 157-60 (2010)
Novartis Institutes For Biomedical Research
Towards development of selective and reversible pyrazoline based MAO-inhibitors: Synthesis, biological evaluation and docking studies.EBI
Bioorg Med Chem Lett 20: 132-6 (2010)
Institute of Technology
Oxime derivatives related to AP18: Agonists and antagonists of the TRPA1 receptor.EBI
Bioorg Med Chem Lett 20: 276-9 (2010)
Renovis
A novel chemotype of kinase inhibitors: Discovery of 3,4-ring fused 7-azaindoles and deazapurines as potent JAK2 inhibitors.EBI
Bioorg Med Chem Lett 20: 153-6 (2010)
Vertex Pharmaceuticals
Discovery of benzimidazole-diamide finger loop (Thumb Pocket I) allosteric inhibitors of HCV NS5B polymerase: Implementing parallel synthesis for rapid linker optimization.EBI
Bioorg Med Chem Lett 20: 196-200 (2010)
Boehringer Ingelheim (Canada)
Pyrrole derivatives as potent inhibitors of lymphocyte-specific kinase: Structure, synthesis, and SAR.EBI
Bioorg Med Chem Lett 20: 108-11 (2010)
Taisho Pharmaceutical
Ring-fused pyrazole derivatives as potent inhibitors of lymphocyte-specific kinase (Lck): Structure, synthesis, and SAR.EBI
Bioorg Med Chem Lett 20: 112-6 (2010)
Taisho Pharmaceutical
Theoretical and structural analysis of the active site of the transcriptional regulators LasR and TraR, using molecular docking methodology for identifying potential analogues of acyl homoserine lactones (AHLs) with anti-quorum sensing activity.EBI
Eur J Med Chem 45: 608-15 (2010)
Universidad De Cartagena-Facultad De Ciencias Exactas Y
Novel tumor-targeted RGD peptide-camptothecin conjugates: synthesis and biological evaluation.EBI
Bioorg Med Chem 18: 64-72 (2010)
Istituto Di Ricerche Chimiche E Biochimiche G. Ronzoni
A single step purification for autolytic zinc proteinases.EBI
Bioorg Med Chem Lett 20: 280-2 (2010)
Duke University
Biotransformation of isoimperatorin and imperatorin by Glomerella cingulata and beta-secretase inhibitory activity.EBI
Bioorg Med Chem 18: 455-9 (2010)
Kinki University
Identification and characterisation of new inhibitors for the human hematopoietic prostaglandin D2 synthase.EBI
Eur J Med Chem 45: 447-54 (2010)
The University of Queensland
8-Sulfonyl-substituted tetrahydro-1H-pyrido[4,3-b]indoles as 5-HT6 receptor antagonists.EBI
Eur J Med Chem 45: 782-9 (2010)
Chemical Diversity Research Institute
The binding of synthetic retinoids to lipocalin beta-lactoglobulins.EBI
J Med Chem 53: 514-8 (2010)
University of Helsinki
TMC278, a next-generation nonnucleoside reverse transcriptase inhibitor (NNRTI), active against wild-type and NNRTI-resistant HIV-1.EBI
Antimicrob Agents Chemother 54: 718-27 (2010)
Tibotec-Virco
SCY-635, a novel nonimmunosuppressive analog of cyclosporine that exhibits potent inhibition of hepatitis C virus RNA replication in vitro.EBI
Antimicrob Agents Chemother 54: 660-72 (2010)
Scynexis
Modulation of Wnt signaling through inhibition of secreted frizzled-related protein I (sFRP-1) with N-substituted piperidinyl diphenylsulfonyl sulfonamides: part II.EBI
Bioorg Med Chem 18: 190-201 (2010)
Wyeth Research
Isoxazole analogues bind the system xc- transporter: structure-activity relationship and pharmacophore model.EBI
Bioorg Med Chem 18: 202-13 (2010)
The University of Montana
Synthesis and structure-activity relationship of novel lactam-fused chroman derivatives having dual affinity at the 5-HT(1A) receptor and the serotonin transporter.EBI
Bioorg Med Chem Lett 20: 222-7 (2010)
Wyeth Research
Highly selective and potent mu opioid ligands by unexpected substituent on morphine skeleton.EBI
Bioorg Med Chem Lett 20: 418-21 (2010)
Fudan University
Addressing species specific metabolism and solubility issues in a quinoline series of oral PDE4 inhibitors.EBI
Bioorg Med Chem Lett 20: 137-40 (2010)
Glaxosmithkline
Novel lead for potent inhibitors of breast cancer resistance protein (BCRP).EBI
Bioorg Med Chem Lett 20: 180-3 (2010)
University of Bonn
4-(3-Aryloxyaryl)quinoline sulfones are potent liver X receptor agonists.EBI
Bioorg Med Chem Lett 20: 209-12 (2010)
Wyeth Pharmaceuticals
Scaffold hopping from pyridones to imidazo[1,2-a]pyridines. New positive allosteric modulators of metabotropic glutamate 2 receptor.EBI
Bioorg Med Chem Lett 20: 175-9 (2010)
Janssen-Cilag
Synthesis and biological evaluation of novel 4-hydroxybenzaldehyde derivatives as tyrosinase inhibitors.EBI
Eur J Med Chem 45: 639-46 (2010)
Sun Yat-Sen University
Silicon switch approach in TRPV1 antagonist MK-056 and its analogues.EBI
Bioorg Med Chem 18: 111-6 (2010)
Sookmyung Women'S University
Nanomolar affinity, iminosugar-based chemical probes for specific labeling of lysosomal glucocerebrosidase.EBI
Bioorg Med Chem 18: 267-73 (2010)
Utrecht University
Piperidyl amides as novel, potent and orally active mGlu5 receptor antagonists with anxiolytic-like activity.EBI
Bioorg Med Chem Lett 20: 184-8 (2010)
Novartis Institutes For Biomedical Research
Potent and orally active small-molecule inhibitors of the MDM2-p53 interaction.EBI
J Med Chem 52: 7970-3 (2009)
University of Michigan
Synthesis and opioid receptor binding affinities of 2-substituted and 3-aminomorphinans: ligands for mu, kappa, and delta opioid receptors.EBI
J Med Chem 53: 402-18 (2010)
Harvard Medical School
Design of O-acetylserine sulfhydrylase inhibitors by mimicking nature.EBI
J Med Chem 53: 345-56 (2010)
University of Parma
Displacement assay for the detection of stabilizers of inactive kinase conformations.EBI
J Med Chem 53: 357-67 (2010)
Chemical Genomics Centre of The Max Planck Society
Subnanomolar inhibitor of cytochrome bc1 complex designed by optimizing interaction with conformationally flexible residues.EBI
J Am Chem Soc 132: 185-94 (2010)
Central China Normal University
Synthesis, affinity profile and functional activity of potent chiral muscarinic antagonists with a pyrrolidinylfuran structure.EBI
J Med Chem 53: 201-7 (2010)
Universita Di Firenze
Novel bisaryl substituted thiazoles and oxazoles as highly potent and selective peroxisome proliferator-activated receptor delta agonists.EBI
J Med Chem 53: 77-105 (2010)
The Genomics Institute of The Novartis Research Foundation
Synthesis and in vitro evaluation of fluorinated diphenyloxide derivatives and sulfur analogs as serotonin transporter ligands.EBI
Bioorg Med Chem 18: 236-41 (2010)
University of Tours
2,4-Diaminopyrimidine MK2 inhibitors. Part II: Structure-based inhibitor optimization.EBI
Bioorg Med Chem Lett 20: 334-7 (2010)
Abbott Laboratories
Synthesis and inhibitory activity against human monoamine oxidase of N1-thiocarbamoyl-3,5-di(hetero)aryl-4,5-dihydro-(1H)-pyrazole derivatives.EBI
Eur J Med Chem 45: 800-4 (2010)
Universit£
Design and synthesis of novel P2 substituents in diol-based HIV protease inhibitors.EBI
Eur J Med Chem 45: 160-70 (2010)
Stockholm University
Improving the developability profile of pyrrolidine progesterone receptor partial agonists.EBI
Bioorg Med Chem Lett 20: 371-4 (2010)
Glaxosmithkline
Novel benzoylpiperidine-based stearoyl-CoA desaturase-1 inhibitors: Identification of 6-[4-(2-methylbenzoyl)piperidin-1-yl]pyridazine-3-carboxylic acid (2-hydroxy-2-pyridin-3-ylethyl)amide and its plasma triglyceride-lowering effects in Zucker fatty rats.EBI
Bioorg Med Chem Lett 20: 341-5 (2010)
Daiichi Sankyo
X-ray crystallographic analysis of alpha-ketoheterocycle inhibitors bound to a humanized variant of fatty acid amide hydrolase.EBI
J Med Chem 53: 230-40 (2010)
The Scripps Research Institute
Indol-3-ylcycloalkyl ketones: effects of N1 substituted indole side chain variations on CB(2) cannabinoid receptor activity.EBI
J Med Chem 53: 295-315 (2010)
Abbott Laboratories
2,4-Diaminopyrimidine MK2 inhibitors. Part I: Observation of an unexpected inhibitor binding mode.EBI
Bioorg Med Chem Lett 20: 330-3 (2010)
Abbott Laboratories
Novel sulfamoyl benzamides as selective CB(2) agonists with improved in vitro metabolic stability.EBI
Bioorg Med Chem Lett 20: 387-91 (2010)
Adolor
Chloro-substituted 3-alkylamino-4H-1,2,4-benzothiadiazine 1,1-dioxides as ATP-sensitive potassium channel activators: impact of the position of the chlorine atom on the aromatic ring on activity and tissue selectivity.EBI
J Med Chem 53: 147-54 (2010)
Universite De Liege
Identification of a brain penetrant PDE9A inhibitor utilizing prospective design and chemical enablement as a rapid lead optimization strategy.EBI
J Med Chem 52: 7946-9 (2009)
Pfizer
Structure-based design of pteridine reductase inhibitors targeting African sleeping sickness and the leishmaniases.EBI
J Med Chem 53: 221-9 (2010)
University of Dundee
5-OHKF and NorKA, depsipeptides from a Hawaiian collection of Bryopsis pennata: binding properties for NorKA to the human neuropeptide Y Y1 receptor.EBI
J Nat Prod 72: 2172-6 (2009)
The University of Mississippi
Morpholine derivatives greatly enhance the selectivity of mammalian target of rapamycin (mTOR) inhibitors.EBI
J Med Chem 52: 7942-5 (2009)
Wyeth Research
Synthesis and structure-activity relationships of N-benzyl-N-(X-2-hydroxybenzyl)-N'-phenylureas and thioureas as antitumor agents.EBI
Bioorg Med Chem 18: 305-13 (2010)
Nanjing University
Synthesis of glycyrrhetinic acid derivatives for the treatment of metabolic diseases.EBI
Bioorg Med Chem 18: 433-54 (2010)
Vienna University of Technology
Design, synthesis and biological evaluation of thiazolidinone derivatives as potential EGFR and HER-2 kinase inhibitors.EBI
Bioorg Med Chem 18: 314-9 (2010)
Nanjing University
Synthesis of a hydrolytically stable, fluorescent-labeled ATP analog as a tool for probing adenylyl cyclases.EBI
Bioorg Med Chem Lett 20: 232-5 (2010)
Ernst-Moritz-Arndt-University
p16(INK4a) Peptide mimetics identified via virtual screening.EBI
Bioorg Med Chem Lett 20: 403-5 (2010)
Veterans Affairs Medical Center
Benzylidene cyclopentenediones: First irreversible inhibitors against botulinum neurotoxin A's zinc endopeptidase.EBI
Bioorg Med Chem Lett 20: 206-8 (2010)
The Scripps Research Institute
5-Lipoxygenase-activating protein inhibitors. Part 2: 3-{5-((S)-1-Acetyl-2,3-dihydro-1H-indol-2-ylmethoxy)-3-tert-butylsulfanyl-1-[4-(5-methoxy-pyrimidin-2-yl)-benzyl]-1H-indol-2-yl}-2,2-dimethyl-propionic acid (AM679)--a potent FLAP inhibitor.EBI
Bioorg Med Chem Lett 20: 213-7 (2010)
Amira Pharmaceuticals
Aminopyridinecarboxamide-based inhibitors: Structure-activity relationship.EBI
Bioorg Med Chem 18: 403-14 (2010)
Pfizer
Antimalarial and antileishmanial activities of histone deacetylase inhibitors with triazole-linked cap group.EBI
Bioorg Med Chem 18: 415-25 (2010)
Georgia Institute of Technology
Pyrazolone based TGFbetaR1 kinase inhibitors.EBI
Bioorg Med Chem Lett 20: 326-9 (2010)
Biogen Idec
Application of ring-closing metathesis macrocyclization to the development of Tsg101-binding antagonists.EBI
Bioorg Med Chem Lett 20: 318-21 (2010)
National Cancer Institute-Frederick
2-Arylbenzoxazoles as CETP inhibitors: Substitution of the benzoxazole moiety.EBI
Bioorg Med Chem Lett 20: 346-9 (2010)
Merck Research Laboratories
Synthesis and antiplasmodial activity of novel 2,4-diaminopyrimidines.EBI
Bioorg Med Chem Lett 20: 228-31 (2010)
Institute Infectious Diseases Initiative
Design and synthesis of orally-active and selective azaindane 5HT2c agonist for the treatment of obesity.EBI
Bioorg Med Chem Lett 20: 266-71 (2010)
Pfizer
Antimalarial activity of azadipeptide nitriles.EBI
Bioorg Med Chem Lett 20: 252-5 (2010)
University of Queensland
Dipeptide-derived nitriles containing additional electrophilic sites: potentially irreversible inhibitors of cysteine proteases.BDB
J Enzyme Inhib Med Chem 24: 1245-52 (2009)
Rheinische Friedrich-Wilhelms-Universitat Bonn
Deciphering the mechanism of carbonic anhydrase inhibition with coumarins and thiocoumarins.EBI
J Med Chem 53: 335-44 (2010)
Universita Degli Studi Di Firenze
Structure-activity relationship study of betulinic acid, a novel and selective TGR5 agonist, and its synthetic derivatives: potential impact in diabetes.EBI
J Med Chem 53: 178-90 (2010)
Universite Louis Pasteur
Synthesis and biological evaluation of new nanomolar competitive inhibitors of Helicobacter pylori type II dehydroquinase. Structural details of the role of the aromatic moieties with essential residues.EBI
J Med Chem 53: 191-200 (2010)
Universidad De Santiago De Compostela
Discovery of orally available integrin alpha5beta1 antagonists.EBI
Bioorg Med Chem Lett 20: 380-2 (2010)
Jerini
Identification and optimization of inhibitors of Trypanosomal cysteine proteases: cruzain, rhodesain, and TbCatB.EBI
J Med Chem 53: 52-60 (2010)
National Human Genome Research Institute
Quantitative analyses of aggregation, autofluorescence, and reactivity artifacts in a screen for inhibitors of a thiol protease.EBI
J Med Chem 53: 37-51 (2010)
National Human Genome Research Institute
Dihydroxyphenylisoindoline amides as orally bioavailable inhibitors of the heat shock protein 90 (hsp90) molecular chaperone.EBI
J Med Chem 53: 499-503 (2010)
Pfizer
Discovery of potent, selective, and orally bioavailable PDE5 inhibitor: Methyl-4-(3-chloro-4-methoxybenzylamino)-8-(2-hydroxyethyl)-7-methoxyquinazolin-6-ylmethylcarbamate (CKD 533).EBI
Bioorg Med Chem Lett 20: 383-6 (2010)
Chong Kun Dang Research Institute
Identification of a series of substituted 2-piperazinyl-5-pyrimidylhydroxamic acids as potent histone deacetylase inhibitors.EBI
Bioorg Med Chem Lett 20: 294-8 (2010)
Ortho-Biotech Oncology Research & Development
Development of 5-benzylpaullones and paullone-9-carboxylic acid alkyl esters as selective inhibitors of mitochondrial malate dehydrogenase (mMDH).EBI
Eur J Med Chem 45: 335-42 (2010)
Technische Universit£T Braunschweig
Synthesis of aryl phosphates based on pyrimidine and triazine scaffolds.EBI
Eur J Med Chem 45: 244-55 (2010)
Cnrs Umr 176
4-Oxo-beta-lactams (azetidine-2,4-diones) are potent and selective inhibitors of human leukocyte elastase.EBI
J Med Chem 53: 241-53 (2010)
University of Lisbon
Human P2Y(14) receptor agonists: truncation of the hexose moiety of uridine-5'-diphosphoglucose and its replacement with alkyl and aryl groups.EBI
J Med Chem 53: 471-80 (2010)
National Institute of Diabetes and Digestive and Kidney Diseases
Solid phase synthesis of novel pyrrolidinedione analogs as potent HIV-1 integrase inhibitors.BDB
J Comb Chem 12: 84-90 (2010)
Bristol-Myers Squibb
Discovery of 3-aryl-4-isoxazolecarboxamides as TGR5 receptor agonists.EBI
J Med Chem 52: 7962-5 (2009)
Glaxosmithkline
Novel ambler class A carbapenem-hydrolyzing beta-lactamase from a Pseudomonas fluorescens isolate from the Seine River, Paris, France.EBI
Antimicrob Agents Chemother 54: 328-32 (2009)
Bicetre Hospital
A novel class of meso-tetrakis-porphyrin derivatives exhibits potent activities against hepatitis C virus genotype 1b replicons in vitro.EBI
Antimicrob Agents Chemother 54: 197-206 (2010)
Yale University
Design, synthesis, and SAR of cis-1,2-diaminocyclohexane derivatives as potent factor Xa inhibitors. Part II: exploration of 6-6 fused rings as alternative S1 moieties.BDB
Bioorg Med Chem 17: 8221-33 (2009)
Daiichi Sankyo
Optimization of (4,4-difluoro-1,2,3,4-tetrahydro-5H-1-benzazepine-5-ylidene)acetamide derivatives as arginine vasopressin V2 receptor agonists and discussion of their binding modes.BDB
Bioorg Med Chem 17: 8161-7 (2009)
Astellas Pharma
Thyroid receptor agonists for the treatment of androgenetic alopecia.EBI
Bioorg Med Chem Lett 20: 306-8 (2010)
Pfizer
Structural studies of pterin-based inhibitors of dihydropteroate synthase.EBI
J Med Chem 53: 166-77 (2010)
University of Tennessee Health Science Center
Phosphinic tripeptides as dual angiotensin-converting enzyme C-domain and endothelin-converting enzyme-1 inhibitors.EBI
J Med Chem 53: 208-20 (2010)
Cea
Interaction studies between human alpha-tocopherol transfer protein and nitric oxide donor tocopherol analogues with LDL-protective activity.EBI
Bioorg Med Chem 17: 8143-8 (2009)
Universidad De La Rep£Blica
Synthesis and structural optimization of multiple H-bonding region of diarylalkyl (thio)amides as novel TRPV1 antagonists.EBI
Bioorg Med Chem 17: 8149-60 (2009)
Seoul National University
Bioisosterism of urea-based GCPII inhibitors: Synthesis and structure-activity relationship studies.EBI
Bioorg Med Chem Lett 20: 392-7 (2010)
Institutions
Synthesis and in vivo evaluation of 3-substituted gababutins.EBI
Bioorg Med Chem Lett 20: 362-5 (2010)
Pfizer
Discovery of 2-arylthieno[3,2-d]pyrimidines containing 8-oxa-3-azabi-cyclo[3.2.1]octane in the 4-position as potent inhibitors of mTOR with selectivity over PI3K.EBI
Bioorg Med Chem Lett 20: 375-9 (2010)
Wyeth Research
Aroylguanidine-based factor Xa inhibitors: the discovery of BMS-344577.BDB
Bioorg Med Chem Lett 19: 6882-9 (2009)
Bristol-Myers Squibb
Synthesis and monoamine transporter affinity of 3alpha-arylmethoxy-3beta-arylnortropanes.EBI
Bioorg Med Chem Lett 19: 6865-8 (2009)
University of New Orleans
Incorporation of water-solubilizing groups in pyrazolopyrimidine mTOR inhibitors: discovery of highly potent and selective analogs with improved human microsomal stability.EBI
Bioorg Med Chem Lett 19: 6830-5 (2009)
Wyeth Research
Tetrahydroquinoline derivatives as CRTH2 antagonists.EBI
Bioorg Med Chem Lett 19: 6840-4 (2009)
Amgen
N3-arylmalonamides: a new series of thieno[3,2-b]pyridine based inhibitors of c-Met and VEGFR2 tyrosine kinases.EBI
Bioorg Med Chem Lett 19: 6836-9 (2009)
Methylgene
Properly substituted 1,4-dioxane nucleus favours the selective M3 muscarinic receptor activation.EBI
Bioorg Med Chem 17: 8174-85 (2009)
Universit£
Exploration of O-spiroketal C-arylglucosides as novel and selective renal sodium-dependent glucose co-transporter 2 (SGLT2) inhibitors.EBI
Bioorg Med Chem Lett 19: 6877-81 (2009)
Chinese Academy of Sciences
Multivalent binding oligomers inhibit HIV Tat-TAR interaction critical for viral replication.EBI
Bioorg Med Chem Lett 19: 6893-7 (2009)
Niddk
Synthesis and pharmacological evaluation of analogs of indole-based cannabimimetic agents.BDB
Chem Biol Drug Des 75: 106-14 (2010)
UniversitÀ
Structural analysis of DFG-in and DFG-out dual Src-Abl inhibitors sharing a common vinyl purine template.BDB
Chem Biol Drug Des 75: 18-28 (2010)
Ariad Pharmaceuticals
Discovery of 4-morpholino-6-aryl-1H-pyrazolo[3,4-d]pyrimidines as highly potent and selective ATP-competitive inhibitors of the mammalian target of rapamycin (mTOR): optimization of the 6-aryl substituent.EBI
J Med Chem 52: 8010-24 (2009)
Wyeth Research
Design, synthesis, and characterization of peptide-based rab geranylgeranyl transferase inhibitors.EBI
J Med Chem 52: 8025-37 (2009)
Max Planck Institute of Molecular Physiology
Three dimensional pharmacophore modelling for c-Kit receptor tyrosine kinase inhibitors.EBI
Eur J Med Chem 45: 393-404 (2010)
Punjabi University
Discovery of a 2,4-diamino-7-aminoalkoxyquinazoline as a potent and selective inhibitor of histone lysine methyltransferase G9a.EBI
J Med Chem 52: 7950-3 (2009)
University of North Carolina
1,2,4-Triazolyl azabicyclo[3.1.0]hexanes: a new series of potent and selective dopamine D(3) receptor antagonists.EBI
J Med Chem 53: 374-91 (2010)
Glaxosmithkline
Discovery of trans-4-[1-[[2,5-Dichloro-4-(1-methyl-3-indolylcarboxamido)phenyl]acetyl]-(4S)-methoxy-(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylic acid: an orally active, selective very late antigen-4 antagonist.EBI
J Med Chem 52: 7974-92 (2009)
Daiichi Sankyo
Discovery of novel thieno[2,3-d]pyrimidin-4-yl hydrazone-based inhibitors of cyclin D1-CDK4: synthesis, biological evaluation and structure-activity relationships. Part 2.EBI
Bioorg Med Chem 17: 7850-60 (2009)
Daiichi Sankyo
Structure-activity relationships of 6-(2,6-dichlorophenyl)-8-methyl-2-(phenylamino)pyrido[2,3-d]pyrimidin-7-ones: toward selective Abl inhibitors.EBI
Bioorg Med Chem Lett 19: 6872-6 (2009)
Memorial Sloan-Kettering Cancer Center
Fragment-based discovery of selective inhibitors of the Mycobacterium tuberculosis protein tyrosine phosphatase PtpA.EBI
Bioorg Med Chem Lett 19: 6851-4 (2009)
University of California
Terpenoids. III: Synthesis and biological evaluation of 23-hydroxybetulinic acid derivatives as novel inhibitors of glycogen phosphorylase.EBI
Bioorg Med Chem Lett 19: 6966-9 (2009)
China Pharmaceutical University
Discovery of a novel Her-1/Her-2 dual tyrosine kinase inhibitor for the treatment of Her-1 selective inhibitor-resistant non-small cell lung cancer.EBI
J Med Chem 52: 6880-8 (2009)
Hanmi Research Center
Synthesis and evaluation of a new generation of orally efficacious benzimidazole-based poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors as anticancer agents.EBI
J Med Chem 52: 6803-13 (2009)
Abbott Laboratories
Identification of novel, selective, and stable inhibitors of class II histone deacetylases. Validation studies of the inhibition of the enzymatic activity of HDAC4 by small molecules as a novel approach for cancer therapy.EBI
J Med Chem 52: 6782-9 (2009)
Istituto Di Ricerche Di Biologia Molecolare
Multidentate small-molecule inhibitors of vaccinia H1-related (VHR) phosphatase decrease proliferation of cervix cancer cells.EBI
J Med Chem 52: 6716-23 (2009)
Institute For Medical Research
Constrained peptidomimetics reveal detailed geometric requirements of covalent prolyl oligopeptidase inhibitors.EBI
J Med Chem 52: 6672-84 (2009)
Mcgill University
Selective Kv1.5 blockers: development of (R)-1-(methylsulfonylamino)-3-[2-(4-methoxyphenyl)ethyl]-4-(4-methoxyphenyl)-2-imidazolidinone (KVI-020/WYE-160020) as a potential treatment for atrial arrhythmia.EBI
J Med Chem 52: 6531-4 (2009)
Wyeth Research
Binding ensemble profiling with photoaffinity labeling (BEProFL) approach: mapping the binding poses of HDAC8 inhibitors.EBI
J Med Chem 52: 7003-13 (2009)
University of Illinois At Chicago
Might adrenergic alpha2C-agonists/alpha2A-antagonists become novel therapeutic tools for pain treatment with morphine?EBI
J Med Chem 52: 7319-22 (2009)
Universita Degli Studi Di Camerino
BEL-2, an extended-spectrum beta-lactamase with increased activity toward expanded-spectrum cephalosporins in Pseudomonas aeruginosa.EBI
Antimicrob Agents Chemother 54: 533-5 (2010)
H�Pital De Bic�Tre
Molecular and biochemical characterization of the natural chromosome-encoded class A beta-lactamase from Pseudomonas luteola.EBI
Antimicrob Agents Chemother 54: 45-51 (2010)
Institut Pasteur
Design, synthesis, and SAR of cis-1,2-diaminocyclohexane derivatives as potent factor Xa inhibitors. Part I: exploration of 5-6 fused rings as alternative S1 moieties.BDB
Bioorg Med Chem 17: 8206-20 (2009)
Daiichi Sankyo
5-Vinyl-3-pyridinecarbonitrile inhibitors of PKCtheta: optimization of enzymatic and functional activity.BDB
Bioorg Med Chem 17: 7933-48 (2009)
Wyeth Research
Synthesis, antibacterial activities and molecular docking studies of peptide and Schiff bases as targeted antibiotics.EBI
Bioorg Med Chem 17: 7861-71 (2009)
Nanjing University
Discovery of benzo[g]indol-3-carboxylates as potent inhibitors of microsomal prostaglandin E(2) synthase-1.EBI
Bioorg Med Chem 17: 7924-32 (2009)
Eberhard Karls University Tuebingen
Hit to lead optimization of pyrazolo[1,5-a]pyrimidines as B-Raf kinase inhibitors.EBI
Bioorg Med Chem Lett 19: 6890-2 (2009)
Wyeth Research
Synthesis and biological evaluation of salicylic acid and N-acetyl-2-carboxybenzenesulfonamide regioisomers possessing a N-difluoromethyl-1,2-dihydropyrid-2-one pharmacophore: dual inhibitors of cyclooxygenases and 5-lipoxygenase with anti-inflammatory activity.EBI
Bioorg Med Chem Lett 19: 6855-61 (2009)
University of Alberta
1-(2-Aminoethyl)-3-(arylsulfonyl)-1H-pyrrolopyridines are 5-HT(6) receptor ligands.EBI
Bioorg Med Chem Lett 19: 6935-8 (2009)
Wyeth Research
3-arylidene-5-(4-isobutylphenyl)-2(3H)-furanones: a new series of anti-inflammatory and analgesic compounds having antimicrobial activity.BDB
J Enzyme Inhib Med Chem 25: 323-30 (2010)
Jamia Hamdard
Biaryl ethers as novel non-nucleoside reverse transcriptase inhibitors with improved potency against key mutant viruses.EBI
J Med Chem 52: 7163-9 (2009)
Merck Research Laboratory
Bis(dialkylaminethiocarbonyl)disulfides as potent and selective monoglyceride lipase inhibitors.EBI
J Med Chem 52: 7310-4 (2009)
Universite Catholique De Louvain
4-Pregnen-21-ol-3,20-dione-21-(4-bromobenzenesulfonate) (NSC 88915) and related novel steroid derivatives as tyrosyl-DNA phosphodiesterase (Tdp1) inhibitors.EBI
J Med Chem 52: 7122-31 (2009)
National Cancer Institute-Bethesda
Discovery of novel benzoxazinones as potent and orally active long chain fatty acid elongase 6 inhibitors.EBI
J Med Chem 52: 7289-300 (2009)
Tsukuba Research Institute
N-acylpolyamine inhibitors of HDM2 and HDMX binding to p53.BDB
Bioorg Med Chem 17: 7884-93 (2009)
Nih
COX, LOX and platelet aggregation inhibitory properties of Lauraceae neolignans.EBI
Bioorg Med Chem Lett 19: 6922-5 (2009)
Universidad Nacional De Colombia
Spare interactions of highly potent [Arg(14),Lys(15)]nociceptin for cooperative induction of ORL1 receptor activation.EBI
Bioorg Med Chem 17: 7904-8 (2009)
Kyushu University
Synthesis and HMG-CoA reductase inhibition of 2-cyclopropyl-4-thiophenyl-quinoline mevalonolactones.EBI
Bioorg Med Chem 17: 7915-23 (2009)
Institute of Pharmaceutical Industry
N-Bridged bicyclic sulfonamides as inhibitors of gamma-secretase.EBI
Bioorg Med Chem Lett 19: 6952-6 (2009)
Elan Pharmaceuticals
NSAID-derived gamma-secretase modulators. Part III: Membrane anchoring.EBI
Bioorg Med Chem Lett 19: 6986-90 (2009)
Technische Universit£T Darmstadt
Identification of novel agonists of the integrin CD11b/CD18.EBI
Bioorg Med Chem Lett 19: 6902-6 (2009)
Department of Medicine and University of Miami
Synthesis and preliminary biological evaluation of new derivatives of the marine alkaloid leucettamine B as kinase inhibitors.EBI
Eur J Med Chem 45: 805-10 (2010)
TBA
Structural aspects of flavonoids as inhibitors of human butyrylcholinesterase.EBI
Eur J Med Chem 45: 186-92 (2010)
Institute For Medical Research and Occupational Health
Identification of (beta-carboxyethyl)-rhodanine derivatives exhibiting peroxisome proliferator-activated receptor gamma activity.EBI
Eur J Med Chem 45: 193-202 (2010)
Sookmyung Women'S University
Design and synthesis of N(6)-substituted-4'-thioadenosine-5'-uronamides as potent and selective human A(3) adenosine receptor agonists.EBI
Bioorg Med Chem 17: 8003-11 (2009)
Ewha Womans University
Imidazo[1,2-a]pyrazine diaryl ureas: inhibitors of the receptor tyrosine kinase EphB4.EBI
Bioorg Med Chem Lett 19: 6991-5 (2009)
Cgi Pharmaceuticals
Synthesis and cytotoxic activity of 2-methylimidazo[1,2-a]pyridine- and quinoline-substituted 2-aminopyrimidine derivatives.EBI
Eur J Med Chem 45: 379-86 (2010)
Universidad Nacional Aut£Noma De M£Xico
Synthesis and biological evaluation of coumarin-based inhibitors of NAD(P)H: quinone oxidoreductase-1 (NQO1).BDB
J Med Chem 52: 7142-56 (2009)
University of Manchester
beta-Lactams derived from a carbapenem chiron are selective inhibitors of human fatty acid amide hydrolase versus human monoacylglycerol lipase.EBI
J Med Chem 52: 7054-68 (2009)
Universite Catholique De Louvain
Identification of death-associated protein kinases inhibitors using structure-based virtual screening.EBI
J Med Chem 52: 7323-7 (2009)
Pharmadesign
Synthesis and evaluation of three 18F-labeled aminophenylbenzothiazoles as amyloid imaging agents.EBI
J Med Chem 52: 7090-102 (2009)
Katholieke Universiteit Leuven
Identification and Biological Evaluation of a Series of 1H-Benzo[de]isoquinoline-1,3(2H)-diones as Hepatitis C Virus NS5B Polymerase Inhibitors.BDB
J Med Chem 52: 5217-27 (2009)
Irbm, Mrl Rome
The spirocyclopropyl moiety as a methyl surrogate in the structure of l-fucosidase and l-rhamnosidase inhibitors.EBI
Bioorg Med Chem 17: 8020-6 (2009)
Universit£
Synthesis and SAR of novel, non-MPEP chemotype mGluR5 NAMs identified by functional HTS.EBI
Bioorg Med Chem Lett 19: 6502-6 (2009)
Vanderbilt University Medical Center
Use of 5-hydroxy-4H-benzo[1,4]oxazin-3-ones as beta2-adrenoceptor agonists.EBI
Bioorg Med Chem Lett 19: 6640-4 (2009)
Boehringer Ingelheim Pharma
Novel pyrazolopyrimidines as highly potent B-Raf inhibitors.EBI
Bioorg Med Chem Lett 19: 6957-61 (2009)
Wyeth Research
Synthesis and biological evaluation of piperazinyl carbamates and ureas as fatty acid amide hydrolase (FAAH) and transient receptor potential (TRP) channel dual ligands.EBI
Bioorg Med Chem Lett 19: 6806-9 (2009)
Sapienza University of Rome
Sigma-1 ligands: Tic-hydantoin as a key pharmacophore.EBI
Eur J Med Chem 45: 256-63 (2010)
University of Lille
Discovery of potent and reversible monoacylglycerol lipase inhibitors.BDB
Chem Biol 16: 1045-52 (2009)
University of California Irvine
New insights into homopiperazine-based 5-HT1A/5-HT7R ligands: synthesis and biological evaluation.BDB
J Enzyme Inhib Med Chem 25: 301-5 (2010)
University of Orleans
Synthesis and biological activity of progesterone derivatives as 5alpha-reductase inhibitors, and their effect on hamster prostate weight.BDB
J Enzyme Inhib Med Chem 25: 306-11 (2010)
Universidad Nacional Autonoma De Mexico
Inhibitory effects of thioethers on fatty acid synthase and 3T3-L1 cells.BDB
J Enzyme Inhib Med Chem 25: 290-5 (2010)
Graduate University of Chinese Academy of Sciences
Synthesis and biological evaluation of biguanide and dihydrotriazine derivatives as potential inhibitors of dihydrofolate reductase of opportunistic microorganisms.BDB
J Enzyme Inhib Med Chem 25: 331-9 (2010)
Institute of Chemical Technology
Discovery of 2-{4-[(3S)-piperidin-3-yl]phenyl}-2H-indazole-7-carboxamide (MK-4827): a novel oral poly(ADP-ribose)polymerase (PARP) inhibitor efficacious in BRCA-1 and -2 mutant tumors.EBI
J Med Chem 52: 7170-85 (2009)
Irbm/Merck Research Laboratories
Azaindole hydroxamic acids are potent HIV-1 integrase inhibitors.EBI
J Med Chem 52: 7211-9 (2009)
Pfizer
Non-hinge-binding pyrazolo[1,5-a]pyrimidines as potent B-Raf kinase inhibitors.EBI
Bioorg Med Chem Lett 19: 6519-23 (2009)
Wyeth Research
Discovery and SAR of cyclic isothioureas as novel NPY Y1 receptor antagonists.EBI
Bioorg Med Chem Lett 19: 6801-5 (2009)
Schering-Plough Research Institute
2-Amino-5-aryl-pyridines as selective CB2 agonists: synthesis and investigation of structure-activity relationships.EBI
Bioorg Med Chem Lett 19: 6578-81 (2009)
Glaxosmithkline
5-Aryl indanones and derivatives as non-steroidal progesterone receptor modulators.EBI
Bioorg Med Chem Lett 19: 6666-9 (2009)
Wyeth Research
Design and synthesis of 6-oxo-1,6-dihydropyridines as CDK5 inhibitors.EBI
Bioorg Med Chem Lett 19: 6591-4 (2009)
Amgen
The lecanindoles, nonsteroidal progestins from the terrestrial fungus Verticillium lecanii 6144.EBI
J Nat Prod 72: 1944-8 (2009)
Wyeth Research
Inhibitors for human glutaminyl cyclase by structure based design and bioisosteric replacement.EBI
J Med Chem 52: 7069-80 (2009)
Probiodrug
Synthesis and biological evaluation of the metabolites of 2-(1-{3-[(6-chloronaphthalen-2-yl)sulfonyl]propanoyl}piperidin-4-yl)-5-methyl-1,2-dihydro-3H-imidazo[1,5-c]imidazol-3-one.EBI
Bioorg Med Chem 17: 7993-8002 (2009)
Takeda Pharmaceutical
alphavbeta3 Integrin-targeting Arg-Gly-Asp (RGD) peptidomimetics containing oligoethylene glycol (OEG) spacers.EBI
J Med Chem 52: 7029-43 (2009)
Universite Catholique De Louvain
chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.EBI
J Med Chem 52: 6991-7002 (2009)
Xenome
Structural basis of the selectivity of the beta(2)-adrenergic receptor for fluorinated catecholamines.EBI
Bioorg Med Chem 17: 7987-92 (2009)
National Institute of Diabetes and Digestive and Kidney Diseases
2-Aminopyrazolo[1,5-a]pyrimidines as potent and selective inhibitors of JAK2.EBI
Bioorg Med Chem Lett 19: 6529-33 (2009)
Vertex Pharmaceuticals
Discovery of pyrazol-3-ylamino pyrazines as novel JAK2 inhibitors.EBI
Bioorg Med Chem Lett 19: 6524-8 (2009)
Astrazeneca R&D Boston
Structural basis for the inhibitor recognition of human Lyn kinase domain.EBI
Bioorg Med Chem Lett 19: 6557-60 (2009)
Osaka Prefecture University
(1-(4-(Naphthalen-2-yl)pyrimidin-2-yl)piperidin-4-yl)methanamine: a wingless beta-catenin agonist that increases bone formation rate.EBI
J Med Chem 52: 6962-5 (2009)
Wyeth Research
Lorneic acids, trialkyl-substituted aromatic acids from a marine-derived actinomycete.EBI
J Nat Prod 72: 2046-8 (2009)
Nippon Suisan Kaisha
Neuroprotective and cholinergic properties of multifunctional glutamic acid derivatives for the treatment of Alzheimer's disease.EBI
J Med Chem 52: 7249-57 (2009)
Instituto De Quimica Medica (Csic)
Synthesis, structure-activity relationships, and characterization of novel nonsteroidal and selective androgen receptor modulators.EBI
J Med Chem 52: 7186-91 (2009)
Acadia Pharmaceuticals
Discovery and optimization of chromenotriazolopyrimidines as potent inhibitors of the mouse double minute 2-tumor protein 53 protein-protein interaction.EBI
J Med Chem 52: 7044-53 (2009)
Amgen
Heterobiaryl purine derivatives as potent antiproliferative agents: inhibitors of cyclin dependent kinases. Part II.EBI
Bioorg Med Chem Lett 19: 6613-7 (2009)
Amri
Discovery of highly potent and selective type I B-Raf kinase inhibitors.EBI
Bioorg Med Chem Lett 19: 6571-4 (2009)
Wyeth Research
Discovery of the first known small-molecule inhibitors of heme-regulated eukaryotic initiation factor 2alpha (HRI) kinase.EBI
Bioorg Med Chem Lett 19: 6548-51 (2009)
Johnson & Johnson Pharmaceutical Research and Development
Novel thienopyrimidine and thiazolopyrimidine kinase inhibitors with activity against Tie-2 in vitro and in vivo.EBI
Bioorg Med Chem Lett 19: 6670-4 (2009)
Astrazeneca
Synthesis and PKCtheta inhibitory activity of a series of 5-vinyl phenyl sulfonamide-3-pyridinecarbonitriles.EBI
Bioorg Med Chem Lett 19: 6575-7 (2009)
Wyeth Research
Design and synthesis of novel histone deacetylase inhibitor derived from nuclear localization signal peptide.EBI
Bioorg Med Chem Lett 19: 6588-90 (2009)
Georgia Institute of Technology
Nitric oxide-donating carbonic anhydrase inhibitors for the treatment of open-angle glaucoma.EBI
Bioorg Med Chem Lett 19: 6565-70 (2009)
Nicox Research Institute
Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.EBI
Bioorg Med Chem Lett 19: 6604-7 (2009)
Pfizer
Discovery of pyrimidine benzimidazoles as Src-family selective Lck inhibitors. Part II.EBI
Bioorg Med Chem Lett 19: 6691-5 (2009)
Genomics Institute of The Novartis Research Foundation
N-(4-(6,7-Disubstituted-quinolin-4-yloxy)-3-fluorophenyl)-2-oxo-3-phenylimidazolidine-1-carboxamides: a novel series of dual c-Met/VEGFR2 receptor tyrosine kinase inhibitors.EBI
Bioorg Med Chem Lett 19: 6552-6 (2009)
Methylgene
Discovery and SAR of 6-substituted-4-anilinoquinazolines as non-competitive antagonists of mGlu5.EBI
Bioorg Med Chem Lett 19: 6623-6 (2009)
Vanderbilt University Medical Center
Discovery of novel non-peptide inhibitors of BACE-1 using virtual high-throughput screening.EBI
Bioorg Med Chem Lett 19: 6770-4 (2009)
University of Leeds
4-(3-aryloxyaryl)quinoline alcohols are liver X receptor agonists.BDB
Bioorg Med Chem 17: 8086-92 (2009)
Wyeth Research
(4-Piperidinyl)-piperazine: a new platform for acetyl-CoA carboxylase inhibitors.EBI
Bioorg Med Chem Lett 19: 6645-8 (2009)
Taisho Pharmaceutical
New classes of potent and bioavailable human renin inhibitors.EBI
Bioorg Med Chem Lett 19: 6762-5 (2009)
Actelion Pharmaceuticals
Synthesis and evaluation of D-gluco-pyranocyclopropyl amines as potential glucosidase inhibitors.EBI
Bioorg Med Chem Lett 19: 6600-3 (2009)
Leiden University
Novel biphenylcarboxylic acid peroxisome proliferator-activated receptor (PPAR) delta selective antagonists.EBI
Bioorg Med Chem Lett 19: 6595-9 (2009)
The University of Tokyo
Synthesis, spectral characterization and biological evaluation of phosphorylated derivatives of galanthamine.EBI
Eur J Med Chem 45: 203-9 (2010)
Sri Venkateswara University
Identification of lead compounds as antagonists of protein Bcl-xL with a diversity-oriented multidisciplinary approach.EBI
J Med Chem 52: 7856-67 (2009)
Universita Degli Studi Di Salerno
Peptide inhibitors of HIV-1 integrase: from mechanistic studies to improved lead compounds.EBI
Bioorg Med Chem 17: 7635-42 (2009)
The Hebrew University of Jerusalem
Mining biologically-active molecules for inhibitors of fatty acid amide hydrolase (FAAH): identification of phenmedipham and amperozide as FAAH inhibitors.EBI
Bioorg Med Chem Lett 19: 6793-6 (2009)
Renovis
Pentacycle derivatives as cannabinoid CB1 receptor ligands.EBI
Bioorg Med Chem Lett 19: 6632-6 (2009)
Green Cross
Using enzyme assays to evaluate the structure and bioactivity of sponge-derived meroterpenes.EBI
J Nat Prod 72: 1857-63 (2009)
University of California Santa Cruz
Aza-peptidyl Michael acceptor and epoxide inhibitors--potent and selective inhibitors of Schistosoma mansoni and Ixodes ricinus legumains (asparaginyl endopeptidases).EBI
J Med Chem 52: 7192-210 (2009)
Georgia Institute of Technology
Discovery of potent and selective inhibitors of the mammalian target of rapamycin (mTOR) kinase.BDB
J Med Chem 52: 7081-9 (2009)
Wyeth Research
Biaryl purine derivatives as potent antiproliferative agents: inhibitors of cyclin dependent kinases. Part I.EBI
Bioorg Med Chem Lett 19: 6608-12 (2009)
Amri
Synthesis and biological evaluation of heterocyclic ring-substituted maslinic acid derivatives as novel inhibitors of protein tyrosine phosphatase 1B.EBI
Bioorg Med Chem Lett 19: 6618-22 (2009)
East China Normal University
Carbonic anhydrase inhibitors. Characterization and inhibition studies of the most active beta-carbonic anhydrase from Mycobacterium tuberculosis, Rv3588c.EBI
Bioorg Med Chem Lett 19: 6649-54 (2009)
Universit£
Histamine H3 and H4 receptor affinity of branched 3-(1H-imidazol-4-yl)propyl N-alkylcarbamates.EBI
Bioorg Med Chem Lett 19: 6682-5 (2009)
Jagiellonian University Medical College
Evaluation of basic, heterocyclic ring systems as templates for use as potassium competitive acid blockers (pCABs).EBI
Bioorg Med Chem Lett 19: 6813-7 (2009)
Glaxosmithkline
Protein tyrosine phosphatase 1B inhibitors isolated from Morus bombycis.EBI
Bioorg Med Chem Lett 19: 6759-61 (2009)
Korea Research Institute of Bioscience and Biotechnology
Application of desirability-based multi(bi)-objective optimization in the design of selective arylpiperazine derivates for the 5-HT1A serotonin receptor.EBI
Eur J Med Chem 44: 5045-54 (2009)
University of Porto
18F stilbenes and styrylpyridines for PET imaging of A beta plaques in Alzheimer's disease: a miniperspective.EBI
J Med Chem 53: 933-41 (2010)
University of Pennsylvania
Lipophilic 2,5-disubstituted pyrroles from the marine sponge Mycale sp. inhibit mitochondrial respiration and HIF-1 activation.EBI
J Nat Prod 72: 1927-36 (2009)
University of Mississippi
The design, synthesis and potential utility of fluorescence probes that target DFG-out conformation of p38alpha for high throughput screening binding assay.BDB
Chem Biol Drug Des 74: 547-59 (2009)
Pfizer
Inactivation of acetylcholinesterase by various fluorophores.BDB
J Enzyme Inhib Med Chem 25: 116-20 (2010)
The University of Montana
14beta-Arylpropiolylamino-17-cyclopropylmethyl-7,8-dihydronormorphinones and related opioids. Further examples of pseudoirreversible mu opioid receptor antagonists.EBI
J Med Chem 52: 6926-30 (2009)
University of Bristol
Discovery of 3H-benzo[4,5]thieno[3,2-d]pyrimidin-4-ones as potent, highly selective, and orally bioavailable inhibitors of the human protooncogene proviral insertion site in moloney murine leukemia virus (PIM) kinases.BDB
J Med Chem 52: 6621-36 (2009)
Abbott Laboratories
Exploring the importance of piperazine N-atoms for sigma(2) receptor affinity and activity in a series of analogs of 1-cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine (PB28).EBI
J Med Chem 52: 7817-28 (2009)
Universita Degli Studi Di Bari
MK-7009, a potent and selective inhibitor of hepatitis C virus NS3/4A protease.EBI
Antimicrob Agents Chemother 54: 305-11 (2009)
Merck Research Laboratories
Hepatitis C virus NS3 protease is activated by low concentrations of protease inhibitors.BDB
Biochemistry 48: 11592-602 (2009)
Uppsala University
Cytotoxic xanthone constituents of the stem bark of Garcinia mangostana (mangosteen).EBI
J Nat Prod 72: 2028-31 (2009)
The Ohio State University
Tea catechins inhibit hepatocyte growth factor receptor (MET kinase) activity in human colon cancer cells: kinetic and molecular docking studies.EBI
J Med Chem 52: 6543-5 (2009)
Oregon State University
Synthesis and biological evaluation of 2-alkynyl-N6-methyl-5'-N-methylcarboxamidoadenosine derivatives as potent and highly selective agonists for the human adenosine A3 receptor.EBI
J Med Chem 52: 7897-900 (2009)
University of Camerino
Benzothiazoles as Rho-associated kinase (ROCK-II) inhibitors.EBI
Bioorg Med Chem Lett 19: 6686-90 (2009)
Translational Research Institute and Department of Molecular Therapeutics
Evaluation of substituted 6-arylquinazolin-4-amines as potent and selective inhibitors of cdc2-like kinases (Clk).EBI
Bioorg Med Chem Lett 19: 6700-5 (2009)
National Human Genome Research Institute
1,2-Diamines as inhibitors of co-activator associated arginine methyltransferase 1 (CARM1).EBI
Bioorg Med Chem Lett 19: 6725-32 (2009)
Methylgene
Design, synthesis and biological evaluation of a bivalent micro opiate and adenosine A1 receptor antagonist.EBI
Bioorg Med Chem Lett 19: 6736-9 (2009)
Aix-Marseille Universit£
Structure-based design, synthesis and in vitro characterization of potent 17beta-hydroxysteroid dehydrogenase type 1 inhibitors based on 2-substitutions of estrone and D-homo-estrone.EBI
Bioorg Med Chem Lett 19: 6740-4 (2009)
Institute of Experimental Genetics
Discovery of colon tumor cell growth inhibitory agents through a combinatorial approach.EBI
Eur J Med Chem 45: 90-7 (2010)
German University In Cairo
3,4-Dihydropyrimido(1,2-a)indol-10(2H)-ones as potent non-peptidic inhibitors of caspase-3.BDB
Bioorg Med Chem 17: 7755-68 (2009)
Wyeth Research
Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.BDB
Bioorg Med Chem 17: 7802-15 (2009)
Wyeth Research
Design, synthesis and biological evaluation of novel thiazole derivatives as potent FabH inhibitors.EBI
Bioorg Med Chem Lett 19: 6750-4 (2009)
Nanjing University
2-Benzimidazolyl-9-(chroman-4-yl)-purinone derivatives as JAK3 inhibitors.EBI
Bioorg Med Chem Lett 19: 6788-92 (2009)
Ligand Pharmaceuticals
Heterocyclic 1,7-disubstituted indole sulfonamides are potent and selective human EP3 receptor antagonists.EBI
Bioorg Med Chem Lett 19: 6797-800 (2009)
Decode Chemistry
Lead optimization and structure-based design of potent and bioavailable deoxycytidine kinase inhibitors.EBI
Bioorg Med Chem Lett 19: 6784-7 (2009)
Lexicon Pharmaceuticals
Cytotoxic and PTP1B inhibitory activities from Erythrina abyssinica.EBI
Bioorg Med Chem Lett 19: 6745-9 (2009)
Chosun University
5-Fluorocytosine derivatives as inhibitors of deoxycytidine kinase.EBI
Bioorg Med Chem Lett 19: 6780-3 (2009)
Lexicon Pharmaceuticals
Total synthesis of (-)-uniflorine A.EBI
J Nat Prod 72: 2058-60 (2009)
Universit£
Discovery and optimization of substituted 1-(1-phenyl-1H-pyrazol-3-yl)methanamines as potent and efficacious type II calcimimetics.EBI
J Med Chem 52: 6535-8 (2009)
Amgen
Crystal structure of 3-isopropylmalate dehydrogenase in complex with NAD(+) and a designed inhibitor.EBI
Bioorg Med Chem 17: 7789-94 (2009)
Tokyo Institute of Technology
The design of potent and selective inhibitors of DPP-4: optimization of ADME properties by amide replacements.EBI
Bioorg Med Chem Lett 19: 6340-5 (2009)
Santhera Pharmaceuticals (Switzerland)
2'-Fluorosugar analogues of the highly potent anti-varicella-zoster virus bicyclic nucleoside analogue (BCNA) Cf 1743.EBI
Bioorg Med Chem Lett 19: 6264-7 (2009)
Cardiff University
Novel, potent, and selective quinoxaline-based 5-HT(3) receptor ligands. 1. Further structure-activity relationships and pharmacological characterization.EBI
J Med Chem 52: 6946-50 (2009)
European Research Centre For Drug Discovery and Development (Natsyndrugs)
New insights into the SAR and binding modes of bis(hydroxyphenyl)thiophenes and -benzenes: influence of additional substituents on 17beta-hydroxysteroid dehydrogenase type 1 (17beta-HSD1) inhibitory activity and selectivity.EBI
J Med Chem 52: 6724-43 (2009)
Saarland University
Stereoselective behavior of the functional diltiazem analogue 1-[(4-chlorophenyl)sulfonyl]-2-(2-thienyl)pyrrolidine, a new L-type calcium channel blocker.EBI
J Med Chem 52: 6637-48 (2009)
Universita Degli Studi Di Perugia
Novel class of LIM-kinase 2 inhibitors for the treatment of ocular hypertension and associated glaucoma.EBI
J Med Chem 52: 6515-8 (2009)
Lexicon Pharmaceuticals
Chemical validation of trypanothione synthetase: a potential drug target for human trypanosomiasis.BDB
J Biol Chem 284: 36137-45 (2009)
University of Dundee
S-glycosyl primary sulfonamides--a new structural class for selective inhibition of cancer-associated carbonic anhydrases.EBI
J Med Chem 52: 6421-32 (2009)
Griffith University
Structure-guided design of potent and selective pyrimidylpyrrole inhibitors of extracellular signal-regulated kinase (ERK) using conformational control.BDB
J Med Chem 52: 6362-8 (2009)
Vertex Pharmaceuticals
Structure-based design of DevR inhibitor active against nonreplicating Mycobacterium tuberculosis.EBI
J Med Chem 52: 6324-34 (2009)
Indian Institute of Medical Sciences
Discovery of 3-(1H-indol-3-yl)-4-[2-(4-methylpiperazin-1-yl)quinazolin-4-yl]pyrrole-2,5-dione (AEB071), a potent and selective inhibitor of protein kinase C isotypes.BDB
J Med Chem 52: 6193-6 (2009)
Novartis
Preparation and structural, biochemical, and pharmaceutical characterizations of bile acid-modified long-acting exendin-4 derivatives.EBI
J Med Chem 52: 6889-96 (2009)
Sungkyunkwan University
New selective phosphodiesterase 4D inhibitors differently acting on long, short, and supershort isoforms.EBI
J Med Chem 52: 6546-57 (2009)
University of Genoa
Agonist vs antagonist behavior of delta opioid peptides containing novel phenylalanine analogues in place of Tyr(1).EBI
J Med Chem 52: 6941-5 (2009)
Clinical Research Institute of Montreal
A fragment-based approach to probing adenosine recognition sites by using dynamic combinatorial chemistry.BDB
Chembiochem 10: 2772-9 (2009)
University of Cambridge
Carbonic anhydrase inhibitors: glycosylsulfanilamides act as subnanomolar inhibitors of the human secreted isoform VI.BDB
Chem Biol Drug Des 74: 636-9 (2009)
Institut Des BiomolÉCules Max Mousseron (Ibmm)
Synthesis and biological evaluation of 17beta-hydroxysteroid dehydrogenase type 1 (17beta-HSD1) inhibitors based on a thieno[2,3-d]pyrimidin-4(3H)-one core.EBI
J Med Chem 52: 6660-71 (2009)
Fin-00014 University of Helsinki
Aspergillusol A, an alpha-glucosidase inhibitor from the marine-derived fungus Aspergillus aculeatus.EBI
J Nat Prod 72: 2049-52 (2009)
Institute and The Center For Environmental Health
Synthesis and radiopharmacological investigation of 3-[4'-[(18)F]fluorobenzylidene]indolin-2-one as possible tyrosine kinase inhibitor.EBI
Bioorg Med Chem 17: 7732-42 (2009)
Institute of Radiopharmacy
Structure-based virtual screening approach to the discovery of novel inhibitors of factor-inhibiting HIF-1: identification of new chelating groups for the active-site ferrous ion.EBI
Bioorg Med Chem 17: 7769-74 (2009)
Sejong University
1,3,4-Oxadiazole-2(3H)-thione and its analogues: a new class of non-competitive nucleotide pyrophosphatases/phosphodiesterases 1 inhibitors.EBI
Bioorg Med Chem 17: 7816-22 (2009)
University of Karachi
Inhibitors of bacterial N-succinyl-L,L-diaminopimelic acid desuccinylase (DapE) and demonstration of in vitro antimicrobial activity.EBI
Bioorg Med Chem Lett 19: 6350-2 (2009)
Loyola University
Novel N-hydroxybenzamide-based HDAC inhibitors with branched CAP group.EBI
Bioorg Med Chem Lett 19: 6284-8 (2009)
China Pharmaceutical University
Synthesis and biological evaluation of p38alpha kinase-targeting dialkynylimidazoles.EBI
Bioorg Med Chem Lett 19: 6293-7 (2009)
The University of Texas At Austin
Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.EBI
J Med Chem 52: 6768-81 (2009)
Research Triangle Institute
Antagonists of the calcium receptor. 2. Amino alcohol-based parathyroid hormone secretagogues.EBI
J Med Chem 52: 6599-605 (2009)
Glaxosmithkline
Discovery and validation of a series of aryl sulfonamides as selective inhibitors of tissue-nonspecific alkaline phosphatase (TNAP).EBI
J Med Chem 52: 6919-25 (2009)
Institute For Medical Research
Structure-activity relationships of 9-substituted-9-dihydroerythromycin-based motilin agonists: optimizing for potency and safety.EBI
J Med Chem 52: 6851-9 (2009)
Kosan Biosciences
Discovery and preclinical evaluation of [4-[[1-(3-fluorophenyl)methyl]-1H-indazol-5-ylamino]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl]carbamic acid, (3S)-3-morpholinylmethyl ester (BMS-599626), a selective and orally efficacious inhibitor of human epidermal growth factor receptor 1 and 2 kinases.EBI
J Med Chem 52: 6527-30 (2009)
Bristol-Myers Squibb Research and Development
Antimalarial and antitrypanosomal activity of a series of amide and sulfonamide derivatives of a 2,5-diaminobenzophenone.EBI
Bioorg Med Chem 17: 7690-7 (2009)
Philipps-Universit£T Marburg
Removal of the 20-methyl group from 2-methylene-19-nor-(20S)-1alpha,25-dihydroxyvitamin D(3) (2MD) selectively eliminates bone calcium mobilization activity.EBI
Bioorg Med Chem 17: 7658-69 (2009)
University of Wisconsin-Madison
Identification of iminooxothiazolidines as secreted frizzled related protein-1 inhibitors.EBI
Bioorg Med Chem Lett 19: 6337-9 (2009)
Wyeth Research
Discovery and optimization of potent and selective triazolopyridazine series of c-Met inhibitors.EBI
Bioorg Med Chem Lett 19: 6307-12 (2009)
Amgen
Design and synthesis of a simplified inhibitor for XIAP-BIR3 domain.EBI
Bioorg Med Chem Lett 19: 6413-8 (2009)
Institute For Medical Research
Syntheses of aminoalcohol-derived macrocycles leading to a small-molecule binder to and inhibitor of Sonic Hedgehog.EBI
Bioorg Med Chem Lett 19: 6319-25 (2009)
Massachusetts General Hospital
Substituted 2-aminothiopen-derivatives: a potential new class of GluR6-antagonists.EBI
Eur J Med Chem 45: 69-77 (2010)
Universit£T Leipzig
Optimization of azepanone calcitonin gene-related peptide (CGRP) receptor antagonists: development of novel spiropiperidines.EBI
Bioorg Med Chem Lett 19: 6368-72 (2009)
Merck Research Laboratories
Rapid access towards follow-up NOP receptor agonists using a knowledge based approach.EBI
Bioorg Med Chem Lett 19: 6441-6 (2009)
Schering-Plough Research Institute
Identification of a critical residue in the transmembrane domain 2 of tachykinin neurokinin 3 receptor affecting the dissociation kinetics and antagonism mode of osanetant (SR 142801) and piperidine-based structures.EBI
J Med Chem 52: 7103-12 (2009)
F. Hoffmann-La Roche
Phenoxy herbicides and fibrates potently inhibit the human chemosensory receptor subunit T1R3.EBI
J Med Chem 52: 6931-5 (2009)
Mount Sinai School of Medicine
Synthesis and biological evaluation of pyrrolopyridazine derivatives as novel HER-2 tyrosine kinase inhibitors.EBI
Bioorg Med Chem Lett 19: 6437-40 (2009)
Shanghai Hengrui Pharmaceuticals
Scaffold-based design and synthesis of potent N-type calcium channel blockers.EBI
Bioorg Med Chem Lett 19: 6467-72 (2009)
University of Calgary
Anthranilic sulfonamide CCK1/CCK2 dual receptor antagonists II: tuning of receptor selectivity and in vivo efficacy.EBI
Bioorg Med Chem Lett 19: 6376-8 (2009)
Johnson & Johnson Pharmaceutical Research and Development
Inhibition of the dimerization and active site of HIV-1 protease by secondary metabolites from the Vietnamese mushroom Ganoderma colossum.EBI
J Nat Prod 72: 2019-23 (2009)
University of Toyama
Toward a rational design of multitarget-directed antioxidants: merging memoquin and lipoic acid molecular frameworks.EBI
J Med Chem 52: 7883-6 (2009)
University of Bologna
Development of a highly water-soluble peptide-based human neutrophil elastase inhibitor; AE-3763 for treatment of acute organ injury.BDB
Bioorg Med Chem 17: 7477-86 (2009)
Dainippon Sumitomo Pharma
Design and synthesis of cell potent BACE-1 inhibitors: structure-activity relationship of P1' substituents.EBI
Bioorg Med Chem Lett 19: 6386-91 (2009)
Elan Pharmaceuticals
Pyranocoumarins: a new class of anti-hyperglycemic and anti-dyslipidemic agents.EBI
Bioorg Med Chem Lett 19: 6447-51 (2009)
Central Drug Research Institute
Anthranilic sulfonamide CCK1/CCK2 dual receptor antagonists I: discovery of CCKR1 selectivity in a previously CCKR2-selective lead series.EBI
Bioorg Med Chem Lett 19: 6373-5 (2009)
Johnson & Johnson Pharmaceutical Research and Development
Knowledge-based characterization of similarity relationships in the human protein-tyrosine phosphatase family for rational inhibitor design.EBI
J Med Chem 52: 6649-59 (2009)
University of Miami
Discovery of a novel class of potent coumarin monoamine oxidase B inhibitors: development and biopharmacological profiling of 7-[(3-chlorobenzyl)oxy]-4-[(methylamino)methyl]-2H-chromen-2-one methanesulfonate (NW-1772) as a highly potent, selective, reversible, and orally active monoamine oxidase B EBI
J Med Chem 52: 6685-706 (2009)
Universita Degli Studi Di Bari
Active site ring-opening of a thiirane moiety and picomolar inhibition of gelatinases.BDB
Chem Biol Drug Des 74: 527-34 (2009)
University of Notre Dame
Chemical library screens targeting an HIV-1 accessory factor/host cell kinase complex identify novel antiretroviral compounds.BDB
ACS Chem Biol 4: 939-47 (2009)
University of Pittsburgh
7-Hydroxy-benzopyran-4-one derivatives: a novel pharmacophore of peroxisome proliferator-activated receptor alpha and -gamma (PPARalpha and gamma) dual agonists.EBI
J Med Chem 52: 6835-50 (2009)
The University of Sydney
1,1'-Disubstituted ferrocenes as molecular hinges in mono- and bivalent dopamine receptor ligands.EBI
J Med Chem 52: 6860-70 (2009)
Friedrich-Alexander University
The effects of C-terminal modifications on the opioid activity of [N-benzylTyr(1)]dynorphin A-(1-11) analogues.EBI
J Med Chem 52: 6814-21 (2009)
University of Kansas
Long-lasting enfuvirtide carrier pentasaccharide conjugates with potent anti-human immunodeficiency virus type 1 activity.EBI
Antimicrob Agents Chemother 54: 134-42 (2009)
Endotis Pharma
Synthesis and in vitro evaluation of pteridine analogues as monoamine oxidase B and nitric oxide synthase inhibitors.EBI
Bioorg Med Chem 17: 7523-30 (2009)
North-West University
Synthesis, molecular docking and biological evaluation of metronidazole derivatives as potent Helicobacter pylori urease inhibitors.EBI
Bioorg Med Chem 17: 7531-6 (2009)
Nanjing University
Discovery and optimization of CRTH2 and DP dual antagonists.EBI
Bioorg Med Chem Lett 19: 6419-23 (2009)
Amgen
Design of novel alpha7-subtype-preferring nicotinic acetylcholine receptor agonists: application of docking and MM-PBSA computational approaches, synthetic and pharmacological studies.EBI
Bioorg Med Chem Lett 19: 6353-7 (2009)
Universit£
The discovery and optimisation of benzazepine sulfonamide and sulfones as potent agonists of the motilin receptor.EBI
Bioorg Med Chem Lett 19: 6452-8 (2009)
Glaxosmithkline
Phosphorylated hydroxyethylamines as novel inhibitors of the bacterial cell wall biosynthesis enzymes MurC to MurF.BDB
Bioorg Chem 37: 217-22 (2009)
University of Ljubljana
Discovery of selective nonpeptidergic neuropeptide FF2 receptor agonists.EBI
J Med Chem 52: 6511-4 (2009)
Acadia Pharmaceuticals
Structure-based drug design identifies novel LPA3 antagonists.EBI
Bioorg Med Chem 17: 7457-64 (2009)
The University of Memphis
Synthesis of isoquinolinone-based tetracycles as poly (ADP-ribose) polymerase-1 (PARP-1) inhibitors.EBI
Bioorg Med Chem 17: 7537-41 (2009)
Sookmyung Women'S University
Synthesis and structure-activity relationships of pyrazolodiazepine derivatives as human P2X7 receptor antagonists.EBI
Bioorg Med Chem Lett 19: 6053-8 (2009)
Institute of Science & Technology
N,N-Diethyl-4-[(3-hydroxyphenyl)(piperidin-4-yl)amino] benzamide derivatives: the development of diaryl amino piperidines as potent delta opioid receptor agonists with in vivo anti-nociceptive activity in rodent models.EBI
Bioorg Med Chem Lett 19: 5994-8 (2009)
Astrazeneca R & D Montr£Al
Delta agonist hydroxy bioisosteres: the discovery of 3-((1-benzylpiperidin-4-yl){4-[(diethylamino)carbonyl]phenyl}amino)benzamide with improved delta agonist activity and in vitro metabolic stability.EBI
Bioorg Med Chem Lett 19: 5999-6003 (2009)
Astrazeneca R & D Montr£Al
Insights into the inhibition of xanthine oxidase by curcumin.EBI
Bioorg Med Chem Lett 19: 5990-3 (2009)
Shandong University of Technology
Triazine and pyrimidine based ROCK inhibitors with efficacy in spontaneous hypertensive rat model.EBI
Bioorg Med Chem Lett 19: 6027-31 (2009)
Ligand Pharmaceuticals
Tetrahydroquinoline sulfonamides as vasopressin 1b receptor antagonists.EBI
Bioorg Med Chem Lett 19: 6018-22 (2009)
Schering-Plough Research Institute
Evaluation of triazolamers as active site inhibitors of HIV-1 protease.EBI
Bioorg Med Chem Lett 19: 6023-6 (2009)
New York University
Discovery of 4-functionalized phenyl-O-beta-D-glycosides as a new class of mushroom tyrosinase inhibitors.EBI
Bioorg Med Chem Lett 19: 6157-60 (2009)
Sun Yat-Sen University
Discovery of novel sphingosine kinase 1 inhibitors.EBI
Bioorg Med Chem Lett 19: 6119-21 (2009)
Genzyme
Effect of the structure of adenosine mimic of bisubstrate-analog inhibitors on their activity towards basophilic protein kinases.EBI
Bioorg Med Chem Lett 19: 6098-101 (2009)
University of Tartu
QSAR modeling of photosynthesis-inhibiting nostoclide derivatives.EBI
Pest Manag Sci 66: 196-202 (2010)
Federal University of Vi£Osa
Synthesis and binding affinity of potential atypical antipsychotics with the tetrahydroquinazolinone motif.EBI
Bioorg Med Chem Lett 19: 6059-62 (2009)
Universidad De Santiago De Compostela
Piperazinyl-glutamate-pyrimidines as potent P2Y12 antagonists for inhibition of platelet aggregation.EBI
Bioorg Med Chem Lett 19: 6148-56 (2009)
Pfizer
Carbonic anhydrase II-induced selection of inhibitors from a dynamic combinatorial library of Schiff's bases.EBI
Bioorg Med Chem Lett 19: 6014-7 (2009)
Enscm-Umii-Cnrs 5635
Synthesis and anti-HIV-1 integrase activity of modified dinucleotides.EBI
Eur J Med Chem 44: 5029-44 (2009)
Affiliated With The University of Orl£Ans and With Inserm Rue Charles Sadron
Evaluation of spirocyclic 3-(3-fluoropropyl)-2-benzofurans as sigma1 receptor ligands for neuroimaging with positron emission tomography.EBI
J Med Chem 52: 6062-72 (2009)
Institut F£R Pharmazeutische Und Medizinische Chemie Der Westf£Lischen Wilhelms-Universit£T M£Nster
Hydroxamic acids as a novel family of serine racemase inhibitors: mechanistic analysis reveals different modes of interaction with the pyridoxal-5'-phosphate cofactor.EBI
J Med Chem 52: 6032-41 (2009)
Institute of Organic Chemistry and Biochemistry of The Ascr
Modeling, synthesis and biological evaluation of potential retinoid X receptor (RXR) selective agonists: novel analogues of 4-[1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)ethynyl]benzoic acid (bexarotene).EBI
J Med Chem 52: 5950-66 (2009)
Arizona State University
Synthesis of 1,1-[1-naphthyloxy-2-thiophenyl]-2-methylaminomethylcyclopropanes and their evaluation as inhibitors of serotonin, norepinephrine, and dopamine transporters.EBI
J Med Chem 52: 5872-9 (2009)
Oregon State University
Pyridine analogues of nimesulide: design, synthesis, and in vitro and in vivo pharmacological evaluation as promising cyclooxygenase 1 and 2 inhibitors.EBI
J Med Chem 52: 5864-71 (2009)
University of Liege
RNase H active site inhibitors of human immunodeficiency virus type 1 reverse transcriptase: design, biochemical activity, and structural information.BDB
J Med Chem 52: 5781-4 (2009)
Gilead Sciences
Kinase inhibitor data modeling and de novo inhibitor design with fragment approaches.EBI
J Med Chem 52: 6456-66 (2009)
Eli Lilly
Synthesis and biological evaluation of 2-heteroarylthioalkanoic acid analogues of clofibric acid as peroxisome proliferator-activated receptor alpha agonists.EBI
J Med Chem 52: 6224-32 (2009)
Universit£
Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists.EBI
J Med Chem 52: 6297-313 (2009)
University of Regensburg
Synthesis, kinase inhibitory potencies, and in vitro antiproliferative evaluation of new Pim kinase inhibitors.EBI
J Med Chem 52: 6369-81 (2009)
Clermont Universit£
Rational design and synthesis of potent dibenzazepine motifs as beta-secretase inhibitors.EBI
J Med Chem 52: 6484-8 (2009)
University of Sharjah
Structure-based optimization of potent and selective inhibitors of the tyrosine kinase erythropoietin producing human hepatocellular carcinoma receptor B4 (EphB4).EBI
J Med Chem 52: 6433-46 (2009)
University of Zurich
Pentapeptides displaying mu opioid receptor agonist and delta opioid receptor partial agonist/antagonist properties.EBI
J Med Chem 52: 7724-31 (2009)
University of Michigan
Further studies on arylpiperazinyl alkyl pyridazinones: discovery of an exceptionally potent, orally active, antinociceptive agent in thermally induced pain.EBI
J Med Chem 52: 7397-409 (2009)
Dipartimento Di Scienze Farmaceutiche
Benzoxazole piperidines as selective and potent somatostatin receptor subtype 5 antagonists.EBI
Bioorg Med Chem Lett 19: 6106-13 (2009)
F. Hoffmann-La Roche
Nanomolar potency pyrimido-pyrrolo-quinoxalinedione CFTR inhibitor reduces cyst size in a polycystic kidney disease model.EBI
J Med Chem 52: 6447-55 (2009)
University of California
Novel L-xylose derivatives as selective sodium-dependent glucose cotransporter 2 (SGLT2) inhibitors for the treatment of type 2 diabetes.EBI
J Med Chem 52: 6201-4 (2009)
Lexicon Pharmaceuticals
Chemical genomics in Escherichia coli identifies an inhibitor of bacterial lipoprotein targeting.EBI
Nat Chem Biol 5: 849-56 (2009)
Mcmaster University
Synthesis and evaluation of non-hydrolyzable D-mannose 6-phosphate surrogates reveal 6-deoxy-6-dicarboxymethyl-D-mannose as a new strong inhibitor of phosphomannose isomerases.EBI
Bioorg Med Chem 17: 7100-7 (2009)
Univ Paris-Sud
Synthesis and evaluation of novel alpha-heteroaryl-phenylpropanoic acid derivatives as PPARalpha/gamma dual agonists.BDB
Bioorg Med Chem 17: 7113-25 (2009)
Pfizer
Synthesis and biological evaluation of flavan-3-ol derivatives as positive modulators of GABAA receptors.EBI
Bioorg Med Chem 17: 7156-73 (2009)
The University of Sydney
Pyrazole-based arylalkyne cathepsin S inhibitors. Part II: optimization of cellular potency.EBI
Bioorg Med Chem Lett 19: 6135-9 (2009)
Johnson & Johnson Pharmaceutical Research and Development
Structure-activity relationship study of EphB3 receptor tyrosine kinase inhibitors.EBI
Bioorg Med Chem Lett 19: 6122-6 (2009)
Harvard Medical School
Analogs of a 4-aminothieno[2,3-d]pyrimidine lead (QB13) as modulators of P-glycoprotein substrate specificity.EBI
Bioorg Med Chem Lett 19: 6102-5 (2009)
University of Bonn
Special ergolines are highly selective, potent antagonists of the chemokine receptor CXCR3: discovery, characterization and preliminary SAR of a promising lead.EBI
Bioorg Med Chem Lett 19: 6185-8 (2009)
Novartis Institutes For Biomedical Research
Thiazolidinedione derivatives as PTP1B inhibitors with antihyperglycemic and antiobesity effects.EBI
Bioorg Med Chem Lett 19: 6161-5 (2009)
Inha University
Discovery of 3-(2-cyano-4-pyridyl)-5-(4-pyridyl)-1,2,4-triazole, FYX-051 - a xanthine oxidoreductase inhibitor for the treatment of hyperuricemia [corrected]EBI
Bioorg Med Chem Lett 19: 6225-9 (2009)
Fuji Yakuhin
Design, synthesis, and preliminary studies of the activity of novel derivatives of N-cinnamoyl-L-aspartic acid as inhibitors of aminopeptidase N/CD13.EBI
Bioorg Med Chem 17: 7398-404 (2009)
Shandong University
Optimising metabolic stability in lipophilic chemical space: the identification of a metabolically stable pyrazolopyrimidine CRF-1 receptor antagonist.EBI
Bioorg Med Chem Lett 19: 6144-7 (2009)
Pfizer
Isolation of the protein tyrosine phosphatase 1B inhibitory metabolite from the marine-derived fungus Cosmospora sp. SF-5060.EBI
Bioorg Med Chem Lett 19: 6095-7 (2009)
Silla University
Synthesis and evaluation of benzo[b]thiophene derivatives as inhibitors of alkaline phosphatases.EBI
Bioorg Med Chem 17: 7290-300 (2009)
Universit£
Discovery and structure-activity relationship analysis of Staphylococcus aureus sortase A inhibitors.BDB
Bioorg Med Chem 17: 7174-85 (2009)
University of California Los Angeles
Glucose-based spiro-isoxazolines: a new family of potent glycogen phosphorylase inhibitors.BDB
Bioorg Med Chem 17: 7368-80 (2009)
Universite De Lyon
Development of new and selective Trypanosoma cruzi trans-sialidase inhibitors from sulfonamide chalcones and their derivatives.BDB
Chembiochem 10: 2475-9 (2009)
University of British Columbia
Discovery of a 2,4-disubstituted pyrrolo[1,2-f][1,2,4]triazine inhibitor (BMS-754807) of insulin-like growth factor receptor (IGF-1R) kinase in clinical development.EBI
J Med Chem 52: 7360-3 (2009)
Bristol-Myers Squibb
Pochonicine, a polyhydroxylated pyrrolizidine alkaloid from fungus Pochonia suchlasporia var. suchlasporia TAMA 87 as a potent beta-N-acetylglucosaminidase inhibitor.EBI
Bioorg Med Chem 17: 7248-53 (2009)
Okayama University
2-Oxoglutarate analogue inhibitors of prolyl hydroxylase domain 2.EBI
Bioorg Med Chem Lett 19: 6192-5 (2009)
University of Oxford
New 2-aryloxy-3-phenyl-propanoic acids as peroxisome proliferator-activated receptors alpha/gamma dual agonists with improved potency and reduced adverse effects on skeletal muscle function.EBI
J Med Chem 52: 6382-93 (2009)
Universit£
Discovery of azetidinyl ketolides for the treatment of susceptible and multidrug resistant community-acquired respiratory tract infections.EBI
J Med Chem 52: 7446-57 (2009)
Pfizer
Crystallographic study of a novel subnanomolar inhibitor provides insight on the binding interactions of alkenyldiarylmethanes with human immunodeficiency virus-1 reverse transcriptase.EBI
J Med Chem 52: 6467-73 (2009)
Purdue University
2-{3-[4-(Alkylsulfinyl)phenyl]-1-benzofuran-5-yl}-5-methyl-1,3,4-oxadiazole derivatives as novel inhibitors of glycogen synthase kinase-3beta with good brain permeability.EBI
J Med Chem 52: 6270-86 (2009)
Takeda Pharmaceutical
Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.EBI
J Med Chem 52: 6347-61 (2009)
Universit£
2,4-Diaminopyrimidines as histamine H4 receptor ligands--Scaffold optimization and pharmacological characterization.EBI
Bioorg Med Chem 17: 7186-96 (2009)
Johann Wolfgang Goethe University
Carbonic anhydrase inhibitors. Diazenylbenzenesulfonamides are potent and selective inhibitors of the tumor-associated isozymes IX and XII over the cytosolic isoforms I and II.BDB
Bioorg Med Chem 17: 7093-9 (2009)
Universita Degli Studi Di Firenze
Novel non-peptidic vinylsulfones targeting the S2 and S3 subsites of parasite cysteine proteases.EBI
Bioorg Med Chem Lett 19: 6218-21 (2009)
University of California
Pyrazole-based cathepsin S inhibitors with arylalkynes as P1 binding elements.BDB
Bioorg Med Chem Lett 19: 6131-4 (2009)
Johnson & Johnson Pharmaceutical
Synthesis and structure-activity relationships of 2-(1,4'-bipiperidin-1'-yl)thiazolopyridine as H3 receptor antagonists.EBI
Bioorg Med Chem Lett 19: 6176-80 (2009)
Schering-Plough Research Institute
Inhibitor profiling of the Pseudomonas aeruginosa virulence factor LasB using N-alpha mercaptoamide template-based inhibitors.EBI
Bioorg Med Chem Lett 19: 6230-2 (2009)
Queen'S University of Belfast
Pyrimidine-based antagonists of h-MCH-R1 derived from ATC0175: in vitro profiling and in vivo evaluation.EBI
Bioorg Med Chem Lett 19: 6166-71 (2009)
Arena Pharmaceuticals
Potent inhibitors of beta-tryptase and human leukocyte elastase based on the MCoTI-II scaffold.EBI
J Med Chem 52: 6197-200 (2009)
Imperial College
Potent and selective steroidal inhibitors of 17beta-hydroxysteroid dehydrogenase type 7, an enzyme that catalyzes the reduction of the key hormones estrone and dihydrotestosterone.EBI
J Med Chem 52: 7488-502 (2009)
Chuq (Chul) Research Center and Laval University
p38alpha mitogen-activated protein kinase inhibitors: optimization of a series of biphenylamides to give a molecule suitable for clinical progression.EBI
J Med Chem 52: 6257-69 (2009)
Glaxosmithkline
An approach to the site-selective diversification of apoptolidin A with peptide-based catalysts.EBI
J Nat Prod 72: 1864-9 (2009)
Yale University
Structure-guided development of selective TbcatB inhibitors.EBI
J Med Chem 52: 6489-93 (2009)
University of California
Inhibitors of human immunodeficiency virus type 1 (HIV-1) attachment. 5. An evolution from indole to azaindoles leading to the discovery of 1-(4-benzoylpiperazin-1-yl)-2-(4,7-dimethoxy-1H-pyrrolo[2,3-c]pyridin-3-yl)ethane-1,2-dione (BMS-488043), a drug candidate that demonstrates antiviral activityEBI
J Med Chem 52: 7778-87 (2009)
Bristol-Myers Squibb Research and Development
Synthesis and structure-activity relationships of dehydroaltenusin derivatives as selective DNA polymerase alpha inhibitors.BDB
Bioorg Med Chem 17: 7227-38 (2009)
Kyoto Prefectural University
Discovery and optimization of novel 4-[(aminocarbonyl)amino]-N-[4-(2-aminoethyl)phenyl]benzenesulfonamide ghrelin receptor antagonists.EBI
Bioorg Med Chem Lett 19: 6237-40 (2009)
Merck Research Laboratories
Synthesis and SAR of 2-phenyl-1-sulfonylaminocyclopropane carboxylates as ADAMTS-5 (Aggrecanase-2) inhibitors.EBI
Bioorg Med Chem Lett 19: 6213-7 (2009)
Central Pharmaceutical Research Institute
Synthesis and in vitro autoradiographic evaluation of a novel high-affinity radioiodinated ligand for imaging brain cannabinoid subtype-1 receptors.EBI
Bioorg Med Chem Lett 19: 6209-12 (2009)
National Institute of Mental Health
PET-compatible endothelin receptor radioligands: synthesis and first in vitro and in vivo studies.EBI
Bioorg Med Chem 17: 7197-208 (2009)
University Hospital M£Nster
Selective inhibitors of the mutant B-Raf pathway: discovery of a potent and orally bioavailable aminoisoquinoline.BDB
J Med Chem 52: 6189-92 (2009)
Amgen
The biological activity and metabolic stability of peptidic bifunctional compounds that are opioid receptor agonists and neurokinin-1 receptor antagonists with a cystine moiety.EBI
Bioorg Med Chem 17: 7337-43 (2009)
University of Arizona
Design, synthesis and evaluation of monovalent ligands for the asialoglycoprotein receptor (ASGP-R).EBI
Bioorg Med Chem 17: 7254-64 (2009)
University of Basel
The discovery and unique pharmacological profile of RO4938581 and RO4882224 as potent and selective GABAA alpha5 inverse agonists for the treatment of cognitive dysfunction.EBI
Bioorg Med Chem Lett 19: 5940-4 (2009)
F. Hoffmann-La Roche
Structure-activity relationship study on alpha1 adrenergic receptor antagonists from beer.EBI
Bioorg Med Chem Lett 19: 5905-8 (2009)
University of Shizuoka and Global Coe Program
Phenylaminopyrimidines as inhibitors of Janus kinases (JAKs).EBI
Bioorg Med Chem Lett 19: 5887-92 (2009)
Cytopia Research
First generation 5-vinyl-3-pyridinecarbonitrile PKCtheta inhibitors.EBI
Bioorg Med Chem Lett 19: 5829-32 (2009)
Wyeth Research
The discovery and optimisation of pyrido[2,3-d]pyrimidine-2,4-diamines as potent and selective inhibitors of mTOR kinase.EBI
Bioorg Med Chem Lett 19: 5950-3 (2009)
Kudos Pharmaceuticals
Synthesis, SAR, and X-ray structure of tricyclic compounds as potent FBPase inhibitors.EBI
Bioorg Med Chem Lett 19: 5909-12 (2009)
Daiichi Sankyo
Synthesis and pharmacological evaluation of sulfamide-based analogues of anandamide.EBI
Eur J Med Chem 44: 4889-95 (2009)
Instituto De Qu£Mica M£Dica
Structure mechanism insights and the role of nitric oxide donation guide the development of oxadiazole-2-oxides as therapeutic agents against schistosomiasis.EBI
J Med Chem 52: 6474-83 (2009)
National Human Genome Research Institute
Benzamide derivatives as dual-action hypoglycemic agents that inhibit glycogen phosphorylase and activate glucokinase.BDB
Bioorg Med Chem 17: 7301-12 (2009)
Shanghai Institutes For Biological Sciences
Indene-based frameworks targeting the 5-HT6 serotonin receptor: ring constraint in indenylsulfonamides using cyclic amines and structurally abbreviated counterparts.BDB
Bioorg Med Chem 17: 7387-97 (2009)
Universitat De Barcelona
Design and synthesis of substituted nicotinamides as inhibitors of soluble epoxide hydrolase.EBI
Bioorg Med Chem Lett 19: 5864-8 (2009)
Boehringer Ingelheim Pharmaceuticals
The replacement of His(4) in angiotensin IV by conformationally constrained residues provides highly potent and selective analogues.EBI
J Med Chem 52: 5612-8 (2009)
Vrije Universiteit Brussel
Aminoimidazoles as potent and selective human beta-secretase (BACE1) inhibitors.EBI
J Med Chem 52: 6314-23 (2009)
Wyeth Research
Physical binding pocket induction for affinity prediction.EBI
J Med Chem 52: 6107-25 (2009)
University of California
Identification of N-(5-tert-butyl-isoxazol-3-yl)-N'-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea dihydrochloride (AC220), a uniquely potent, selective, and efficacious FMS-like tyrosine kinase-3 (FLT3) inhibitor.EBI
J Med Chem 52: 7808-16 (2009)
Ambit Biosciences
Identification and characterization of a small molecule inhibitor of Fatty Acid binding proteins.EBI
J Med Chem 52: 6024-31 (2009)
University of Minnesota
3- and 6-Substituted 2-amino-4,5,6,7-tetrahydrothieno[2,3-c]pyridines as A1 adenosine receptor allosteric modulators and antagonists.EBI
Bioorg Med Chem 17: 7353-61 (2009)
Monash University (Parkville Campus)
The proteoglycan region of the tumor-associated carbonic anhydrase isoform IX acts as anintrinsic buffer optimizing CO2 hydration at acidic pH values characteristic of solid tumors.EBI
Bioorg Med Chem Lett 19: 5825-8 (2009)
Universita Degli Studi Di Firenze
Discovery of N-substituted pyridinones as potent and selective inhibitors of p38 kinase.EBI
Bioorg Med Chem Lett 19: 5851-6 (2009)
Pfizer
Design, synthesis, and X-ray crystal structures of 2,4-diaminofuro[2,3-d]pyrimidines as multireceptor tyrosine kinase and dihydrofolate reductase inhibitors.BDB
Bioorg Med Chem 17: 7324-36 (2009)
Duquesne University
Thienopyrimidine-based P2Y12 platelet aggregation inhibitors.EBI
Bioorg Med Chem Lett 19: 5919-23 (2009)
Pfizer
Discovery of disubstituted phenanthrene imidazoles as potent, selective and orally active mPGES-1 inhibitors.EBI
Bioorg Med Chem Lett 19: 5837-41 (2009)
Merck Frosst Centre For Therapeutic Research
Pyrazole NNRTIs 4: selection of UK-453,061 (lersivirine) as a development candidate.EBI
Bioorg Med Chem Lett 19: 5857-60 (2009)
Pfizer
Tetraiodobenzimidazoles are potent inhibitors of protein kinase CK2.BDB
Bioorg Med Chem 17: 7281-9 (2009)
University of Padova
Phosphoinositide-3-kinase (PI3K) inhibitors: identification of new scaffolds using virtual screening.EBI
Bioorg Med Chem Lett 19: 5842-7 (2009)
University of Auckland
Thienylhalomethylketones: Irreversible glycogen synthase kinase 3 inhibitors as useful pharmacological tools.EBI
Bioorg Med Chem 17: 6914-25 (2009)
Instituto De Qu£Mica M£Dica-Csic
Novel 7H-pyrrolo[2,3-d]pyrimidine derivatives as potent and orally active STAT6 inhibitors.EBI
Bioorg Med Chem 17: 6926-36 (2009)
Astellas Pharma
Allosteric functional switch of neurokinin A-mediated signaling at the neurokinin NK2 receptor: structural exploration.EBI
J Med Chem 52: 5999-6011 (2009)
Umr Uds/Cnrs 7200
Structure-based optimization of arylamides as inhibitors of soluble epoxide hydrolase.EBI
J Med Chem 52: 5880-95 (2009)
Boehringer Ingelheim Pharmaceuticals
Design, synthesis, protein-ligand X-ray structure, and biological evaluation of a series of novel macrocyclic human immunodeficiency virus-1 protease inhibitors to combat drug resistance.BDB
J Med Chem 52: 7689-705 (2009)
Purdue University
Discovery of new inhibitors of resistant Streptococcus pneumoniae penicillin binding protein (PBP) 2x by structure-based virtual screening.EBI
J Med Chem 52: 5926-36 (2009)
Institut De Biologie Structurale Jean-Pierre Ebel (Cea/Cnrs/Ujf)
Synthesis and biological evaluation of novel phthalazinone derivatives as topically active phosphodiesterase 4 inhibitors.EBI
Bioorg Med Chem 17: 6959-70 (2009)
Kyoto 601-8550
Dibenzazecine scaffold rebuilding--is the flexibility always essential for high dopamine receptor affinities?EBI
Bioorg Med Chem 17: 6898-907 (2009)
Friedrich-Schiller-Universit£T Jena
Characterization of the CHK1 allosteric inhibitor binding site.BDB
Biochemistry 48: 9823-30 (2009)
Pfizer
Discovery of 1-[4-(3-chlorophenylamino)-1-methyl-1H-pyrrolo[3,2-c]pyridin-7-yl]-1-morpholin-4-ylmethanone (GSK554418A), a brain penetrant 5-azaindole CB2 agonist for the treatment of chronic pain.EBI
J Med Chem 52: 5785-8 (2009)
Glaxosmithkline
Structure-activity relationships for substrate-based inhibitors of human complement factor B.EBI
J Med Chem 52: 6042-52 (2009)
The University of Queensland
2-Phenylpyrazolo[4,3-d]pyrimidin-7-one as a new scaffold to obtain potent and selective human A3 adenosine receptor antagonists: new insights into the receptor-antagonist recognition.EBI
J Med Chem 52: 7640-52 (2009)
Universit£
Structure-activity relationship and molecular mechanisms of ethyl 2-amino-4-(2-ethoxy-2-oxoethyl)-6-phenyl-4h-chromene-3-carboxylate (sha 14-1) and its analogues.EBI
J Med Chem 52: 5937-49 (2009)
University of Minnesota
Inhibition of serotonin and norepinephrine reuptake and inhibition of phosphodiesterase by multi-target inhibitors as potential agents for depression.EBI
Bioorg Med Chem 17: 6890-7 (2009)
Human Biomolecular Research Institute
Potent biphenyl- and 3-phenyl pyridine-based inhibitors of acetyl-CoA carboxylase.EBI
Bioorg Med Chem Lett 19: 5872-6 (2009)
Bristol-Myers Squibb Research and Development
Design and optimisation of selective serotonin re-uptake inhibitors with high synthetic accessibility: part 2.EBI
Bioorg Med Chem Lett 19: 5893-7 (2009)
Pfizer
Imidazo[1,5-a][1,2,4]-triazolo[1,5-d][1,4]benzodiazepines as potent and highly selective GABAA alpha5 inverse agonists with potential for the treatment of cognitive dysfunction.EBI
Bioorg Med Chem Lett 19: 5958-61 (2009)
F. Hoffmann-La Roche
Amiodarone and its putative metabolites fail to activate wild type hTAAR1.EBI
Bioorg Med Chem Lett 19: 5913-4 (2009)
Rti International
Identification of novel indanylsulfonamide guanylhydrazones as potent 5-HT6 serotonin receptor antagonists.EBI
J Med Chem 52: 6153-7 (2009)
Universitat De Barcelona
Synthesis, conformational analysis, and biological evaluation of 19-nor-vitamin D3 analogues with A-ring modifications.EBI
J Med Chem 52: 6158-62 (2009)
Universidad De Oviedo
5-lipoxygenase-activating protein inhibitors: development of 3-[3-tert-butylsulfanyl-1-[4-(6-methoxy-pyridin-3-yl)-benzyl]-5-(pyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethyl-propionic acid (AM103).EBI
J Med Chem 52: 5803-15 (2009)
Amira Pharmaceuticals
Rapid generation of a high quality lead for transforming growth factor-beta (TGF-beta) type I receptor (ALK5).BDB
J Med Chem 52: 7901-5 (2009)
Astrazeneca
The design and optimization of a series of 2-(pyridin-2-yl)-1H-benzimidazole compounds as allosteric glucokinase activators.EBI
Bioorg Med Chem 17: 7042-51 (2009)
Banyu Tsukuba Research Institute
Design, synthesis and biological evaluations of novel 7-[3-(1-aminocycloalkyl)pyrrolidin-1-yl]-6-desfluoro-8-methoxyquinolones with potent antibacterial activity against multi-drug resistant Gram-positive bacteria.EBI
Bioorg Med Chem 17: 6879-89 (2009)
Daiichi Sankyo
Novel pyridine derivatives as potent and selective CB2 cannabinoid receptor agonists.EBI
Bioorg Med Chem Lett 19: 5931-5 (2009)
Adolor
Augmented photoswitching modulates immune signaling.EBI
Nat Chem Biol 5: 724-6 (2009)
Max Planck Research Unit For Enzymology of Protein Folding
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.EBI
Bioorg Med Chem 17: 6983-92 (2009)
The University of Texas
Identification and characterization of novel sirtuin inhibitor scaffolds.EBI
Bioorg Med Chem 17: 7031-41 (2009)
Institute
Discovery and optimization of potent and selective functional antagonists of the human adenosine A2B receptor.EBI
Bioorg Med Chem Lett 19: 5945-9 (2009)
Vernalis (R&D)
Identification and optimisation of novel and selective small molecular weight kinase inhibitors of mTOR.EBI
Bioorg Med Chem Lett 19: 5898-901 (2009)
Kudos Pharmaceuticals
Nonpeptide urotensin-II receptor antagonists: a new ligand class based on piperazino-phthalimide and piperazino-isoindolinone subunits.EBI
J Med Chem 52: 7432-45 (2009)
Johnson & Johnson Pharmaceutical Research & Development
Carbonic anhydrase inhibitors. Comparison of aliphatic sulfamate/bis-sulfamate adducts with isozymes II and IX as a platform for designing tight-binding, more isoform-selective inhibitors.BDB
J Med Chem 52: 5990-8 (2009)
Cnr
Synthesis and evaluation of 3-(dihydroxyboryl)benzoic acids as D,D-carboxypeptidase R39 inhibitors.EBI
J Med Chem 52: 6097-106 (2009)
University of Oxford
Neuraminidase inhibitory activities of flavonols isolated from Rhodiola rosea roots and their in vitro anti-influenza viral activities.EBI
Bioorg Med Chem 17: 6816-23 (2009)
Korea Research Institute of Bioscience and Biotechnology
Identification of small molecule regulators of the nuclear receptor HNF4alpha based on naphthofuran scaffolds.EBI
Bioorg Med Chem 17: 7021-30 (2009)
Universit£
Structure-based design of novel human Pin1 inhibitors (I).BDB
Bioorg Med Chem Lett 19: 5613-6 (2009)
Pfizer
Structure-affinity relationships of glutamine mimics incorporated into phosphopeptides targeted to the SH2 domain of signal transducer and activator of transcription 3.EBI
J Med Chem 52: 6126-41 (2009)
The University of Texas M.D. Anderson Cancer Center
Synthesis of heteroaromatic tropeines and heterogeneous binding to glycine receptors.EBI
Bioorg Med Chem 17: 6872-8 (2009)
Hungarian Academy of Sciences
Rational design and synthesis of highly potent anti-acetylcholinesterase activity huperzine A derivatives.EBI
Bioorg Med Chem 17: 6937-41 (2009)
The Chinese Academy of Sciences
Discovery of the imidazo[1,5-a][1,2,4]-triazolo[1,5-d][1,4]benzodiazepine scaffold as a novel, potent and selective GABA(A) alpha5 inverse agonist series.EBI
Bioorg Med Chem Lett 19: 5746-52 (2009)
F. Hoffmann-La Roche
Discovery and structure-activity relationships of a novel class of quinazoline glucokinase activators.EBI
Bioorg Med Chem Lett 19: 5531-8 (2009)
Banyu Tsukuba Research Institute
Prediction of telomerase inhibitory activity for acridinic derivatives based on chemical structure.EBI
Eur J Med Chem 44: 4826-40 (2009)
Central University of Las Villas
Identification of an orally efficacious matrix metalloprotease 12 inhibitor for potential treatment of asthma.EBI
J Med Chem 52: 5408-19 (2009)
Wyeth Research
Modulation of multidrug resistance protein 1 (MRP1/ABCC1)-mediated multidrug resistance by bivalent apigenin homodimers and their derivatives.EBI
J Med Chem 52: 5311-22 (2009)
The Hong Kong Polytechnic University
Design and evaluation of novel biphenyl sulfonamide derivatives with potent histamine H(3) receptor inverse agonist activity.EBI
J Med Chem 52: 5603-11 (2009)
Arena Pharmaceuticals
1- or 3-(3-Amino-2-hydroxy-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones: potent, selective, and orally efficacious norepinephrine reuptake inhibitors.EBI
J Med Chem 52: 5703-11 (2009)
Wyeth Research
Nonclinical pharmacokinetics of oseltamivir and oseltamivir carboxylate in the central nervous system.EBI
Antimicrob Agents Chemother 53: 4753-61 (2009)
F. Hoffmann-La Roche
Discovery of trans-N-[1-(2-fluorophenyl)-3-pyrazolyl]-3-oxospiro[6-azaisobenzofuran-1(3H),1'-cyclohexane]-4'-carboxamide, a potent and orally active neuropeptide Y Y5 receptor antagonist.EBI
Bioorg Med Chem 17: 6971-82 (2009)
Tsukuba Research Institute
Potent small molecule mouse CD22-inhibitors: exploring the interaction of the residue at C-2 of sialic acid scaffold.EBI
Bioorg Med Chem Lett 19: 5573-5 (2009)
Gifu University
Tetrahydrocarbazole-based serotonin reuptake inhibitor/dopamine D2 partial agonists for the potential treatment of schizophrenia.EBI
Bioorg Med Chem Lett 19: 5552-5 (2009)
Wyeth Research
Arylpyrrolizines as inhibitors of microsomal prostaglandin E2 synthase-1 (mPGES-1) or as dual inhibitors of mPGES-1 and 5-lipoxygenase (5-LOX).EBI
J Med Chem 52: 4968-72 (2009)
Eberhard Karls University Tuebingen
Synthesis, potency, and in vivo evaluation of 2-piperazin-1-ylquinoline analogues as dual serotonin reuptake inhibitors and serotonin 5-HT1A receptor antagonists.EBI
J Med Chem 52: 4955-9 (2009)
Wyeth Research
Doxazosin-related alpha1-adrenoceptor antagonists with prostate antitumor activity.EBI
J Med Chem 52: 4951-4 (2009)
University of Camerino
Design, synthesis, and X-ray crystal structure of classical and nonclassical 2-amino-4-oxo-5-substituted-6-ethylthieno[2,3-d]pyrimidines as dual thymidylate synthase and dihydrofolate reductase inhibitors and as potential antitumor agents.BDB
J Med Chem 52: 4892-902 (2009)
Duquesne University
Quinolone carboxylic acids as a novel monoketo acid class of human immunodeficiency virus type 1 integrase inhibitors.EBI
J Med Chem 52: 4869-82 (2009)
Jt
Activation of peroxisome proliferator-activated receptor gamma (PPARgamma) by nitroalkene fatty acids: importance of nitration position and degree of unsaturation.EBI
J Med Chem 52: 4631-9 (2009)
Wake Forest University
Synthesis, in vitro and in vivo evaluation, and radiolabeling of aryl anandamide analogues as candidate radioligands for in vivo imaging of fatty acid amide hydrolase in the brain.EBI
J Med Chem 52: 4613-22 (2009)
Ghent University
Pursuing aldose reductase inhibitors through in situ cross-docking and similarity-based virtual screening.EBI
J Med Chem 52: 5578-81 (2009)
Universita Di Napoli "Federico Ii
Structure and allosteric effects of low-molecular-weight activators on the protein kinase PDK1.EBI
Nat Chem Biol 5: 758-64 (2009)
Universit£Tsklinikum Frankfurt
Synthesis of organophosphates with fluorine-containing leaving groups as serine esterase inhibitors with potential for Alzheimer disease therapeutics.EBI
Bioorg Med Chem Lett 19: 5528-30 (2009)
Institute of Physiologically Active Compounds Russian Academy of Sciences
The discovery of tertiary-amine LXR agonists with potent cholesterol efflux activity in macrophages.EBI
Bioorg Med Chem Lett 19: 5617-21 (2009)
Glaxosmithkline
Synthesis and serotonin transporter activity of sulphur-substituted alpha-alkyl phenethylamines as a new class of anticancer agents.EBI
Eur J Med Chem 44: 4862-88 (2009)
Trinity College
Synthesis and pharmacological evaluation of novel N-alkyl/aryl substituted thiazolidinone arecoline analogues as muscarinic receptor 1 agonist in Alzheimer's dementia models.EBI
Eur J Med Chem 44: 4848-54 (2009)
University of Mysore
Synthesis and in vitro evaluation of 2,4-diamino-1,3,5-triazine derivatives as neuronal voltage-gated sodium channel blockers.EBI
Bioorg Med Chem Lett 19: 5644-7 (2009)
National University of Singapore
The discovery of thienopyridine analogues as potent IkappaB kinase beta inhibitors. Part II.EBI
Bioorg Med Chem Lett 19: 5547-51 (2009)
Boehringer Ingelheim Pharmaceuticals
Targeting NAD biosynthesis in bacterial pathogens: Structure-based development of inhibitors of nicotinate mononucleotide adenylyltransferase NadD.BDB
Chem Biol 16: 849-61 (2009)
Burnham Institute For Medical Research
Substrate specificity effects of lipoxygenase products and inhibitors on soybean lipoxygenase-1.EBI
Bioorg Med Chem 17: 6534-9 (2009)
University of California
Design and synthesis of pyridazinone-based 5-HT(2C) agonists.EBI
Bioorg Med Chem Lett 19: 5791-5 (2009)
Pfizer
GDC-0449-a potent inhibitor of the hedgehog pathway.EBI
Bioorg Med Chem Lett 19: 5576-81 (2009)
Genentech
The first Hes1 dimer inhibitors from natural products.EBI
Bioorg Med Chem Lett 19: 5778-81 (2009)
Chiba University
Structure-activity relationship of isoform selective inhibitors of Rac1/1b GTPase nucleotide binding.EBI
Bioorg Med Chem Lett 19: 5594-8 (2009)
Exonhit Therapeutics
On-bead screening of a combinatorial fumaric acid derived peptide library yields antiplasmodial cysteine protease inhibitors with unusual peptide sequences.EBI
J Med Chem 52: 5662-72 (2009)
University of Duisburg-Essen
Grassystatins A-C from marine cyanobacteria, potent cathepsin E inhibitors that reduce antigen presentation.EBI
J Med Chem 52: 5732-47 (2009)
University of Florida
Design, synthesis, and pharmacological activities of dynorphin A analogues cyclized by ring-closing metathesis.EBI
J Med Chem 52: 5619-25 (2009)
The University of Kansas
Inhibition of ribonuclease A by nucleoside-dibasic acid conjugates.EBI
Bioorg Med Chem 17: 6491-5 (2009)
Institute of Technology
Discovery of N-{N-[(3-cyanobenzene) sulfonyl]-4(R)-(3,3-difluoropiperidin-1-yl)-(l)-prolyl}-4-[(3',5'-dichloro-isonicotinoyl) amino]-(l)-phenylalanine (MK-0617), a highly potent and orally active VLA-4 antagonist.EBI
Bioorg Med Chem Lett 19: 5803-6 (2009)
Merck Research Laboratories
Design, synthesis, and evaluation of novel 3-amino-4-hydrazine-cyclobut-3-ene-1,2-diones as potent and selective CXCR2 chemokine receptor antagonists.EBI
Bioorg Med Chem Lett 19: 5741-5 (2009)
Wuxi Pharmatech
Structure-activity studies on seco-pancratistatin analogs: potent inhibitors of human cytochrome P450 3A4.EBI
Bioorg Med Chem Lett 19: 5607-12 (2009)
Mcmaster University
Structure-activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors.EBI
Bioorg Med Chem Lett 19: 5807-10 (2009)
Wyeth Research
Matrix metalloproteinase-2 inhibitors from Clinopodium chinense var. parviflorum.EBI
J Nat Prod 72: 1379-84 (2009)
Tohoku Pharmaceutical University
Novel 2H-isoquinolin-3-ones as antiplasmodial falcipain-2 inhibitors.EBI
Bioorg Med Chem 17: 6505-11 (2009)
Universit£
Non-nucleoside inhibitors of HCV polymerase NS5B. Part 4: structure-based design, synthesis, and biological evaluation of benzo[d]isothiazole-1,1-dioxides.EBI
Bioorg Med Chem Lett 19: 5652-6 (2009)
Roche Palo Alto
Synthesis of sigma receptor ligands with unsymmetrical spiro connection of the piperidine moiety.EBI
Eur J Med Chem 44: 4306-14 (2009)
Institut F£R Pharmazeutische Und Medizinische Chemie
Conferin, potent antioxidant and anti-inflammatory isoflavone from Caragana conferta Benth.BDB
J Enzyme Inhib Med Chem 25: 440-4 (2010)
University of Karachi
N-hydroxybenzimidazole inhibitors of the transcription factor LcrF in Yersinia: novel antivirulence agents.EBI
J Med Chem 52: 5626-34 (2009)
Paratek Pharmaceuticals
Synthesis and characterization of environment-sensitive fluorescent ligands for human 5-HT1A receptors with 1-arylpiperazine structure.EBI
J Med Chem 52: 7892-6 (2009)
Universita Degli Studi Di Bari
Isoflavonoids from Erythrina poeppigiana: evaluation of their binding affinity for the estrogen receptor.EBI
J Nat Prod 72: 1603-7 (2009)
University of Athens
Discovery of potent and selective histone deacetylase inhibitors via focused combinatorial libraries of cyclic alpha3beta-tetrapeptides.EBI
J Med Chem 52: 7836-46 (2009)
The Scripps Research Institute
Impact of novel human immunodeficiency virus type 1 reverse transcriptase mutations P119S and T165A on 4'-ethynylthymidine analog resistance profile.EBI
Antimicrob Agents Chemother 53: 4640-6 (2009)
Yale University
Human immunodeficiency virus type 1 recombinant reverse transcriptase enzymes containing the G190A and Y181C resistance mutations remain sensitive to etravirine.EBI
Antimicrob Agents Chemother 53: 4667-72 (2009)
Mcgill University Aids Centre
Synthesis and glycogen phosphorylase inhibitory activity of N-(beta-D-glucopyranosyl)amides possessing 1,4-benzodioxane moiety.EBI
Bioorg Med Chem 17: 6738-41 (2009)
University of Debrecen
Synthesis and biological evaluation of 4-fluoroproline and 4-fluoropyrrolidine-2-acetic acid derivatives as new GABA uptake inhibitors.EBI
Bioorg Med Chem 17: 6540-6 (2009)
Institute of Microbiology
C-5 substituted heteroaryl-3-pyridinecarbonitriles as PKCtheta inhibitors: part II.EBI
Bioorg Med Chem Lett 19: 5799-802 (2009)
Wyeth Research
The identification of beta-hydroxy carboxylic acids as selective MMP-12 inhibitors.EBI
Bioorg Med Chem Lett 19: 5760-3 (2009)
Gsk Medicines Research Centre
Pharmacophore-guided lead optimization: the rational design of a non-zinc coordinating, sub-micromolar inhibitor of the botulinum neurotoxin serotype a metalloprotease.EBI
Bioorg Med Chem Lett 19: 5811-3 (2009)
National Cancer Institute At Frederick
Structure-activity relationship and improved hydrolytic stability of pyrazole derivatives that are allosteric inhibitors of West Nile Virus NS2B-NS3 proteinase.EBI
Bioorg Med Chem Lett 19: 5773-7 (2009)
Sanford-Burnham Medical Research Institute
Identification of orally bioavailable, non-amidine inhibitors of Urokinase Plasminogen Activator (uPA).EBI
Bioorg Med Chem Lett 19: 5712-5 (2009)
Berlex Biosciences
Novel CGRP receptor antagonists through a design strategy of target simplification with addition of molecular flexibility.EBI
Bioorg Med Chem Lett 19: 5787-90 (2009)
Merck
Antiproliferative activity against MCF-7 breast cancer cells by diamino-triazaspirodiene antifolates.BDB
Chem Biol Drug Des 74: 322-6 (2009)
National University of Singapore
Which carbonic anhydrases are targeted by the antiepileptic sulfonamides and sulfamates?BDB
Chem Biol Drug Des 74: 317-21 (2009)
Istituto Di Biostrutture E Bioimmagini-Cnr
In silico screening for non-nucleoside HIV-1 reverse transcriptase inhibitors using physicochemical filters and high-throughput docking followed by in vitro evaluation.BDB
Chem Biol Drug Des 74: 258-65 (2009)
University of Jordan
Chemical Constituents of the Roots of Euphorbia micractina.EBI
J Nat Prod 72: 1620-6 (2009)
Chinese Academy of Medical Sciences and Peking Union Medical College
Eleven amino acid glucagon-like peptide-1 receptor agonists with antidiabetic activity.EBI
J Med Chem 52: 7788-99 (2009)
Bristol-Myers Squibb
Development and biological activity of a new antagonist of the pheromone of the codling moth Cydia pomonella.EBI
J Agric Food Chem 57: 8514-9 (2009)
University of Lleida
Discovery of a series of acrylic acids and their derivatives as chemical leads for selective EP3 receptor antagonists.BDB
Bioorg Med Chem 17: 6567-82 (2009)
Ono Pharmaceutical
Synthesis, structure-affinity relationships, and modeling of AMDA analogs at 5-HT2A and H1 receptors: structural factors contributing to selectivity.BDB
Bioorg Med Chem 17: 6496-504 (2009)
Virginia Commonwealth University
mu-Opioid/5-HT4 dual pharmacologically active agents-efforts towards an effective opioid analgesic with less GI and respiratory side effects (Part I).EBI
Bioorg Med Chem Lett 19: 5679-83 (2009)
Sepracor
Identification of a cell-active non-peptide sirtuin inhibitor containing N-thioacetyl lysine.EBI
Bioorg Med Chem Lett 19: 5670-2 (2009)
Nagoya City University
Potent and cellularly active 4-aminoimidazole inhibitors of cyclin-dependent kinase 5/p25 for the treatment of Alzheimer's disease.EBI
Bioorg Med Chem Lett 19: 5703-7 (2009)
Pfizer
Amplification of the inhibitory activity of miglitol by monofluorination.EBI
Bioorg Med Chem Lett 19: 5673-4 (2009)
Martin-Luther-Universit£T Halle-Wittenberg
Non-nucleoside inhibitors of HCV polymerase NS5B. Part 3: synthesis and optimization studies of benzothiazine-substituted tetramic acids.EBI
Bioorg Med Chem Lett 19: 5648-51 (2009)
Roche Palo Alto
O-Spiro C-aryl glucosides as novel sodium-dependent glucose co-transporter 2 (SGLT2) inhibitors.EBI
Bioorg Med Chem Lett 19: 5632-5 (2009)
Chinese Academy of Sciences
A strategy of employing aminoheterocycles as amide mimics to identify novel, potent and bioavailable soluble epoxide hydrolase inhibitors.EBI
Bioorg Med Chem Lett 19: 5716-21 (2009)
Merck Research Laboratories
Design, synthesis, screening, and molecular modeling study of a new series of ROS1 receptor tyrosine kinase inhibitors.EBI
Bioorg Med Chem Lett 19: 5622-6 (2009)
University of Science and Technology
Kojic acid-amino acid conjugates as tyrosinase inhibitors.EBI
Bioorg Med Chem Lett 19: 5586-9 (2009)
Seoul National University
Design, synthesis, and biological evaluation of hydroquinone derivatives as novel inhibitors of the sarco/endoplasmic reticulum calcium ATPase.BDB
Bioorg Med Chem 17: 6613-9 (2009)
Northern Kentucky University
Synthesis and in vitro DMPK profiling of a 1,2-dioxolane-based library with activity against Plasmodium falciparum.EBI
Bioorg Med Chem Lett 19: 5657-60 (2009)
Institute Infectious Diseases Initiative
Synthesis and SAR of 1,4,5,6-tetrahydropyridazines as potent cannabinoid CB1 receptor antagonists.EBI
Bioorg Med Chem Lett 19: 5675-8 (2009)
Solvay Pharma
Diphenylmethylene hydroxamic acids as selective class IIa histone deacetylase inhibitors.EBI
Bioorg Med Chem Lett 19: 5684-8 (2009)
Methylgene
Effectiveness and mode of action of phosphonate inhibitors of plant glutamine synthetase.EBI
Pest Manag Sci 66: 51-8 (2010)
University of Ferrara
Antagonists of the human A(2A) receptor. Part 6: Further optimization of pyrimidine-4-carboxamides.BDB
Bioorg Med Chem 17: 6590-605 (2009)
Vernalis (R&D)
Identification of new agonists of urotensin-II from a cyclic peptide library.EBI
Bioorg Med Chem 17: 6742-7 (2009)
Prism Bio. Lab.
Synthesis and evaluation of a full-agonist orvinol for PET-imaging of opioid receptors: [11C]PEO.EBI
J Med Chem 52: 5586-9 (2009)
Biomedizinische Forschungsreagenzien
Spirocyclic delta opioid receptor agonists for the treatment of pain: discovery of N,N-diethyl-3-hydroxy-4-(spiro[chromene-2,4'-piperidine]-4-yl) benzamide (ADL5747).EBI
J Med Chem 52: 5685-702 (2009)
Adolor
Recent advances in the identification of gamma-secretase inhibitors to clinically test the Abeta oligomer hypothesis of Alzheimer's disease.EBI
J Med Chem 52: 6169-88 (2009)
Wyeth Research
Design, synthesis and evaluation of flavonoid derivatives as potent AChE inhibitors.EBI
Bioorg Med Chem 17: 6692-8 (2009)
Zhejiang University
A new structural class of S-adenosylhomocysteine hydrolase inhibitors.EBI
Bioorg Med Chem 17: 6707-14 (2009)
Boston College
Substituted 2-arylbenzothiazoles as kinase inhibitors: hit-to-lead optimization.EBI
Bioorg Med Chem 17: 6728-37 (2009)
4Sc
Discovery and biological profile of isoindolinone derivatives as novel metabotropic glutamate receptor 1 antagonists: a potential treatment for psychotic disorders.EBI
Bioorg Med Chem Lett 19: 5310-3 (2009)
Tsukuba Research Institute
Design and synthesis of piperazinylpyrimidinones as novel selective 5-HT(2C) agonists.EBI
Bioorg Med Chem Lett 19: 5346-50 (2009)
Pfizer
Improving potency and selectivity of a new class of non-Zn-chelating MMP-13 inhibitors.BDB
Bioorg Med Chem Lett 19: 5321-4 (2009)
Boehringer Ingelheim Pharmaceuticals
Discovering potent small molecule inhibitors of cyclophilin A using de novo drug design approach.EBI
J Med Chem 52: 5295-8 (2009)
East China University of Science and Technology
Pyrrolidine analogues of lobelane: relationship of affinity for the dihydrotetrabenazine binding site with function of the vesicular monoamine transporter 2 (VMAT2).EBI
J Med Chem 52: 7878-82 (2009)
University of Kentucky
Chemical interrogation of FOXO3a nuclear translocation identifies potent and selective inhibitors of phosphoinositide 3-kinases.BDB
J Biol Chem 284: 28392-400 (2009)
Spanish National Cancer Research Center (Cnio)
Minor furanocoumarins and coumarins in grapefruit peel oil as inhibitors of human cytochrome P450 3A4.EBI
J Nat Prod 72: 1702-4 (2009)
University of Sao Paulo State
A critical electrostatic interaction mediates inhibitor recognition by human asparagine synthetase.EBI
Bioorg Med Chem 17: 6641-50 (2009)
Kyoto University
Pyrrole[2,3-d]azepino compounds as agonists of the farnesoid X receptor (FXR).EBI
Bioorg Med Chem Lett 19: 5289-92 (2009)
Wyeth Research
5-(2-Pyrimidinyl)-imidazo[1,2-a]pyridines are antibacterial agents targeting the ATPase domains of DNA gyrase and topoisomerase IV.EBI
Bioorg Med Chem Lett 19: 5302-6 (2009)
Pfizer
Bioisosteric replacement of the hydrazide pharmacophore of the cannabinoid-1 receptor antagonist SR141716A. Part I: potent, orally-active 1,4-disubstituted imidazoles.EBI
Bioorg Med Chem Lett 19: 5351-4 (2009)
Pfizer
Reactivity of isothiazolones and isothiazolone-1-oxides in the inhibition of the PCAF histone acetyltransferase.EBI
Eur J Med Chem 44: 4855-61 (2009)
University of Groningen
Novel cyclic-imide peptidomimetics as aminopeptidase N inhibitors. Design, chemistry and activity evaluation. Part I.EBI
Eur J Med Chem 44: 4819-25 (2009)
Shandong University
Omega-conotoxin GVIA mimetics based on an anthranilamide core: effect of variation in ammonium side chain lengths and incorporation of fluorine.EBI
Bioorg Med Chem 17: 6659-70 (2009)
The University of Queensland
Synthesis and pharmacological evaluation of 6-naltrexamine analogs for alcohol cessation.EBI
Bioorg Med Chem 17: 6671-81 (2009)
Human Biomolecular Research Institute
Discovery of isoxazole voltage gated sodium channel blockers for treatment of chronic pain.EBI
Bioorg Med Chem Lett 19: 5334-8 (2009)
Merck Research Laboratories
Discovery of novel diarylketoxime derivatives as selective and orally active melanin-concentrating hormone 1 receptor antagonists.EBI
Bioorg Med Chem Lett 19: 5339-45 (2009)
Tsukuba Research Institute
A fluorescence quenching assay to discriminate between specific and nonspecific inhibitors of dengue virus protease.BDB
Anal Biochem 395: 195-204 (2009)
Novartis Institute For Tropical Diseases
Inhibition of S-ribosylhomocysteinase (LuxS) by substrate analogues modified at the ribosyl C-3 position.EBI
Bioorg Med Chem 17: 6699-706 (2009)
Florida International University
Synthesis and pharmacological evaluation of novel 1- and 8-substituted-3-furfuryl xanthines as adenosine receptor antagonists.EBI
Bioorg Med Chem 17: 6755-60 (2009)
Universidade De Santiago De Compostela
Synthesis and molecular modeling of some novel hexahydroindazole derivatives as potent monoamine oxidase inhibitors.EBI
Bioorg Med Chem 17: 6761-72 (2009)
Hacettepe University
Spiro-naphthyridinone piperidines as inhibitors of S. aureus and E. coli enoyl-ACP reductase (FabI).EBI
Bioorg Med Chem Lett 19: 5355-8 (2009)
Affinium Pharmaceuticals
2,3,4,5-Tetrahydro-1H-pyrido[2,3-b and e][1,4]diazepines as inhibitors of the bacterial enoyl ACP reductase, FabI.EBI
Bioorg Med Chem Lett 19: 5359-62 (2009)
Affinium Pharmaceuticals
Discovery of 3,3-disubstituted piperidine-derived trisubstituted ureas as highly potent soluble epoxide hydrolase inhibitors.EBI
Bioorg Med Chem Lett 19: 5314-20 (2009)
Merck Research Laboratories
C-5 Substituted heteroaryl 3-pyridinecarbonitriles as PKCtheta inhibitors: Part I.EBI
Bioorg Med Chem Lett 19: 5423-5 (2009)
Wyeth Research
Photoregulation of thrombin aptamer activity using Bhc caging strategy.EBI
Bioorg Med Chem Lett 19: 5368-71 (2009)
University of Science and Technology of China
Guttiferones O and P, prenylated benzophenone MAPKAPK-2 inhibitors from Garcinia solomonensis.EBI
J Nat Prod 72: 1699-701 (2009)
Griffith University
Fluorinated indazoles as novel selective inhibitors of nitric oxide synthase (NOS): synthesis and biological evaluation.EBI
Bioorg Med Chem 17: 6180-7 (2009)
Uned
Synthesis and evaluation of inhibitors of cytochrome P450 3A (CYP3A) for pharmacokinetic enhancement of drugs.EBI
Bioorg Med Chem Lett 19: 5444-8 (2009)
Abbott Laboratories
A novel class of highly potent multidrug resistance reversal agents: disubstituted adamantyl derivatives.EBI
Bioorg Med Chem Lett 19: 5376-9 (2009)
Chung-Ang University
Molecular modeling studies to predict the possible binding modes of endomorphin analogs in mu opioid receptor.EBI
Bioorg Med Chem Lett 19: 5387-91 (2009)
Lanzhou University
Identification of positron emission tomography ligands for NPY Y5 receptors in the brain.EBI
Bioorg Med Chem Lett 19: 5436-9 (2009)
Tsukuba Research Institute
Synthesis and preliminary pharmacological evaluation of imidazo[2,1-f]purine-2,4-dione derivatives.EBI
Eur J Med Chem 44: 4288-96 (2009)
Jagiellonian University Medical College
Design, synthesis, and structure-activity relationships of aminopyridine N-oxides, a novel scaffold for the potent and selective inhibition of p38 mitogen activated protein kinase.BDB
J Med Chem 52: 5531-45 (2009)
Almirall
Discovery of orally active 3-pyridinyl-tropane as a potent nociceptin receptor agonist for the management of cough.EBI
J Med Chem 52: 5323-9 (2009)
Schering-Plough Research Institute
The nucleoside analogue D-carba T blocks HIV-1 reverse transcription.EBI
J Med Chem 52: 5356-64 (2009)
Nci-Frederick
Synthesis of pentopyranosyl-containing thiodisaccharides. Inhibitory activity against beta-glycosidases.EBI
Bioorg Med Chem 17: 6203-12 (2009)
Universidad De Buenos Aires
Disubstituted pyrimidines as Lck inhibitors.EBI
Bioorg Med Chem Lett 19: 5440-3 (2009)
Merck Research Laboratories
Spiropiperidine CCR5 antagonists.EBI
Bioorg Med Chem Lett 19: 5401-6 (2009)
Roche Palo Alto
From natural products to achiral drug prototypes: potent thrombin inhibitors based on P2/P3 dihydropyrid-2-one core motifs.EBI
Bioorg Med Chem Lett 19: 5429-32 (2009)
Universit£
Discovery of a novel class of isoxazoline voltage gated sodium channel blockers.EBI
Bioorg Med Chem Lett 19: 5329-33 (2009)
Merck Research Laboratories
Discovery and in vitro and in vivo profiles of 4-fluoro-N-[4-[6-(isopropylamino)pyrimidin-4-yl]-1,3-thiazol-2-yl]-N-methylbenzamide as novel class of an orally active metabotropic glutamate receptor 1 (mGluR1) antagonist.EBI
Bioorg Med Chem Lett 19: 5464-8 (2009)
Tsukuba Research Institute
Discovery of potential ZAP-70 kinase inhibitors: pharmacophore design, database screening and docking studies.EBI
Eur J Med Chem 44: 4793-800 (2009)
Gvk Biosciences
Synthesis, biological evaluation, and three-dimensional in silico pharmacophore model for sigma(1) receptor ligands based on a series of substituted benzo[d]oxazol-2(3H)-one derivatives.EBI
J Med Chem 52: 5380-93 (2009)
University of Trieste
Design, synthesis, and examination of neuron protective properties of alkenylated and amidated dehydro-silybin derivatives.EBI
J Med Chem 52: 7732-52 (2009)
Pharmacy School of Wenzhou Medical College
Efficacious 11beta-hydroxysteroid dehydrogenase type I inhibitors in the diet-induced obesity mouse model.EBI
J Med Chem 52: 5449-61 (2009)
Wyeth Research
Inhibitors of aldose reductase and formation of advanced glycation end-products in moutan cortex (Paeonia suffruticosa).EBI
J Nat Prod 72: 1465-70 (2009)
Chungnam National University
Synthetic partial agonists reveal key steps in IP3 receptor activation.EBI
Nat Chem Biol 5: 631-9 (2009)
University of Cambridge
Molecular modeling of human acidic mammalian chitinase in complex with the natural-product cyclopentapeptide chitinase inhibitor argifin.EBI
Bioorg Med Chem 17: 6270-8 (2009)
Kitasato University
Synthesis of branched 9-[2-(2-phosphonoethoxy)ethyl]purines as a new class of acyclic nucleoside phosphonates which inhibit Plasmodium falciparum hypoxanthine-guanine-xanthine phosphoribosyltransferase.EBI
Bioorg Med Chem 17: 6218-32 (2009)
Academy of Sciences of The Czech Republic
Solubilized phenyl-pyrazole ureas as potent, selective 5-HT(2A) inverse-agonists and their application as antiplatelet agents.EBI
Bioorg Med Chem Lett 19: 5486-9 (2009)
Arena Pharmaceuticals
Dihydropyrazolopyrimidines containing benzimidazoles as K(V)1.5 potassium channel antagonists.EBI
Bioorg Med Chem Lett 19: 5469-73 (2009)
Bristol-Myers Squibb
Novel 4-aryl-pyrido[1,2-c]pyrimidines with dual SSRI and 5-HT1A activity: part 2.EBI
Eur J Med Chem 44: 4702-15 (2009)
Medical University of Warsaw
Synthesis, antifungal, haemolytic and cytotoxic activities of a series of bis(alkylpyridinium)alkanes.EBI
Bioorg Med Chem 17: 6329-39 (2009)
The University of Sydney
Synthesis and kinase inhibitory activity of novel substituted indigoids.EBI
Bioorg Med Chem 17: 6257-63 (2009)
Universit£
Design and synthesis of new stabilized combi-triazenes for targeting solid tumors expressing the epidermal growth factor receptor (EGFR) or its closest homologue HER2.EBI
Bioorg Med Chem Lett 19: 5505-9 (2009)
Mcgill University/Royal Victoria Hospital
Design and synthesis of dipeptidyl nitriles as potent, selective, and reversible inhibitors of cathepsin C.EBI
Bioorg Med Chem Lett 19: 5392-6 (2009)
Merck Frosst Canada
Synthesis of novel ageladine A analogs showing more potent matrix metalloproteinase (MMP)-12 inhibitory activity than the natural product.EBI
Bioorg Med Chem Lett 19: 5461-3 (2009)
Kyorin Pharmaceutical
2-Amino-9-aryl-3-cyano-4-methyl-7-oxo-6,7,8,9-tetrahydropyrido[2',3':4,5]thieno[2,3-b]pyridine derivatives as selective progesterone receptor agonists.EBI
Bioorg Med Chem Lett 19: 4916-9 (2009)
Glaxosmithkline
Potent inhibitory effects of benzyl and p-xylidine-bis dithiocarbamate sodium salts on activities of mushroom tyrosinase.BDB
J Enzyme Inhib Med Chem 25: 272-81 (2010)
University of Tehran
Developing dual and specific inhibitors of dimethylarginine dimethylaminohydrolase-1 and nitric oxide synthase: toward a targeted polypharmacology to control nitric oxide.BDB
Biochemistry 48: 8624-35 (2009)
The University of Texas
A multivalent approach to the design and discovery of orally efficacious 5-HT4 receptor agonists.EBI
J Med Chem 52: 5330-43 (2009)
Theravance
Probing the fibrate binding specificity of rat liver fatty acid binding protein.EBI
J Med Chem 52: 5344-55 (2009)
Monash University
Pyrano[3,2-c]quinoline-6-chlorotacrine hybrids as a novel family of acetylcholinesterase- and beta-amyloid-directed anti-Alzheimer compounds.BDB
J Med Chem 52: 5365-79 (2009)
Universitat De Barcelona
Characterization of novel selective H1-antihistamines for clinical evaluation in the treatment of insomnia.EBI
J Med Chem 52: 5307-10 (2009)
Neurocrine Biosciences
Structural determinants for histamine H(1) affinity, hERG affinity and QTc prolongation in a series of terfenadine analogs.EBI
Bioorg Med Chem Lett 19: 5043-7 (2009)
The Schering Plough Research Institute
Design, synthesis, and structure-activity relationship of novel orally efficacious pyrazole/sulfonamide based dihydroquinoline gamma-secretase inhibitors.EBI
Bioorg Med Chem Lett 19: 4920-3 (2009)
Elan Pharmaceuticals
3-Substituted phenylalanines as selective AMPA- and kainate receptor ligands.EBI
Bioorg Med Chem 17: 6390-401 (2009)
University of Copenhagen
Quinolines as a novel structural class of potent and selective PDE4 inhibitors. Optimisation for inhaled administration.EBI
Bioorg Med Chem Lett 19: 5261-5 (2009)
Glaxosmithkline
AC220 is a uniquely potent and selective inhibitor of FLT3 for the treatment of acute myeloid leukemia (AML).EBI
Blood 114: 2984-92 (2009)
Ambit Biosciences
14,15-Epoxyeicosa-5,8,11-trienoic acid (14,15-EET) surrogates containing epoxide bioisosteres: influence upon vascular relaxation and soluble epoxide hydrolase inhibition.EBI
J Med Chem 52: 5069-75 (2010)
University of Texas Southwestern Medical Center
Radiolabeled 5-iodo-3'-O-(17beta-succinyl-5alpha-androstan-3-one)-2'-deoxyuridine and its 5'-monophosphate for imaging and therapy of androgen receptor-positive cancers: synthesis and biological evaluation.EBI
J Med Chem 52: 5124-43 (2010)
University of Nebraska Medical Center
Curcumin inhibits ACTH- and angiotensin II-stimulated cortisol secretion and Ca(v)3.2 current.EBI
J Nat Prod 72: 1533-7 (2009)
The Ohio State University College of Medicine and Public Health
Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinol esters as potent and long-acting muscarinic antagonists with potential for minimal systemic exposure after inhaled administration: identification of (3R)-3-{[hydroxy(di-2-thienyl)acetyl]oxy}-1-(3-phenoxypropyl)-1-azoniabicycloEBI
J Med Chem 52: 5076-92 (2010)
RhôNe-Poulenc Rorer
Carbonic anhydrase inhibitors. Inhibition of the Rv1284 and Rv3273 beta-carbonic anhydrases from Mycobacterium tuberculosis with diazenylbenzenesulfonamides.EBI
Bioorg Med Chem Lett 19: 4929-32 (2009)
Universit£
Isatin derivatives, a novel class of transthyretin fibrillogenesis inhibitors.EBI
Bioorg Med Chem Lett 19: 5270-3 (2009)
Universitat De Barcelona
Design, synthesis and selection of DNA-encoded small-molecule libraries.BDB
Nat Chem Biol 5: 647-54 (2009)
Praecis Pharmaceuticals
Synthesis, structural activity-relationships, and biological evaluation of novel amide-based allosteric binding site antagonists in NR1A/NR2B N-methyl-D-aspartate receptors.EBI
Bioorg Med Chem 17: 6463-80 (2009)
Emory University
Synthesis and evaluation of novel tricyclic benzo[4.5]cyclohepta[1.2]pyridine derivatives as NMDA/NR2B antagonists.EBI
Bioorg Med Chem Lett 19: 5132-5 (2009)
Merck Research Laboratories
Identification of small molecule inhibitors of proline-rich tyrosine kinase 2 (Pyk2) with osteogenic activity in osteoblast cells.EBI
Bioorg Med Chem Lett 19: 4924-8 (2009)
Amgen
Synthesis and adrenolytic activity of 1-(1H-indol-4-yloxy)-3-(2-(2-methoxy phenoxy)ethylamino)propan-2-ol analogs and its enantiomers. Part 2.EBI
Eur J Med Chem 44: 5103-11 (2009)
Rzesz£W University of Technology
1,2,3-Selenadiazole thioacetanilides: synthesis and anti-HIV activity evaluation.EBI
Bioorg Med Chem 17: 6374-9 (2009)
Shandong University
N-[(3S)-Pyrrolidin-3-yl]benzamides as novel dual serotonin and noradrenaline reuptake inhibitors: impact of small structural modifications on P-gp recognition and CNS penetration.EBI
Bioorg Med Chem Lett 19: 5078-81 (2009)
Pfizer
Novel CXCR3 antagonists with a piperazinyl-piperidine core.EBI
Bioorg Med Chem Lett 19: 5205-8 (2009)
Ligand Pharmaceuticals
Novel delta opioid receptor agonists exhibit differential stimulation of signaling pathways.EBI
Bioorg Med Chem 17: 6442-50 (2009)
University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School and The Informatics Institute of Umdnj
Arylcarboxyamino-substituted diaryl ureas as potent and selective FLT3 inhibitors.EBI
Bioorg Med Chem Lett 19: 5182-5 (2009)
Ambit Biosciences
Discovery of N-(3-(morpholinomethyl)-phenyl)-amides as potent and selective CB2 agonists.EBI
Bioorg Med Chem Lett 19: 5004-8 (2009)
Adolor
2-Aminobenzimidazoles as potent Aurora kinase inhibitors.EBI
Bioorg Med Chem Lett 19: 5158-61 (2009)
Sunesis Pharmaceuticals
Discovery of a novel azepine series of potent and selective 5-HT2C agonists as potential treatments for urinary incontinence.EBI
Bioorg Med Chem Lett 19: 4999-5003 (2009)
Pfizer
Characterization of alpha-nitromethyl ketone as a new zinc-binding group based on structural analysis of its complex with carboxypeptidase A.EBI
Bioorg Med Chem Lett 19: 5009-11 (2009)
Yanbian University
Discovery of a highly potent, selective, and bioavailable soluble epoxide hydrolase inhibitor with excellent ex vivo target engagement.EBI
J Med Chem 52: 5009-12 (2010)
Merck Research Laboratories
Structure-Based Design, Synthesis, and Biological Evaluation of a Series of Novel and Reversible Inhibitors for the Severe Acute Respiratory Syndrome-Coronavirus Papain-Like Protease.BDB
J Med Chem 52: 5228-40 (2009)
Purdue University
ATP-Competitive Inhibitors of the Mammalian Target of Rapamycin: Design and Synthesis of Highly Potent and Selective PyrazolopyrimidinesBDB
J Med Chem 52: 5013-6 (2009)
Wyeth Research
Novel flufenamic acid analogues as inhibitors of androgen receptor mediated transcription.BDB
ACS Chem Biol 4: 834-43 (2009)
St. Jude Research Hospital
Design and discovery of 1,3-benzodiazepines as novel dopamine antagonists.EBI
Bioorg Med Chem Lett 19: 5218-21 (2009)
Schering-Plough Research Institute
Design, synthesis and evaluation of novel 5,6-dimethoxy-1-oxo-2,3-dihydro-1H-2-indenyl-3,4-substituted phenyl methanone analogues.EBI
Bioorg Med Chem Lett 19: 5075-7 (2009)
Alwar Pharmacy College
Novel N-substituted 4-hydrazino piperidine derivative as a dipeptidyl peptidase IV inhibitor.EBI
Bioorg Med Chem Lett 19: 5021-5 (2009)
Torrent Pharmaceuticals
Studies towards topical selective beta2-adrenoceptor agonists with a long duration of action.EBI
Bioorg Med Chem Lett 19: 5237-40 (2009)
Boehringer Ingelheim Pharma
Mapping the ribonucleolytic active site of bovine seminal ribonuclease. The binding of pyrimidinyl phosphonucleotide inhibitors.EBI
Eur J Med Chem 44: 4496-508 (2009)
National Hellenic Research Foundation
Synthesis of 3-deoxypentacyclic triterpene derivatives as inhibitors of glycogen phosphorylase.EBI
J Nat Prod 72: 1414-8 (2009)
China Pharmaceutical University
Influence of the side chain next to C-terminal benzimidazole in opioid pseudopeptides containing the Dmt-Tic pharmacophore.EBI
J Med Chem 52: 5556-9 (2009)
University of Cagliari
Synthesis and characterizations of novel quinoline derivatives having mixed ligand activities at the kappa and mu receptors: Potential therapeutic efficacy against morphine dependence.EBI
Bioorg Med Chem 17: 5782-90 (2009)
Institute of Chemical Biology
A comprehensive study on the 5-hydroxytryptamine(3A) receptor binding of agonists serotonin and m-chlorophenylbiguanidine.EBI
Bioorg Med Chem 17: 5796-805 (2009)
Virtua Drug
Alkyl-bridged substituted 8-arylquinolines as highly potent PDE IV inhibitors.EBI
Bioorg Med Chem Lett 19: 5266-9 (2009)
Merck Frosst Center For Therapeutic Research
Synthesis and SAR of a novel positive allosteric modulator (PAM) of the metabotropic glutamate receptor 4 (mGluR4).EBI
Bioorg Med Chem Lett 19: 4967-70 (2009)
Vanderbilt University Medical Center
A conformational constraint improves a beta-secretase inhibitor but for an unexpected reason.EBI
Bioorg Med Chem Lett 19: 4993-5 (2009)
Merck Research Laboratories
Design and synthesis of (2R,3S)-iodoreboxetine analogues for SPECT imaging of the noradrenaline transporter.EBI
Bioorg Med Chem Lett 19: 4996-8 (2009)
University of Glasgow
Synthesis and evaluation of a series of 2,4-diaminopyridine derivatives as potential positron emission tomography tracers for neuropeptide Y Y1 receptors.EBI
Bioorg Med Chem Lett 19: 5124-7 (2009)
Tsukuba Research Institute
Pharmacophore modeling and virtual screening for the discovery of new transforming growth factor-beta type I receptor (ALK5) inhibitors.EBI
Eur J Med Chem 44: 4259-65 (2009)
Sichuan University
6-methyl-2,4-disubstituted pyridazin-3(2H)-ones: a novel class of small-molecule agonists for formyl peptide receptors.EBI
J Med Chem 52: 5044-57 (2010)
Universita Degli Studi Di Firenze
Divergent modes of enzyme inhibition in a homologous structure-activity series.EBI
J Med Chem 52: 5005-8 (2010)
University of California
alpha-Substituted norstatines as the transition-state mimic in inhibitors of multiple digestive vacuole malaria aspartic proteases.EBI
Bioorg Med Chem 17: 5933-49 (2009)
Uppsala University
Dopamine D3 receptor antagonists: the quest for a potentially selective PET ligand. Part 3: Radiosynthesis and in vivo studies.EBI
Bioorg Med Chem Lett 19: 5056-9 (2009)
Imperial College
Semi-rigid tripeptide agonists of melanocortin receptors.EBI
Bioorg Med Chem Lett 19: 5176-81 (2009)
University of Cincinnati
Discovery of novel selective HER-2 sheddase inhibitors through optimization of P1 moiety.EBI
Bioorg Med Chem Lett 19: 5037-42 (2009)
Incyte
Univalent and bivalent ligands of butorphan: characteristics of the linking chain determine the affinity and potency of such opioid ligands.EBI
J Med Chem 52: 7389-96 (2009)
Harvard Medical School
Inhibition of a viral enzyme by a small-molecule dimer disruptor.BDB
Nat Chem Biol 5: 640-6 (2009)
University of California San Francisco
The search for potent, small molecule NNRTIs: A review.EBI
Bioorg Med Chem 17: 5744-62 (2009)
The M.S. University of Baroda
Optimization of a series of quinazolinone-derived antagonists of CXCR3.EBI
Bioorg Med Chem Lett 19: 5114-8 (2009)
Amgen
Discovery of novel phenethylpyridone derivatives as potent melanin-concentrating hormone 1 receptor antagonists.EBI
Bioorg Med Chem Lett 19: 5186-90 (2009)
Tsukuba Research Institute
Benzo[d]imidazole inhibitors of Coactivator Associated Arginine Methyltransferase 1 (CARM1)--Hit to Lead studies.EBI
Bioorg Med Chem Lett 19: 5063-6 (2009)
Bristol-Myers Squibb Pharmaceutical Research and Development
Towards to hENT1-nucleoside transporter selective imaging agents. Synthesis and in vitro evaluation of the radiolabeled SAENTA analogues.EBI
Bioorg Med Chem Lett 19: 5151-4 (2009)
Ulm University
Thiazole analog as stearoyl-CoA desaturase 1 inhibitor.EBI
Bioorg Med Chem Lett 19: 5214-7 (2009)
Merck Frosst Centre For Therapeutic Research
Inhibitory effect of chalcones and their derivatives from Glycyrrhiza inflata on protein tyrosine phosphatase 1B.EBI
Bioorg Med Chem Lett 19: 5155-7 (2009)
Institute
Synthesis and evaluation of N-[(1S,2S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-aminopropanamide as human cannabinoid-1 receptor (CB1R) inverse agonists.EBI
Bioorg Med Chem Lett 19: 5195-9 (2009)
Merck Research Laboratories
Synthesis and evaluation of 2-amino-dihydrotetrabenzine derivatives as probes for imaging vesicular monoamine transporter-2.EBI
Bioorg Med Chem Lett 19: 5026-8 (2009)
Key Laboratory of Radiopharmaceuticals (Beijing Normal University)
ADMET rules of thumb II: A comparison of the effects of common substituents on a range of ADMET parameters.EBI
Bioorg Med Chem 17: 5906-19 (2009)
Glaxosmithkline
Fascaplysin-inspired diindolyls as selective inhibitors of CDK4/cyclin D1.EBI
Bioorg Med Chem 17: 6073-84 (2009)
University of Leicester
4-(Benzimidazol-2-yl)-1,2,5-oxadiazol-3-ylamine derivatives: potent and selective p70S6 kinase inhibitors.EBI
Bioorg Med Chem Lett 19: 5191-4 (2009)
Vertex Pharmaceuticals
4-Anilino-7-pyridyl-3-quinolinecarbonitriles as Src kinase inhibitors.EBI
Bioorg Med Chem Lett 19: 5071-4 (2009)
Wyeth Research
Discovery of a new series of monoamine reuptake inhibitors, the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ols.EBI
Bioorg Med Chem Lett 19: 5029-32 (2009)
Wyeth Research
Evaluation of hydrogen bonds of ecdysteroids in the ligand-receptor interactions using a protein modeling system.EBI
Bioorg Med Chem 17: 5868-73 (2009)
Kyoto University
Design, synthesis, and discovery of novel non-peptide inhibitor of Caspase-3 using ligand based and structure based virtual screening approach.EBI
Bioorg Med Chem 17: 6040-7 (2009)
Osmania University College For Women
Multiple strategies for the preparation of a sulfur-35 labeled NPC1L1 radioligand.EBI
Bioorg Med Chem Lett 19: 5033-6 (2009)
Merck Research Laboratories
Optimization of the aminopyridopyrazinones class of PDE5 inhibitors: discovery of 3-[(trans-4-hydroxycyclohexyl)amino]-7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)pyrido[3,4-b]pyrazin-2(1H)-one.EBI
Bioorg Med Chem Lett 19: 5209-13 (2009)
Pfizer
Substituted 3-(4-(1,3,5-triazin-2-yl)-phenyl)-2-aminopropanoic acids as novel tryptophan hydroxylase inhibitors.EBI
Bioorg Med Chem Lett 19: 5229-32 (2009)
Lexicon Pharmaceuticals
Design, syntheses, and evaluation of Taspase1 inhibitors.EBI
Bioorg Med Chem Lett 19: 5086-90 (2009)
Stanford School of Medicine
Imidazo-pyrazine derivatives as potent CXCR3 antagonists.EBI
Bioorg Med Chem Lett 19: 5200-4 (2009)
Amgen
Substituted tetrahydroquinolines as potent allosteric inhibitors of reverse transcriptase and its key mutants.EBI
Bioorg Med Chem Lett 19: 5119-23 (2009)
Merck Research Laboratory
Structural-thermodynamic relationships of interactions in the N-terminal ATP-binding domain of Hsp90.BDB
J Mol Biol 392: 923-36 (2009)
University College London
Discovery of a Novel Class of Phosphodiesterase 10A Inhibitors and Identification of Clinical Candidate 2-[4-(1-Methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)-phenoxymethyl]-quinoline (PF-2545920) for the Treatment of Schizophrenia (dagger) dagger Coordinates of the PDE10A crystal structures have been depoBDB
J Med Chem 52: 5188-96 (2009)
Pfizer
Identification of enoxacin as an inhibitor of osteoclast formation and bone resorption by structure-based virtual screening.EBI
J Med Chem 52: 5144-51 (2010)
University of Florida College of Medicine
Design, synthesis, and structure-activity relationship of tropane muscarinic acetylcholine receptor antagonists.EBI
J Med Chem 52: 5241-52 (2010)
Glaxosmithkline
Structural basis for alpha-conotoxin potency and selectivity.EBI
Bioorg Med Chem 17: 5894-9 (2009)
Boise State University
Design, synthesis and biological evaluation of novel pyridine derivatives as anticancer agents and phosphodiesterase 3 inhibitors.EBI
Bioorg Med Chem 17: 5974-82 (2009)
German University In Cairo
Benzo[c][2,7]naphthyridines as inhibitors of PDK-1.BDB
Bioorg Med Chem Lett 19: 5225-8 (2009)
Wyeth Research
Synthesis and evaluation of 6-methyl-3-phenylcoumarins as potent and selective MAO-B inhibitors.EBI
Bioorg Med Chem Lett 19: 5053-5 (2009)
Universidad De Santiago De Compostela
Probes for narcotic receptor mediated phenomena. 39. Enantiomeric N-substituted benzofuro[2,3-c]pyridin-6-ols: synthesis and topological relationship to oxide-bridged phenylmorphans.EBI
J Med Chem 52: 7570-9 (2009)
National Institute On Drug Abuse and The National Institute On Alcohol Abuse and Alcoholi
Design and synthesis of novel nitrogen-containing polyhydroxylated aromatics as HIV-1 integrase inhibitors from caffeic acid phenethyl ester.EBI
Bioorg Med Chem Lett 19: 4574-8 (2009)
Shandong University
Investigation of the pharmacophore space of Severe Acute Respiratory Syndrome coronavirus (SARS-CoV) NTPase/helicase by dihydroxychromone derivatives.EBI
Bioorg Med Chem Lett 19: 4538-41 (2009)
Konkuk University
3,4-Disubstituted benzofuran P1' MMP-13 inhibitors: optimization of selectivity and reduction of protein binding.EBI
Bioorg Med Chem Lett 19: 4546-50 (2009)
Wyeth Research
The discovery of azepane sulfonamides as potent 11beta-HSD1 inhibitors.EBI
Bioorg Med Chem Lett 19: 4563-5 (2009)
Schering-Plough Research Institute
Triazole inhibitors of Cryptosporidium parvum inosine 5'-monophosphate dehydrogenase.EBI
J Med Chem 52: 4623-30 (2009)
Brandeis University
Discovery of dermorphin-based affinity labels with subnanomolar affinity for mu opioid receptors.EBI
J Med Chem 52: 7372-5 (2009)
The University of Kansas
Enzymatic transition states and dynamic motion in barrier crossing.EBI
Nat Chem Biol 5: 551-8 (2009)
Albert Einstein College of Medicine
Rational design, synthesis and characterization of potent, non-peptidic Smac mimics/XIAP inhibitors as proapoptotic agents for cancer therapy.BDB
Bioorg Med Chem 17: 5834-56 (2009)
Universita Degli Studi Di Milano
Synthesis, biological evaluation, and metabolic stability of acrylamide derivatives as novel CCR3 antagonists.EBI
Bioorg Med Chem 17: 5989-6002 (2009)
Astellas Pharma
Aerobic oxidation of indolomorphinan without the 4,5-epoxy bridge and subsequent rearrangement of the oxidation product to spiroindolinonyl-C-normorphinan derivative.EBI
Bioorg Med Chem 17: 5983-8 (2009)
Kitasato University
Discovery of leukotriene A4 hydrolase inhibitors using metabolomics biased fragment crystallography.EBI
J Med Chem 52: 4694-715 (2009)
Decode Biostructures
Design, synthesis, enzyme inhibition, and tumor cell growth inhibition of 2-anilinobenzamide derivatives as SIRT1 inhibitors.EBI
Bioorg Med Chem 17: 5900-5 (2009)
Nagoya City University
The marine natural-derived inhibitors of glycogen synthase kinase-3beta phenylmethylene hydantoins: In vitro and in vivo activities and pharmacophore modeling.EBI
Bioorg Med Chem 17: 6032-9 (2009)
University of Louisiana At Monroe
Design, synthesis, and structure-activity relationships of 1,3-dihydrobenzimidazol-2-one analogues as anti-HIV agents.EBI
Bioorg Med Chem 17: 5962-7 (2009)
Universit£
Discovery of pyridone-containing imidazolines as potent and selective inhibitors of neuropeptide Y Y5 receptor.EBI
Bioorg Med Chem 17: 6106-22 (2009)
Tsukuba Research Institute
Dihydroxy-pyrimidine and N-methylpyrimidone HIV-integrase inhibitors: improving cell based activity by the quaternarization of a chiral center.EBI
Bioorg Med Chem Lett 19: 4617-21 (2009)
Irbm-Merck Research Laboratories Rome
Benzothiophene inhibitors of MK2. Part 1: structure-activity relationships, assessments of selectivity and cellular potency.EBI
Bioorg Med Chem Lett 19: 4878-81 (2009)
Pfizer
Discovery of (3-endo)-3-(2-cyano-2,2-diphenylethyl)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octane bromide as an efficacious inhaled muscarinic acetylcholine receptor antagonist for the treatment of COPD.EBI
Bioorg Med Chem Lett 19: 4560-2 (2009)
Glaxosmithkline
Benzothiophene inhibitors of MK2. Part 2: improvements in kinase selectivity and cell potency.EBI
Bioorg Med Chem Lett 19: 4882-4 (2009)
Pfizer
Synthesis and biological evaluation of 1,2,4-trisubstituted imidazoles and 1,3,5-trisubstituted pyrazoles as inhibitors of transforming growth factor beta type 1 receptor (ALK5).EBI
Bioorg Med Chem Lett 19: 4868-72 (2009)
Institute of Pharmacology and Toxicology
3D-QSAR CoMFA/CoMSIA models based on theoretical active conformers of HOE/BAY-793 analogs derived from HIV-1 protease inhibitor complexes.EBI
Eur J Med Chem 44: 4344-52 (2009)
Universidade Federal De Lavras
Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.EBI
Bioorg Med Chem Lett 19: 4579-83 (2009)
Pfizer
Design of selective Cathepsin inhibitors.EBI
Bioorg Med Chem Lett 19: 4622-5 (2009)
Astrazeneca
Discovery of orally active, pyrrolidinone-based progesterone receptor partial agonists.EBI
Bioorg Med Chem Lett 19: 4664-8 (2009)
Glaxosmithkline
Melanogenesis inhibitors from the rhizomes of Alpinia officinarum in B16 melanoma cells.EBI
Bioorg Med Chem 17: 6048-53 (2009)
Kyoto Pharmaceutical University
In vivo targeting of tumor-associated carbonic anhydrases using acetazolamide derivatives.EBI
Bioorg Med Chem Lett 19: 4851-6 (2009)
Institute of Pharmaceutical Sciences
The P1N-isopropyl motif bearing hydroxyethylene dipeptide isostere analogues of aliskiren are in vitro potent inhibitors of the human aspartyl protease renin.EBI
Bioorg Med Chem Lett 19: 4863-7 (2009)
Nagasaki International University
Discovery of imidazo[1,2-a]pyridines as potent MCH1R antagonists.EBI
Bioorg Med Chem Lett 19: 4589-93 (2009)
Tsukuba Research Institute
Synthesis and biological evaluation of 3,6-diamino-1H-pyrazolo[3,4-b]pyridine derivatives as protein kinase inhibitors.EBI
Bioorg Med Chem Lett 19: 4566-9 (2009)
Laboratorio De Radicales Libres Y QuÍMica Computacional (Iqog, Csic)
Investigation of the relative cellular permeability of DNA-binding pyrrole-imidazole polyamides.EBI
J Med Chem 52: 4604-12 (2009)
University of Texas Southwestern Medical Center
Inhibition of the insulin-like growth factor-1 receptor (IGF1R) tyrosine kinase as a novel cancer therapy approach.EBI
J Med Chem 52: 4981-5004 (2010)
University of South Florida
Combining hit identification strategies: fragment-based and in silico approaches to orally active 2-aminothieno[2,3-d]pyrimidine inhibitors of the Hsp90 molecular chaperone.BDB
J Med Chem 52: 4794-809 (2009)
Vernalis (R&D)
Inhibition of glyoxalase I: the first low-nanomolar tight-binding inhibitors.EBI
J Med Chem 52: 4650-6 (2009)
University of Minnesota
Novel indoline-based acyl-CoA: cholesterol acyltransferase inhibitor: Effects of introducing a methanesulfonamide group on physicochemical properties and biological activities.EBI
Bioorg Med Chem 17: 6020-31 (2009)
Kyoto Pharmaceutical Industries
Novel tricyclic antagonists of the prostaglandin D2 receptor DP2 with efficacy in a murine model of allergic rhinitis.EBI
Bioorg Med Chem Lett 19: 4647-51 (2009)
Amira Pharmaceuticals
Synthesis and biochemical evaluation of a range of sulfonated derivatives of 4-hydroxybenzyl imidazole as highly potent inhibitors of rat testicular 17alpha-hydroxylase/17,20-lyase (P-450(17alpha)).EBI
Bioorg Med Chem Lett 19: 4698-701 (2009)
University of The West of Scotland
Discovery of highly potent and selective biphenylacylsulfonamide-based beta3-adrenergic receptor agonists and molecular modeling based on the solved X-ray structure of the beta2-adrenergic receptor: part 6.EBI
Bioorg Med Chem Lett 19: 4679-83 (2009)
Astellas Pharma
Design, synthesis and preliminary biological evaluation of N-hydroxy-4-(3-phenylpropanamido)benzamide (HPPB) derivatives as novel histone deacetylase inhibitors.EBI
Eur J Med Chem 44: 4470-6 (2009)
Shandong University
3,5-Diphenylpent-2-enoic acids as allosteric activators of the protein kinase PDK1: structure-activity relationships and thermodynamic characterization of binding as paradigms for PIF-binding pocket-targeting compounds.EBI
J Med Chem 52: 4683-93 (2009)
Saarland University
N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.EBI
J Med Chem 52: 4757-73 (2009)
Universit£
Design, synthesis, and biological evaluation of 16-substituted 4-azasteroids as tissue-selective androgen receptor modulators (SARMs).EBI
J Med Chem 52: 4578-81 (2009)
Merck Research Laboratories
Dopamine D2, D3, and D4 selective phenylpiperazines as molecular probes to explore the origins of subtype specific receptor binding.EBI
J Med Chem 52: 4923-35 (2009)
Friedrich-Alexander University
Neglected tropical diseases: multi-target-directed ligands in the search for novel lead candidates against Trypanosoma and Leishmania.EBI
J Med Chem 52: 7339-59 (2009)
University of Bologna
Interaction of Mycobacterium tuberculosis CYP130 with heterocyclic arylamines.BDB
J Biol Chem 284: 25211-9 (2009)
University of California San Francisco
Discovery of a novel protein kinase B inhibitor by structure-based virtual screening.EBI
Bioorg Med Chem Lett 19: 4634-8 (2009)
Torrey Pines Institute For Molecular Studies
Synthesis and biological evaluation of imidazole derivatives as novel NOP/ORL1 receptor antagonists: exploration and optimization of alternative pyrazole structure.EBI
Bioorg Med Chem Lett 19: 4611-6 (2009)
Banyu Tsukuba Research Institute
Piperazinyl-glutamate-pyridines as potent orally bioavailable P2Y12 antagonists for inhibition of platelet aggregation.EBI
Bioorg Med Chem Lett 19: 4657-63 (2009)
Pfizer
Identification of N,1,4,4-Tetramethyl-8-{[4-(4-methylpiperazin-1-yl)phenyl]amino}-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide (PHA-848125), a Potent, Orally Available Cyclin Dependent Kinase Inhibitor.BDB
J Med Chem 52: 5152-63 (2009)
Nerviano Medical Sciences
A new glucagon and GLP-1 co-agonist eliminates obesity in rodents.EBI
Nat Chem Biol 5: 749-57 (2009)
Indiana University
Anti-human immunodeficiency virus activity, cross-resistance, cytotoxicity, and intracellular pharmacology of the 3'-azido-2',3'-dideoxypurine nucleosides.EBI
Antimicrob Agents Chemother 53: 3715-9 (2009)
University of Pittsburgh School of Medicine
High-throughput screening identifies three inhibitor classes of the telomere resolvase from the lyme disease spirochete.EBI
Antimicrob Agents Chemother 53: 4441-9 (2009)
University of Calgary
Synthesis and evaluation of a novel 2-azabicyclo[2.2.2]octane class of long chain fatty acid elongase 6 (ELOVL6) inhibitors.EBI
Bioorg Med Chem 17: 5639-47 (2009)
Tsukuba Research Institute
Synthesis and enzymatic evaluation of novel partially fluorinated thiol dual ACE/NEP inhibitors.EBI
Bioorg Med Chem Lett 19: 4715-9 (2009)
Dipartimento Di Chimica
Substituted pyrimidines as cannabinoid CB1 receptor ligands.EBI
Bioorg Med Chem Lett 19: 4692-7 (2009)
Green Cross
Design, synthesis and biological evaluation of new potent and highly selective ROS1-tyrosine kinase inhibitor.EBI
Bioorg Med Chem Lett 19: 4720-3 (2009)
Kyung Hee University
Selective inhibition of nicotinamide adenine dinucleotide kinases by dinucleoside disulfide mimics of nicotinamide adenine dinucleotide analogues.EBI
Bioorg Med Chem 17: 5656-64 (2009)
University of Minnesota
Design and synthesis of new 1,3-benzthiazinan-4-one derivatives as selective cyclooxygenase (COX-2) inhibitors.EBI
Bioorg Med Chem 17: 5369-73 (2009)
Shahid Beheshti University (M.C)
Identification of potential cellular targets of aloisine A by affinity chromatography.EBI
Bioorg Med Chem 17: 5572-82 (2009)
Cnrs Usr-3151
Design, synthesis and evaluation of a novel cyclohexanamine class of neuropeptide Y Y1 receptor antagonists.EBI
Bioorg Med Chem Lett 19: 4781-5 (2009)
Tsukuba Research Institute
Muscarinic receptor 1 agonist activity of novel N-aryl carboxamide substituted 3-morpholino arecoline derivatives in Alzheimer's presenile dementia models.EBI
Bioorg Med Chem 17: 5526-34 (2009)
University of Mysore
7-((4-Substituted)piperazin-1-yl) derivatives of ciprofloxacin: synthesis and in vitro biological evaluation as potential antitumor agents.EBI
Bioorg Med Chem 17: 5396-407 (2009)
Universit£
Synthesis, cannabinoid receptor affinity, molecular modeling studies and in vivo pharmacological evaluation of new substituted 1-aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamides. 2. Effect of the 3-carboxamide substituent on the affinity and selectivity profile.EBI
Bioorg Med Chem 17: 5549-64 (2009)
Sapienza University of Rome
Synthesis and opioid receptor activity of indolopropellanes.EBI
Bioorg Med Chem Lett 19: 4603-6 (2009)
Chinese Academy of Sciences
Rational design of orally-active, pyrrolidine-based progesterone receptor partial agonists.EBI
Bioorg Med Chem Lett 19: 4777-80 (2009)
Glaxosmithkline
Parallel synthesis of potent dopaminergic N-phenyltriazole carboxamides applying a novel click chemistry based phenol linker.EBI
Bioorg Med Chem 17: 5482-7 (2009)
Friedrich-Alexander University
Systematic syntheses of influenza neuraminidase inhibitors: a series of carbosilane dendrimers uniformly functionalized with thioglycoside-type sialic acid moieties.EBI
Bioorg Med Chem 17: 5451-64 (2009)
Saitama University
Highly tractable, sub-nanomolar non-steroidal glucocorticoid receptor agonists.EBI
Bioorg Med Chem Lett 19: 4846-50 (2009)
Glaxosmithkline
Novel derivatives of ISO-1 as potent inhibitors of MIF biological function.EBI
Bioorg Med Chem Lett 19: 4773-6 (2009)
Piramal Life Sciences
Effect of flavonoids on androgen and glucocorticoid receptors based on in vitro reporter gene assay.EBI
Bioorg Med Chem Lett 19: 4706-10 (2009)
Meijo University
7-Azaindole-3-acetic acid derivatives: potent and selective CRTh2 receptor antagonists.EBI
Bioorg Med Chem Lett 19: 4794-8 (2009)
Novartis Institutes of Biomedical Research
Novel, achiral aminoheterocycles as selective monoamine reuptake inhibitors.EBI
Bioorg Med Chem Lett 19: 4630-3 (2009)
Roche Palo Alto
Pyrazole acids as niacin receptor agonists for the treatment of dyslipidemia.EBI
Bioorg Med Chem Lett 19: 4768-72 (2009)
Merck Research Laboratories
Synthesis and biological evaluation of guanidino compounds endowed with subnanomolar affinity as competitive inhibitors of maize polyamine oxidase.EBI
J Med Chem 52: 4774-85 (2009)
Universit£
3,4-Diaryl-isoxazoles and -imidazoles as potent dual inhibitors of p38alpha mitogen activated protein kinase and casein kinase 1delta.EBI
J Med Chem 52: 7618-30 (2009)
Eberhard-Karls University
Imidazopyridine derivatives as potent and selective Polo-like kinase (PLK) inhibitors.EBI
Bioorg Med Chem Lett 19: 4673-8 (2009)
Banyu Tsukuba Research Institute
The glutamate receptor GluR5 agonist (S)-2-amino-3-(3-hydroxy-7,8-dihydro-6H-cyclohepta[d]isoxazol-4-yl)propionic acid and the 8-methyl analogue: synthesis, molecular pharmacology, and biostructural characterization.EBI
J Med Chem 52: 4911-22 (2009)
University of Copenhagen
Design of a new histamine H3 receptor antagonist chemotype: (3aR,6aR)-5-alkyl-1-aryl-octahydropyrrolo[3,4-b]pyrroles, synthesis, and structure-activity relationships.EBI
J Med Chem 52: 4640-9 (2009)
Abbott Laboratories
Synthesis and characterization of 6-deoxy-6-fluoro-D-fructose as a potential compound for imaging breast cancer with PET.EBI
Bioorg Med Chem 17: 5488-95 (2009)
University of Alberta
FXR agonist activity of conformationally constrained analogs of GW 4064.EBI
Bioorg Med Chem Lett 19: 4733-9 (2009)
Glaxosmithkline
Synthesis and in vitro evaluation of N-substituted maleimide derivatives as selective monoglyceride lipase inhibitors.EBI
J Med Chem 52: 7410-20 (2009)
Louvain Drug Research Institute
Discovery of novel thiourea derivatives as potent and selective beta3-adrenergic receptor agonists.EBI
Bioorg Med Chem 17: 5510-9 (2009)
Astellas Pharma
The identification and optimisation of novel and selective diamide neuropeptide Y Y2 receptor antagonists.EBI
Bioorg Med Chem Lett 19: 4022-5 (2009)
Glaxosmithkline
Aromatic 2-(thio)ureidocarboxylic acids as a new family of modulators of multidrug resistance-associated protein 1: synthesis, biological evaluation, and structure-activity relationships.EBI
J Med Chem 52: 4586-95 (2009)
University of Bonn
Carbonic anhydrase-encoded dynamic constitutional libraries: toward the discovery of isozyme-specific inhibitors.EBI
J Med Chem 52: 4853-9 (2009)
Enscm/Umii/Umr-Cnrs 5635
Nucleoside-5'-monophosphates as prodrugs of adenosine A2A receptor agonists activated by ecto-5'-nucleotidase.EBI
J Med Chem 52: 7669-77 (2009)
University of Bonn
Zebrafish chemical screening reveals an inhibitor of Dusp6 that expands cardiac cell lineages.EBI
Nat Chem Biol 5: 680-7 (2009)
University of Pittsburgh
Discriminatory synergistic effect of Trp-substitutions in superagonist [(Arg/Lys)(14), (Arg/Lys)(15)]nociceptin on ORL1 receptor binding and activation.EBI
Bioorg Med Chem 17: 5683-7 (2009)
Kyushu University
Synthesis and optimization of 2-pyridin-3-yl-benzo[d][1,3]oxazin-4-one based inhibitors of human neutrophil elastase.EBI
Bioorg Med Chem Lett 19: 4743-6 (2009)
Activx Biosciences
Potent, orally bioavailable, liver-selective stearoyl-CoA desaturase (SCD) inhibitors.EBI
Bioorg Med Chem Lett 19: 4070-4 (2009)
Gilead Sciences
The identification of potent, orally bioavailable tricyclic CGRP receptor antagonists.EBI
Bioorg Med Chem Lett 19: 4740-2 (2009)
Merck Research Laboratories
Synthesis, radiolabeling and preliminary in vivo evaluation of [18F]FE-PE2I, a new probe for the dopamine transporter.EBI
Bioorg Med Chem Lett 19: 4843-5 (2009)
Institutet
Heterocyclic replacement of the central phenyl core of diamine-based histamine H3 receptor antagonists.EBI
Eur J Med Chem 44: 4413-25 (2009)
Johnson & Johnson Pharmaceutical Research and Development
Identification, structure-activity relationships and molecular modeling of potent triamine and piperazine opioid ligands.EBI
Bioorg Med Chem 17: 5583-97 (2009)
Institute For Molecular Studies
From lead to preclinical candidate: optimization of beta-homophenylalanine based inhibitors of dipeptidyl peptidase IV.EBI
Bioorg Med Chem Lett 19: 4818-23 (2009)
Santhera Pharmaceuticals (Switzerland)
Synthesis and SAR studies of 1,4-diazabicyclo[3.2.2]nonane phenyl carbamates--subtype selective, high affinity alpha7 nicotinic acetylcholine receptor agonists.EBI
Bioorg Med Chem Lett 19: 4747-51 (2009)
Pfizer
Design and synthesis of BACE-1 inhibitors utilizing a tertiary hydroxyl motif as the transition state mimic.EBI
Bioorg Med Chem Lett 19: 4711-4 (2009)
Uppsala University
Discovery of novel dual functional agent as PPARgamma agonist and 11beta-HSD1 inhibitor for the treatment of diabetes.EBI
Bioorg Med Chem 17: 5722-32 (2009)
Chinese Academy of Sciences
Synergism of virtual screening and medicinal chemistry: identification and optimization of allosteric antagonists of metabotropic glutamate receptor 1.EBI
Bioorg Med Chem 17: 5708-15 (2009)
Merz Pharmaceuticals
Glucose-based spiro-heterocycles as potent inhibitors of glycogen phosphorylase.EBI
Bioorg Med Chem 17: 5696-707 (2009)
University of Debrecen
Part 1: Structure-Activity Relationship (SAR) investigations of fused pyrazoles as potent, selective and orally available inhibitors of p38alpha mitogen-activated protein kinase.EBI
Bioorg Med Chem Lett 19: 4724-8 (2009)
Amgen
Carbonic anhydrase inhibitors. Inhibition of the beta-class enzyme from the pathogenic yeast Candida glabrata with anions.EBI
Bioorg Med Chem Lett 19: 4802-5 (2009)
Universit£
Novel inhibitors of the alphavbeta3 integrin--lead identification strategy.EBI
Bioorg Med Chem Lett 19: 4832-5 (2009)
Astrazeneca
Determination of stereoselective interaction between enantiomers of chiral gamma-aryl-1H-1,2,4-triazole derivatives and Penicillium digitatum.EBI
J Agric Food Chem 57: 6914-9 (2009)
Central China Normal University
Cytotoxic pentacyclic triterpenoids from Combretum sundaicum and Lantana camara as inhibitors of Bcl-xL/BakBH3 domain peptide interaction.EBI
J Nat Prod 72: 1314-20 (2009)
Cnrs
Flaviviral protease inhibitors identified by fragment-based library docking into a structure generated by molecular dynamics.BDB
J Med Chem 52: 4860-8 (2009)
University of Zurich
Identification of inhibitors of checkpoint kinase 1 through template screening.BDB
J Med Chem 52: 4810-9 (2009)
The Institute of Cancer Research
9-(Arenethenyl)purines as dual Src/Abl kinase inhibitors targeting the inactive conformation: design, synthesis, and biological evaluation.EBI
J Med Chem 52: 4743-56 (2009)
Ariad Pharmaceuticals
1-alkyl-8-(piperazine-1-sulfonyl)phenylxanthines: development and characterization of adenosine A2B receptor antagonists and a new radioligand with subnanomolar affinity and subtype specificity.EBI
J Med Chem 52: 3994-4006 (2009)
Institute
Identification of MK-1925: a selective, orally active and brain-penetrable opioid receptor-like 1 (ORL1) antagonist.EBI
Bioorg Med Chem Lett 19: 4729-32 (2009)
Tsukuba Research Institute
4-(Phenylsulfonamidomethyl)benzamides as potent and selective inhibitors of the 11beta-hydroxysteroid dehydrogenase type 1 with efficacy in diabetic ob/ob mice.EBI
Bioorg Med Chem Lett 19: 4455-8 (2009)
Chinese Academy of Sciences
Synthesis and evaluation of 5-benzylidene(thio)barbiturate-beta-D-glycosides as mushroom tyrosinase inhibitors.EBI
Bioorg Med Chem Lett 19: 4055-8 (2009)
Sun Yat-Sen University
Bioactivity-guided mapping and navigation of chemical space.EBI
Nat Chem Biol 5: 585-92 (2009)
Institut FüR Molekulare Physiologie
Synthesis and biological evaluation of new 4-carboxyl quinoline derivatives as cyclooxygenase-2 inhibitors.EBI
Bioorg Med Chem 17: 5312-7 (2009)
Shahid Beheshti University (M.C)
An extended study of dimeric phenyl tropanes.EBI
Bioorg Med Chem 17: 4900-9 (2009)
Aarhus University
Conformationally restricted homotryptamines. Part 5: 3-(trans-2-aminomethylcyclopentyl)indoles as potent selective serotonin reuptake inhibitors.EBI
Bioorg Med Chem Lett 19: 4031-3 (2009)
Bristol-Myers Squibb Pharmaceutical Research Institute
Structure-Activity Relationship of novel phenylacetic CXCR1 inhibitors.EBI
Bioorg Med Chem Lett 19: 4026-30 (2009)
Grupo Uriach
Synthesis and evaluation of new endomorphin analogues modified at the Pro(2) residue.EBI
Bioorg Med Chem Lett 19: 4115-8 (2009)
Universit£
Dopamine D3 receptor antagonists: the quest for a potentially selective PET ligand. Part one: lead identification.EBI
Bioorg Med Chem Lett 19: 4799-801 (2009)
Cancer Therapeutics
Sulfonamides with the N-alkyl-N'-dialkylguanidine moiety as 5-HT7 receptor ligands.EBI
Bioorg Med Chem Lett 19: 4827-31 (2009)
Jagiellonian University Medical College
In vitro biological activity and structural analysis of 2,4-diamino-5-(2'-arylpropargyl)pyrimidine inhibitors of Candida albicans.EBI
Bioorg Med Chem 17: 4866-72 (2009)
University of Connecticut
Discovery of a new class of catalytic topoisomerase II inhibitors targeting the ATP-binding site by structure based design. Part I.EBI
Bioorg Med Chem Lett 19: 4014-7 (2009)
Novartis Institutes For Biomedical Research
Evaluation of structurally diverse neuronal nicotinic receptor ligands for selectivity at the alpha6( *) subtype.EBI
Bioorg Med Chem Lett 19: 4359-63 (2009)
Targacept
Identification of new Hsp90 inhibitors by structure-based virtual screening.EBI
Bioorg Med Chem Lett 19: 4839-42 (2009)
Seoul National University
'Click' D(1) receptor agonists with a 5-HT(1A) receptor pharmacophore producing D(2) receptor activity.EBI
Bioorg Med Chem 17: 4873-80 (2009)
Chinese Academy of Sciences
Synthesis of a novel series of benzylether-containing cinnamoyl derivatives as histone deacetylase inhibitors.BDB
J Enzyme Inhib Med Chem 25: 132-8 (2010)
Shandong University
Tetrahydrocarbazole amides with potent activity against human papillomaviruses.EBI
Bioorg Med Chem Lett 19: 4110-4 (2009)
Glaxosmithkline
Structural and theoretical studies of [6-bromo-1-(4-fluorophenylmethyl)-4(1H)-quinolinon-3-yl)]-4-hydroxy-2-oxo-3-buteno´c acid as HIV-1 integrase inhibitor.EBI
Bioorg Med Chem Lett 19: 4806-9 (2009)
Facult£S Universitaires Notre-Dame De La Paix
Discovery of a novel class of 2-mercaptohexanoic acid derivatives as highly active PPARalpha agonists.EBI
Bioorg Med Chem Lett 19: 4421-6 (2009)
Goethe-University Frankfurt
Design, synthesis, and biological evaluation of 3,4,5-trimethoxyphenyl acrylamides as antinarcotic agents.BDB
J Enzyme Inhib Med Chem 25: 38-43 (2010)
Ewha Womans University
Apogossypol derivatives as pan-active inhibitors of antiapoptotic B-cell lymphoma/leukemia-2 (Bcl-2) family proteins.BDB
J Med Chem 52: 4511-23 (2009)
Burnham Institute For Medical Research
Tyrosinase-inhibitory constituents from the twigs of Cinnamomum cassia.EBI
J Nat Prod 72: 1205-8 (2009)
Chungnam National University
Botryllamides: Natural Product Inhibitors of ABCG2.BDB
ACS Chem Biol 4: 637-47 (2009)
Saic-Frederick
Cell division cycle 7 kinase inhibitors: 1H-pyrrolo[2,3-b]pyridines, synthesis and structure-activity relationships.EBI
J Med Chem 52: 4380-90 (2009)
Nerviano Medical Sciences
Brain-penetrating 2-aminobenzimidazole H(1)-antihistamines for the treatment of insomnia.EBI
Bioorg Med Chem Lett 19: 4380-4 (2009)
Neurocrine Biosciences
Synthesis and SAR of novel tricyclic quinoxalinone inhibitors of poly(ADP-ribose)polymerase-1 (PARP-1).EBI
Bioorg Med Chem Lett 19: 4050-4 (2009)
Abbott Laboratories
Dopamine D(3) receptor antagonists: The quest for a potentially selective PET ligand. Part two: Lead optimization.EBI
Bioorg Med Chem Lett 19: 4011-3 (2009)
Glaxosmithkline
Discovery and optimization of a novel Neuromedin B receptor antagonist.EBI
Bioorg Med Chem Lett 19: 4264-7 (2009)
Amgen
Amidine derived inhibitors of acid-sensing ion channel-3 (ASIC3).EBI
Bioorg Med Chem Lett 19: 4059-63 (2009)
Merck
Development of a selective and potent radioactive ligand for histamine H(3) receptors: A compound potentially useful for receptor occupancy studies.EBI
Bioorg Med Chem Lett 19: 4075-8 (2009)
Tsukuba Research Institute
Discovery and structural analysis of Eph receptor tyrosine kinase inhibitors.EBI
Bioorg Med Chem Lett 19: 4467-70 (2009)
Institute
Identification of aminoethyl pyrrolo dihydroisoquinolinones as novel poly(ADP-ribose) polymerase-1 inhibitors.EBI
Bioorg Med Chem Lett 19: 4042-5 (2009)
Irbm-Merck Research Laboratories Rome
Inhibitory effects of 5-benzylidene barbiturate derivatives on mushroom tyrosinase and their antibacterial activities.EBI
Eur J Med Chem 44: 4235-43 (2009)
Sun Yat-Sen University
Synthesis, structure-activity relationships, and in vivo evaluation of N3-phenylpyrazinones as novel corticotropin-releasing factor-1 (CRF1) receptor antagonists.EBI
J Med Chem 52: 4173-91 (2009)
Bristol-Myers Squibb
In vitro intrinsic clearance-based optimization of N3-phenylpyrazinones as corticotropin-releasing factor-1 (CRF1) receptor antagonists.EBI
J Med Chem 52: 4161-72 (2009)
Bristol-Myers Squibb
Discovery of novel 2-aminobenzamide inhibitors of heat shock protein 90 as potent, selective and orally active antitumor agents.EBI
J Med Chem 52: 4288-305 (2009)
Serenex
Octahydropyrrolo[3,4-c]pyrrole: a diamine scaffold for construction of either alpha4beta2 or alpha7-selective nicotinic acetylcholine receptor (nAChR) ligands. Substitutions that switch subtype selectivity.EBI
J Med Chem 52: 4126-41 (2009)
Abbott Laboratories
Novel small molecule bradykinin B2 receptor antagonists.EBI
J Med Chem 52: 4370-9 (2009)
Jerini
Carbonic anhydrase inhibitors: inhibition of cytosolic carbonic anhydrase isozymes II and VII with simple aromatic sulfonamides and some azo dyes.BDB
Chem Biol Drug Des 74: 196-202 (2009)
Universita Degli Studi Di Firenze
Effect of some analgesics on paraoxonase-1 purified from human serum.BDB
J Enzyme Inhib Med Chem 24: 1034-9 (2009)
AtatÜRk University
Synthesis, binding, and modeling studies of new cytisine derivatives, as ligands for neuronal nicotinic acetylcholine receptor subtypes.EBI
J Med Chem 52: 4345-57 (2009)
Università
Effect of Candida glabrata FKS1 and FKS2 mutations on echinocandin sensitivity and kinetics of 1,3-beta-D-glucan synthase: implication for the existing susceptibility breakpoint.EBI
Antimicrob Agents Chemother 53: 3690-9 (2009)
University of Medicine and Dentistry of New Jersey
Structure-activity relationships and cancer-cell selective toxicity of novel inhibitors of glioma-associated oncogene homologue 1 (Gli1) mediated transcription.EBI
J Med Chem 52: 4277-87 (2009)
St. Jude Children'S Research Hospital
Synthesis and biological evaluation of SANT-2 and analogues as inhibitors of the hedgehog signaling pathway.EBI
Bioorg Med Chem 17: 4943-54 (2009)
University of Leipzig
Optimization of peptide-based inhibitors of prostate-specific antigen (PSA) as targeted imaging agents for prostate cancer.EBI
Bioorg Med Chem 17: 4888-93 (2009)
The Johns Hopkins University School of Medicine
Identification of substituted pyrazolo[1,5-a]quinazolin-5(4H)-one as potent poly(ADP-ribose)polymerase-1 (PARP-1) inhibitors.EBI
Bioorg Med Chem Lett 19: 4196-200 (2009)
Irbm-Merck Research Laboratories Rome
Novel and potent inhibitors of stearoyl-CoA desaturase-1. Part II: Identification of 4-ethylamino-3-(2-hydroxyethoxy)-N-[5-(3-trifluoromethylbenzyl)thiazol-2-yl]benzamide and its biological evaluation.EBI
Bioorg Med Chem Lett 19: 4159-66 (2009)
Daiichi Sankyo
Cyanoguanidine-based lactam derivatives as a novel class of orally bioavailable factor Xa inhibitors.EBI
Bioorg Med Chem Lett 19: 4034-41 (2009)
Bristol-Myers Squibb
Bioactive conformation analysis of cyclic imides as protoporphyrinogen oxidase inhibitor by combining DFT calculations, QSAR and molecular dynamic simulations.EBI
Bioorg Med Chem 17: 4935-42 (2009)
Central China Normal University
Nucleoside-amino acid conjugates: An alternative route to the design of ribonuclease A inhibitors.EBI
Bioorg Med Chem 17: 4921-7 (2009)
Institute of Technology
Purinergic P2X(7) receptor antagonists: Chemistry and fundamentals of biological screening.EBI
Bioorg Med Chem 17: 4861-5 (2009)
University of Sydney
Quantitative high-throughput screening identifies inhibitors of anthrax-induced cell death.EBI
Bioorg Med Chem 17: 5139-45 (2009)
National Human Genome Research Institute
Synthesis and investigations of double-pharmacophore ligands for treatment of chronic and neuropathic pain.EBI
Bioorg Med Chem 17: 5044-53 (2009)
University of Arizona
Tetrahydroisoquinolines as dopaminergic ligands: 1-Butyl-7-chloro-6-hydroxy-tetrahydroisoquinoline, a new compound with antidepressant-like activity in mice.EBI
Bioorg Med Chem 17: 4968-80 (2009)
Universidad De Valencia
Novel and potent inhibitors of stearoyl-CoA desaturase-1. Part I: Discovery of 3-(2-hydroxyethoxy)-4-methoxy-N-[5-(3-trifluoromethylbenzyl)thiazol-2-yl]benzamide.EBI
Bioorg Med Chem Lett 19: 4151-8 (2009)
Daiichi Sankyo
Aziridine alkaloids as potential therapeutic agents.EBI
Eur J Med Chem 44: 3373-87 (2009)
Liverpool John Moores University
Discovery of N-[(1-aryl-1H-indazol-5-yl)methyl]amides derivatives as smoothened antagonists for inhibition of the hedgehog pathway.EBI
Bioorg Med Chem Lett 19: 4191-5 (2009)
Irbm-Merck Research Laboratories Rome
Identification, synthesis and SAR of amino substituted pyrido[3,2b]pyrazinones as potent and selective PDE5 inhibitors.EBI
Bioorg Med Chem Lett 19: 4088-91 (2009)
Pfizer
Discovery of novel 2-(pyridine-2-yl)-1H-benzimidazole derivatives as potent glucokinase activators.EBI
Bioorg Med Chem Lett 19: 4450-4 (2009)
Banyu Tsukuba Research Institute
Separation of alpha-glucosidase-inhibitory and liver X receptor-antagonistic activities of phenethylphenyl phthalimide analogs and generation of LXRalpha-selective antagonists.EBI
Bioorg Med Chem 17: 5001-14 (2009)
The University of Tokyo
Proteochemometrics mapping of the interaction space for retroviral proteases and their substrates.EBI
Bioorg Med Chem 17: 5229-37 (2009)
Uppsala University
Carbonic anhydrase inhibitors. Aromatic/heterocyclic sulfonamides incorporating phenacetyl, pyridylacetyl and thienylacetyl tails act as potent inhibitors of human mitochondrial isoforms VA and VB.BDB
Bioorg Med Chem 17: 4894-9 (2009)
Istanbul University
A new small molecule that directly inhibits the DNA binding of NF-kappaB.EBI
Bioorg Med Chem 17: 5293-7 (2009)
Tokushima Bunri University
Aminopiperidine-fused imidazoles as dipeptidyl peptidase-IV inhibitors.EBI
Bioorg Med Chem Lett 19: 4097-101 (2009)
Merck
Investigation of aminopyridiopyrazinones as PDE5 inhibitors: Evaluation of modifications to the central ring system.EBI
Bioorg Med Chem Lett 19: 4092-6 (2009)
Pfizer
Chiral 3-(4,5-dihydrooxazol-2-yl)phenyl alkylcarbamates as novel FAAH inhibitors: Insight into FAAH enantioselectivity by molecular docking and interaction fields.EBI
Eur J Med Chem 44: 4179-91 (2009)
Helsinki University of Technology
Identification of an orally active opioid receptor-like 1 (ORL1) receptor antagonist 4-{3-[(2R)-2,3-dihydroxypropyl]-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl}-1-[(1S,3S,4R)-spiro[bicyclo[2.2.1]heptane-2,1'-cyclopropan]-3-ylmethyl]piperidine as clinical candidate.EBI
J Med Chem 52: 4091-4 (2009)
Tsukuba Research Institute
Discovery of molecular switches that modulate modes of metabotropic glutamate receptor subtype 5 (mGlu5) pharmacology in vitro and in vivo within a series of functionalized, regioisomeric 2- and 5-(phenylethynyl)pyrimidines.EBI
J Med Chem 52: 4103-6 (2009)
Vanderbilt University Medical Center
L337H mutant of rat neuronal nitric oxide synthase resembles human neuronal nitric oxide synthase toward inhibitors.EBI
J Med Chem 52: 4533-7 (2009)
Northwestern University
Improved, selective, human intestinal carboxylesterase inhibitors designed to modulate 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin (Irinotecan; CPT-11) toxicity.EBI
J Med Chem 52: 3742-52 (2009)
St. Jude Children'S Research Hospital
Structure-activity study of new inhibitors of human betaine-homocysteine S-methyltransferase.EBI
J Med Chem 52: 3652-65 (2009)
Academy of Sciences of The Czech Republic
Recent advances in the development of polyamine analogues as antitumor agents.EBI
J Med Chem 52: 4551-73 (2009)
Johns Hopkins University
Side chain flexibilities in the human ether-a-go-go related gene potassium channel (hERG) together with matched-pair binding studies suggest a new binding mode for channel blockers.EBI
J Med Chem 52: 4266-76 (2009)
Astrazeneca
Identification of peptide substrate and small molecule inhibitors of testis-specific serine/threonine kinase1 (TSSK1) by the developed assays.EBI
J Med Chem 52: 4419-28 (2009)
Chinese Academy of Medical Sciences & Peking Union Medical College
Discovery of 2-[5-(4-chloro-phenyl)-1-(2,4-dichloro-phenyl)-4-ethyl-1H-pyrazol-3-yl]-1,5,5-trimethyl-1,5-dihydro-imidazol-4-thione (BPR-890) via an active metabolite. A novel, potent and selective cannabinoid-1 receptor inverse agonist with high antiobesity efficacy in DIO mice.EBI
J Med Chem 52: 4496-510 (2009)
National Health Research Institutes
Discovery of a peroxisome proliferator activated receptor gamma (PPARgamma) modulator with balanced PPARalpha activity for the treatment of type 2 diabetes and dyslipidemia.EBI
J Med Chem 52: 4443-53 (2009)
Merck Research Laboratories
Identification and biochemical characterization of small-molecule inhibitors of Clostridium botulinum neurotoxin serotype A.EBI
Antimicrob Agents Chemother 53: 3478-86 (2009)
U.S. Army Medical Research Institute of Infectious Diseases
Diketoacid-genre HIV-1 integrase inhibitors containing enantiomeric arylamide functionality.EBI
Bioorg Med Chem 17: 5318-24 (2009)
National Cancer Institute-Frederick
Structure-activity studies on the nociceptin/orphanin FQ receptor antagonist 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4'-piperidin-1-yl]propyl} pyrrolidine-2-carboxamide.EBI
Bioorg Med Chem 17: 5080-95 (2009)
University of Ferrara
The protein tyrosine kinase inhibitors imatinib and nilotinib strongly inhibit several mammalian alpha-carbonic anhydrase isoforms.EBI
Bioorg Med Chem Lett 19: 4102-6 (2009)
University of Tampere and Tampere University Hospital
Design, synthesis and evaluation of aspirin analogues having an additional carboxylate substituent for antithrombotic activity.EBI
Bioorg Med Chem Lett 19: 4213-6 (2009)
Royal College of Surgeons In Ireland
Chemical and biological investigation of cyclopropyl containing diaryl-pyrazole-3-carboxamides as novel and potent cannabinoid type 1 receptor antagonists.EBI
J Med Chem 52: 4329-37 (2009)
Gedeon Richter
One scaffold, three binding modes: novel and selective pteridine reductase 1 inhibitors derived from fragment hits discovered by virtual screening.BDB
J Med Chem 52: 4454-65 (2009)
University of Dundee
Virtual screening approach for the identification of new Rac1 inhibitors.EBI
J Med Chem 52: 4087-90 (2009)
Universit£
Inhibition of hypoxanthine-guanine phosphoribosyltransferase by acyclic nucleoside phosphonates: a new class of antimalarial therapeutics.EBI
J Med Chem 52: 4391-9 (2009)
The University of Queensland
Identification of PDE4B Over 4D subtype-selective inhibitors revealing an unprecedented binding mode.BDB
Bioorg Med Chem 17: 5336-41 (2009)
Gsk
Novel orally active NPY Y5 receptor antagonists: Synthesis and structure-activity relationship of spiroindoline class compounds.EBI
Bioorg Med Chem 17: 5015-26 (2009)
Tsukuba Research Institute
[(11)C]PR04.MZ, a promising DAT ligand for low concentration imaging: Synthesis, efficient (11)C-O-methylation and initial small animal PET studies.EBI
Bioorg Med Chem Lett 19: 4343-5 (2009)
Brookhaven National Laboratory
Diaminocyclobutenediones as potent and orally bioavailable CXCR2 receptor antagonists: SAR in the phenolic amide region.EBI
Bioorg Med Chem Lett 19: 4446-9 (2009)
Schering-Plough Research Institute
N-[(Dihydroxyphenyl)acyl]serotonins as potent inhibitors of tyrosinase from mouse and human melanoma cells.EBI
Bioorg Med Chem Lett 19: 4178-82 (2009)
National Institute of Advanced Industrial Science and Technology
5-N,N-Disubstituted 5-aminopyrazole-3-carboxylic acids are highly potent agonists of GPR109b.EBI
Bioorg Med Chem Lett 19: 4207-9 (2009)
Arena Pharmaceuticals
Selective naphthalene H(3) receptor inverse agonists with reduced potential to induce phospholipidosis and their quinoline analogs.EBI
Bioorg Med Chem Lett 19: 4495-500 (2009)
Hoffmann-La Roche
Regioselective synthesis of methylated epigallocatechin gallate via nitrobenzenesulfonyl (Ns) protecting group.EBI
Bioorg Med Chem Lett 19: 4171-4 (2009)
University of Shizuoka and Global Coe Program
Diamine-based human histamine H3 receptor antagonists: (4-aminobutyn-1-yl)benzylamines.EBI
Eur J Med Chem 44: 4098-106 (2009)
Johnson & Johnson Pharmaceutical Research & Development
Synthesis and structure-activity relationship of 3beta-(4-alkylthio, -methylsulfinyl, and -methylsulfonylphenyl)tropane and 3beta-(4-alkylthiophenyl)nortropane derivatives for monoamine transporters.EBI
Bioorg Med Chem 17: 5126-32 (2009)
Research Triangle Institute
Synthesis of uracil nucleotide analogs with a modified, acyclic ribose moiety as P2Y(2) receptor antagonists.EBI
Bioorg Med Chem 17: 5071-9 (2009)
University of Bonn
Novel 1-aminoethyl-3-arylsulfonyl-1H-pyrrolo[2,3-b]pyridines are potent 5-HT(6) agonists.EBI
Bioorg Med Chem 17: 5153-63 (2009)
Wyeth Research
2D-QSAR and 3D-QSAR/CoMFA analyses of the N-terminal substituted anthranilic acid based CCK(1) receptor antagonists: 'Hic Rhodus, hic saltus'.EBI
Bioorg Med Chem 17: 5198-206 (2009)
Aristotelian University of Thessaloniki
A stabilized demethoxyviridin derivative inhibits PI3 kinase.EBI
Bioorg Med Chem Lett 19: 4223-7 (2009)
Harvard Medical School
Prolonged stability by cyclization: Macrocyclic phosphino dipeptide isostere inhibitors of beta-secretase (BACE1).EBI
Bioorg Med Chem Lett 19: 4427-31 (2009)
Technische Universit£T M£Nchen
Identification and optimisation of a novel series of pyrimidine based cyclooxygenase-2 (COX-2) inhibitors. Utilisation of a biotransformation approach.EBI
Bioorg Med Chem Lett 19: 4509-14 (2009)
Glaxosmithkline
N-(4-Fluorobenzyl)-3-hydroxy-9,9-dimethyl-4-oxo-6,7,8,9-tetrahydro-4H-pyrazino[1,2-a]pyrimidine-2-carboxamides a novel class of potent HIV-1 integrase inhibitors.EBI
Bioorg Med Chem Lett 19: 4245-9 (2009)
Irbm-Mrl
Synergistic effect of zanamivir-porphyrin conjugates on inhibition of neuraminidase and inactivation of influenza virus.EBI
J Med Chem 52: 4903-10 (2009)
National Taiwan University
Synthesis and biological evaluation of a novel 3-sulfonyl-8-azabicyclo[3.2.1]octane class of long chain fatty acid elongase 6 (ELOVL6) inhibitors.EBI
J Med Chem 52: 4111-4 (2009)
Tsukuba Research Institute
Design, synthesis, and evaluation of indolinones as triple angiokinase inhibitors and the discovery of a highly specific 6-methoxycarbonyl-substituted indolinone (BIBF 1120).EBI
J Med Chem 52: 4466-80 (2009)
Boehringer Ingelheim Pharma
Structural assessment and biological evaluation of two N3S bombesin derivatives.EBI
J Med Chem 52: 4234-46 (2009)
Institutes of Radioisotopes-Radiodiagnostic Products and Biology
Discovery of a potent and orally active hedgehog pathway antagonist (IPI-926).EBI
J Med Chem 52: 4400-18 (2009)
Infinity Pharmaceuticals
Molecular modifications on carboxylic acid derivatives as potent histone deacetylase inhibitors: Activity and docking studies.EBI
Bioorg Med Chem 17: 5219-28 (2009)
Hacettepe University
Synthesis of novel purine nucleosides towards a selective inhibition of human butyrylcholinesterase.EBI
Bioorg Med Chem 17: 5106-16 (2009)
Faculdade De Ci£Ncias Da Universidade De Lisboa
Carbonic anhydrase inhibitors. Inhibition studies of a coral secretory isoform by sulfonamides.EBI
Bioorg Med Chem 17: 5054-8 (2009)
Centre Scientifique De Monaco
Unsymmetrical non-adamantyl N,N'-diaryl urea and amide inhibitors of soluble expoxide hydrolase.EBI
Bioorg Med Chem Lett 19: 4259-63 (2009)
Arete Therapeutics
Synthesis, structure-activity relationships, and biological profiles of a dihydrobenzoxathiin class of histamine H(3) receptor inverse agonists.EBI
Bioorg Med Chem Lett 19: 4232-6 (2009)
Tsukuba Research Institute
Identification of [4-[4-(methylsulfonyl)phenyl]-6-(trifluoromethyl)-2-pyrimidinyl] amines and ethers as potent and selective cyclooxygenase-2 inhibitors.EBI
Bioorg Med Chem Lett 19: 4504-8 (2009)
Glaxosmithkline
Discovery and functional evaluation of diverse novel human CB(1) receptor ligands.EBI
Bioorg Med Chem Lett 19: 4183-90 (2009)
Vernalis (R&D)
Think twice: understanding the high potency of bis(phenyl)methane inhibitors of thrombin.BDB
J Mol Biol 391: 552-64 (2009)
Philipps University Marburg
Potent triazolothione inhibitor of heat-shock protein-90.BDB
Chem Biol Drug Des 74: 43-50 (2009)
Bayer Healthcare
Novel 3alpha-methoxyserrat-14-en-21beta-ol (PJ-1) and 3beta-methoxyserrat-14-en-21beta-ol (PJ-2)-curcumin, kojic acid, quercetin, and baicalein conjugates as HIV agents.EBI
Bioorg Med Chem 17: 5238-46 (2009)
Osaka University of Pharmaceutical Sciences
Synthesis and biological evaluation of (11)C-labeled beta-galactosyl triazoles as potential PET tracers for in vivo LacZ reporter gene imaging.EBI
Bioorg Med Chem 17: 5117-25 (2009)
Katholieke Universiteit Leuven
SAR and biological evaluation of SEN12333/WAY-317538: Novel alpha 7 nicotinic acetylcholine receptor agonist.EBI
Bioorg Med Chem 17: 5247-58 (2009)
Wyeth Research
Substituted benzothiadizine inhibitors of Hepatitis C virus polymerase.EBI
Bioorg Med Chem Lett 19: 4350-3 (2009)
Glaxosmithkline
Fatty acid amide hydrolase inhibitors. Surprising selectivity of chiral azetidine ureas.EBI
Bioorg Med Chem Lett 19: 4241-4 (2009)
Vernalis (R&D)
Dipeptidyl nitrile inhibitors of Cathepsin L.BDB
Bioorg Med Chem Lett 19: 4280-3 (2009)
Astrazeneca
Discovery of beta-homophenylalanine based pyrrolidin-2-ylmethyl amides and sulfonamides as highly potent and selective inhibitors of dipeptidyl peptidase IV.EBI
Bioorg Med Chem Lett 19: 4201-3 (2009)
Santhera Pharmaceuticals (Switzerland)
HIF-1alpha peptide derivatives with modifications at the hydroxyproline residue as activators of HIF-1alpha.EBI
Bioorg Med Chem Lett 19: 4403-5 (2009)
Institute of Science and Technology
Discovery of potent competitive inhibitors of indoleamine 2,3-dioxygenase with in vivo pharmacodynamic activity and efficacy in a mouse melanoma model.EBI
J Med Chem 52: 7364-7 (2009)
Incyte
Discovery of (2R)-2-(3-{3-[(4-Methoxyphenyl)carbonyl]-2-methyl-6-(trifluoromethoxy)-1H-indol-1-yl}phenoxy)butanoic acid (MK-0533): a novel selective peroxisome proliferator-activated receptor gamma modulator for the treatment of type 2 diabetes mellitus with a reduced potential to increase plasma aEBI
J Med Chem 52: 3846-54 (2009)
Merck Research Laboratories
Structure-activity relationships of memoquin: Influence of the chain chirality in the multi-target mechanism of action.EBI
Bioorg Med Chem Lett 19: 4312-5 (2009)
Alma Mater Studiorum-Bologna University
Synthesis and structure-activity relationships of gamma-carboline derivatives as potent and selective cysLT(1) antagonists.EBI
Bioorg Med Chem Lett 19: 4299-302 (2009)
Universitat De Barcelona
Eusynstyelamides A, B, and C, nNOS inhibitors, from the ascidian Eusynstyela latericius.EBI
J Nat Prod 72: 1115-20 (2009)
Institute of Marine Science
Molecular recognition in the P2Y(14) receptor: Probing the structurally permissive terminal sugar moiety of uridine-5'-diphosphoglucose.EBI
Bioorg Med Chem 17: 5298-311 (2009)
National Institute of Diabetes and Digestive and Kidney Diseases
Application of a 3,3-diphenylpentane skeleton as a multi-template for creation of HMG-CoA reductase inhibitors.EBI
Bioorg Med Chem Lett 19: 4228-31 (2009)
The University of Tokyo
Pyrimido[5,4-e][1,2,4]triazine-5,7(1H,6H)-dione derivatives as novel small molecule chaperone amplifiers.EBI
Bioorg Med Chem Lett 19: 4303-7 (2009)
Cytrx
Identification of a chromone-based retinoid containing a polyolefinic side chain via facile synthetic routes.EBI
Bioorg Med Chem Lett 19: 4339-42 (2009)
Temple University
Combining selectivity and affinity predictions using an integrated Support Vector Machine (SVM) approach: An alternative tool to discriminate between the human adenosine A(2A) and A(3) receptor pyrazolo-triazolo-pyrimidine antagonists binding sites.EBI
Bioorg Med Chem 17: 5259-74 (2009)
Universit£
SAR of a series of inhaled A(2A) agonists and comparison of inhaled pharmacokinetics in a preclinical model with clinical pharmacokinetic data.EBI
Bioorg Med Chem Lett 19: 4471-5 (2009)
Pfizer
Diazen-1-ium-1,2-diolated nitric oxide donor ester prodrugs of 5-(4-carboxymethylphenyl)-1-(4-methanesulfonylphenyl)-3-trifluoromethyl-1H-pyrazole and its aminosulfonyl analog: Synthesis, biological evaluation and nitric oxide release studies.EBI
Bioorg Med Chem 17: 5182-8 (2009)
University of Alberta
Design and synthesis of 3,5-diarylisoxazole derivatives as novel class of anti-hyperglycemic and lipid lowering agents.EBI
Bioorg Med Chem 17: 5285-92 (2009)
Central Drug Research Institute
Optimization of piperidin-4-yl-urea-containing melanin-concentrating hormone receptor 1 (MCH-R1) antagonists: Reducing hERG-associated liabilities.EBI
Bioorg Med Chem Lett 19: 4274-9 (2009)
Astrazeneca R & D M£Lndal
Rapid assessment of a novel series of selective CB(2) agonists using parallel synthesis protocols: A Lipophilic Efficiency (LipE) analysis.EBI
Bioorg Med Chem Lett 19: 4406-9 (2009)
Pfizer
Optimization of 2-piperidin-4-yl-acetamides as melanin-concentrating hormone receptor 1 (MCH-R1) antagonists: Designing out hERG inhibition.EBI
Bioorg Med Chem Lett 19: 4268-73 (2009)
Astrazeneca R & D M£Lndal
Structure-based virtual screening approach to identify novel classes of Cdc25B phosphatase inhibitors.EBI
Bioorg Med Chem Lett 19: 4372-5 (2009)
Sejong University
An efficient steroid pharmacophore-based strategy to identify new aromatase inhibitors.EBI
Eur J Med Chem 44: 4121-7 (2009)
Universidade De Coimbra
Studies towards the identification of putative bioactive conformation of potent vasodilator arylidene N-acylhydrazone derivatives.EBI
Eur J Med Chem 44: 4004-9 (2009)
Universidade Federal Do Rio De Janeiro
Functionalized congeners of A3 adenosine receptor-selective nucleosides containing a bicyclo[3.1.0]hexane ring system.EBI
J Med Chem 52: 7580-92 (2009)
National Institute of Diabetes and Digestive and Kidney Diseases
A small-molecule inhibitor of Nipah virus envelope protein-mediated membrane fusion.EBI
J Med Chem 52: 4257-65 (2009)
University of W£Rzburg
Design and synthesis of orally bioavailable serum and glucocorticoid-regulated kinase 1 (SGK1) inhibitors.EBI
Bioorg Med Chem Lett 19: 4441-5 (2009)
Glaxosmithkline
Structure-based de novo design and biochemical evaluation of novel Cdc25 phosphatase inhibitors.EBI
Bioorg Med Chem Lett 19: 4330-4 (2009)
Sejong University
QSAR study of Akt/protein kinase B (PKB) inhibitors using support vector machine.EBI
Eur J Med Chem 44: 4090-7 (2009)
Zhejiang University
Active site directed docking studies: synthesis and pharmacological evaluation of cis-2,6-dimethyl piperidine sulfonamides as inhibitors of acetylcholinesterase.EBI
Eur J Med Chem 44: 4057-62 (2009)
University of Mysore
Synthesis and evaluation of A-seco type triterpenoids for anti-HIV-1protease activity.EBI
Eur J Med Chem 44: 4112-20 (2009)
University of Toyama
Structural optimization and biological evaluation of 2-substituted 5-hydroxyindole-3-carboxylates as potent inhibitors of human 5-lipoxygenase.BDB
J Med Chem 52: 3474-83 (2009)
Friedrich Alexander University Erlangen
Antagonism of c-IAP and XIAP proteins is required for efficient induction of cell death by small-molecule IAP antagonists.BDB
ACS Chem Biol 4: 557-66 (2009)
Genentech
Antagonists of the calcium receptor I. Amino alcohol-based parathyroid hormone secretagogues.EBI
J Med Chem 52: 3982-93 (2009)
Glaxosmithkline
Inhibition of sphingosine-1-phosphate lyase for the treatment of autoimmune disorders.EBI
J Med Chem 52: 3941-53 (2009)
Lexicon Pharmaceuticals
Discovery of novel aminothiadiazole amides as selective EP(3) receptor antagonists.EBI
Bioorg Med Chem Lett 19: 4292-5 (2009)
Glaxosmithkline
Optimization of a series of 2,4-diaminopyridines as neuropeptide Y Y1 receptor antagonists with reduced hERG activity.EBI
Bioorg Med Chem Lett 19: 4325-9 (2009)
Tsukuba Research Institute
Site-activated multifunctional chelator with acetylcholinesterase and neuroprotective-neurorestorative moieties for Alzheimer's therapy.EBI
J Med Chem 52: 4095-8 (2009)
Institute of Science
Scalarane-based sesterterpenoid RCE-protease inhibitors isolated from the Indonesian marine sponge Carteriospongia foliascens.EBI
J Nat Prod 72: 1106-9 (2009)
University of British Columbia
Phage-encoded combinatorial chemical libraries based on bicyclic peptides.EBI
Nat Chem Biol 5: 502-7 (2009)
Laboratory of Molecular Biology, Medical Research Council
Retinoid receptor subtype-selective modulators through synthetic modifications of RARgamma agonists.EBI
Bioorg Med Chem 17: 4345-59 (2009)
Universidade De Vigo
Bicyclic cyanothiazolidines as novel dipeptidyl peptidase 4 inhibitors.EBI
Bioorg Med Chem Lett 19: 4437-40 (2009)
Phenomix
Synthesis and bioactivity of substituted indan-1-ylideneaminoguanidine derivatives.EBI
Eur J Med Chem 44: 3771-6 (2009)
China Pharmaceutical University
Potential antioxidants and tyrosinase inhibitors from synthetic polyphenolic deoxybenzoins.EBI
Bioorg Med Chem 17: 4360-6 (2009)
National Taiwan University
Synthesis and biological evaluation of novel carbon-11 labeled pyridyl ethers: candidate ligands for in vivo imaging of alpha4beta2 nicotinic acetylcholine receptors (alpha4beta2-nAChRs) in the brain with positron emission tomography.EBI
Bioorg Med Chem 17: 4367-77 (2009)
The Johns Hopkins University School of Medicine
Synthesis of hybrid analogues of caffeine and eudistomin D and its affinity for adenosine receptors.EBI
Bioorg Med Chem 17: 4280-4 (2009)
Hokkaido University
Design, synthesis and dopamine D4 receptor binding activities of new N-heteroaromatic 5/6-ring Mannich bases.EBI
Bioorg Med Chem 17: 4448-58 (2009)
Friedrich-Alexander-Universit£T
Discovery of spirocyclic secondary amine-derived tertiary ureas as highly potent, selective and bioavailable soluble epoxide hydrolase inhibitors.EBI
Bioorg Med Chem Lett 19: 3398-404 (2009)
Merck Research Laboratories
Novel and potent small-molecule urotensin II receptor agonists.EBI
Bioorg Med Chem 17: 4657-65 (2009)
University of Gothenburg
Design and synthesis of ten biphenyl-neolignan derivatives and their in vitro inhibitory potency against cyclooxygenase-1/2 activity and 5-lipoxygenase-mediated LTB4-formation.EBI
Bioorg Med Chem 17: 4459-65 (2009)
Karl-Franzens-Universit£T Graz
Synthesis and biological evaluation of novel 4-azaindolyl-indolyl-maleimides as glycogen synthase kinase-3beta (GSK-3beta) inhibitors.EBI
Bioorg Med Chem 17: 4302-12 (2009)
Zhejiang University
Discovery of novel motilin antagonists: Conversion of tetrapeptide leads to orally available peptidomimetics.EBI
Bioorg Med Chem Lett 19: 3426-9 (2009)
Chugai Pharmaceutical
Substituted benzimidazoles: A novel chemotype for small molecule hKSP inhibitors.EBI
Bioorg Med Chem Lett 19: 3405-9 (2009)
Schering-Plough Research Institute
Novel sulfone-containing di- and trisubstituted cyclohexanes as potent CC chemokine receptor 2 (CCR2) antagonists.EBI
Bioorg Med Chem Lett 19: 3418-22 (2009)
Bristol-Myers Squibb
Synthesis of novel phosphorothioates and phosphorodithioates and their differential inhibition of cholinesterases.EBI
Bioorg Chem 37: 101-5 (2009)
Institute For Advanced Studies In Basic Sciences (Iasbs)
Isoform-specific inhibition of cyclophilins.BDB
Biochemistry 48: 6268-77 (2009)
Max Planck Research
Discovery, characterization and comparison of inhibitors of Bacillus anthracis and Staphylococcus aureus replicative DNA helicases.EBI
Bioorg Med Chem 17: 4466-76 (2009)
Microbiotix
Synthesis and biological activities of aminopyrimidyl-indoles structurally related to meridianins.EBI
Bioorg Med Chem 17: 4420-4 (2009)
Clermont Universit£
Second generation of BACE-1 inhibitors part 2: Optimisation of the non-prime side substituent.BDB
Bioorg Med Chem Lett 19: 3669-73 (2009)
Gsk
QSAR study on maximal inhibition (Imax) of quaternary ammonium antagonists for S-(-)-nicotine-evoked dopamine release from dopaminergic nerve terminals in rat striatum.EBI
Bioorg Med Chem 17: 4477-85 (2009)
University of Kentucky
Synthesis of quinolinyl and isoquinolinyl phenyl ketones as novel agonists for the cannabinoid CB2 receptor.EBI
Bioorg Med Chem 17: 4441-7 (2009)
Helsinki University of Technology
Hop (Humulus lupulus)-derived bitter acids as multipotent bioactive compounds.EBI
J Nat Prod 72: 1220-30 (2009)
Ghent University-Ugent
Chemical constituents from the aerial parts of Artemisia minor.EBI
J Nat Prod 72: 1198-201 (2009)
Chinese Academy of Sciences
Synthesis and structure-activity relationship of Huprine derivatives as human acetylcholinesterase inhibitors.EBI
Bioorg Med Chem 17: 4523-36 (2009)
Cobra
Synthesis and pharmacological evaluation of 1,2,3,4-tetrahydropyrazino[1,2-a]indole and 2-[(phenylmethylamino)methyl]-1H-indole analogues as novel melatoninergic ligands.EBI
Bioorg Med Chem 17: 4583-94 (2009)
University of W£Rzburg
N-(Pyridin-2-yl) arylsulfonamide inhibitors of 11beta-hydroxysteroid dehydrogenase type 1: Discovery of PF-915275.BDB
Bioorg Med Chem Lett 19: 3493-7 (2009)
Pfizer
Substitution of arginine with proline and proline derivatives in melanocyte-stimulating hormones leads to selectivity for human melanocortin 4 receptor.EBI
J Med Chem 52: 3627-35 (2009)
University of Arizona
Further studies at neuropeptide s position 5: discovery of novel neuropeptide S receptor antagonists.EBI
J Med Chem 52: 4068-71 (2009)
National Institute of Neuroscienc
Novel potent BRAF inhibitors: toward 1 nM compounds through optimization of the central phenyl ring.EBI
J Med Chem 52: 3881-91 (2009)
The Institute of Cancer Research
Design of HIV-1 protease inhibitors with pyrrolidinones and oxazolidinones as novel P1'-ligands to enhance backbone-binding interactions with protease: synthesis, biological evaluation, and protein-ligand X-ray studies.BDB
J Med Chem 52: 3902-14 (2009)
Purdue University
Competitive inhibition of human poly(A)-specific ribonuclease (PARN) by synthetic fluoro-pyranosyl nucleosides.BDB
Biochemistry 48: 6044-51 (2009)
University of Thessaly
Curcumin modulates efflux mediated by yeast ABC multidrug transporters and is synergistic with antifungals.EBI
Antimicrob Agents Chemother 53: 3256-65 (2009)
Jawaharlal Nehru University
Molecular basis and phenotype of methicillin resistance in Staphylococcus aureus and insights into new beta-lactams that meet the challenge.EBI
Antimicrob Agents Chemother 53: 4051-63 (2009)
University of Notre Dame
Synthesis and evaluation of a series of heterobiarylamides that are centrally penetrant metabotropic glutamate receptor 4 (mGluR4) positive allosteric modulators (PAMs).EBI
J Med Chem 52: 4115-8 (2009)
Vanderbilt University Medical Center
Improvement of pharmacological properties of irreversible thyroid receptor coactivator binding inhibitors.EBI
J Med Chem 52: 3892-901 (2009)
St. Jude Children'S Hospital
1-amino-4-benzylphthalazines as orally bioavailable smoothened antagonists with antitumor activity.EBI
J Med Chem 52: 3954-68 (2009)
Novartis Institutes For Biomedical Research
Synthesis and evaluation of sphingosine analogues as inhibitors of sphingosine kinases.EBI
J Med Chem 52: 3618-26 (2009)
National University of Singapore
Identification of anxiolytic/nonsedative agents among indol-3-ylglyoxylamides acting as functionally selective agonists at the gamma-aminobutyric acid-A (GABAA) alpha2 benzodiazepine receptor.EBI
J Med Chem 52: 3723-34 (2009)
Universita Di Pisa
Discovery of novel lipophilic inhibitors of OXA-10 enzyme (class D beta-lactamase) by screening amino analogs and homologs of citrate and isocitrate.EBI
Bioorg Med Chem Lett 19: 3593-7 (2009)
Universit£
Orally active C-6 heteroaryl- and heterocyclyl-substituted imidazo[1,2-a]pyridine acid pump antagonists (APAs).EBI
Bioorg Med Chem Lett 19: 3602-6 (2009)
Glaxosmithkline
Synthesis and biological evaluation of novel 4,5-bis(dialkylaminoalkyl)-substituted acridines as potent telomeric G-quadruplex ligands.EBI
Eur J Med Chem 44: 3880-8 (2009)
Universit£
Iodophenyl tagged sphingosine derivatives: synthesis and preliminary biological evaluation.EBI
Bioorg Med Chem Lett 19: 3382-5 (2009)
University of Pennsylvania
Carbamates as potent calcitonin gene-related peptide antagonists with improved solution stability.EBI
Bioorg Med Chem Lett 19: 3555-8 (2009)
Bristol-Myers Squibb Research and Development
Inhibitor hijacking of Akt activation.EBI
Nat Chem Biol 5: 484-93 (2009)
University of California
6-Amino-2-mercapto-3H-pyrimidin-4-one derivatives as new candidates for the antagonism at the P2Y12 receptors.EBI
Bioorg Med Chem 17: 4612-21 (2009)
Universit£
Identification of novel serotonin 2C receptor ligands by sequential virtual screening.EBI
Bioorg Med Chem 17: 4559-68 (2009)
Institute of Science and Technology
Aryl urea derivatives of spiropiperidines as NPY Y5 receptor antagonists.EBI
Bioorg Med Chem Lett 19: 3511-6 (2009)
Tsukuba Research Institute
Exploration and optimization of substituted triazolothiadiazines and triazolopyridazines as PDE4 inhibitors.BDB
Bioorg Med Chem Lett 19: 3686-92 (2009)
National Human Genome Research Institute
Synthesis and activity of quinolinylmethyl P1' alpha-sulfone piperidine hydroxamate inhibitors of TACE.BDB
Bioorg Med Chem Lett 19: 3445-8 (2009)
Wyeth Research
Selective inhibitors of tumor progression loci-2 (Tpl2) kinase with potent inhibition of TNF-alpha production in human whole blood.BDB
Bioorg Med Chem Lett 19: 3485-8 (2009)
Wyeth Research
Synthesis and structure-activity relationships of N-(4-amino-2,6-diisopropylphenyl)-N'-(1,4-diarylpiperidine-4-yl)methylureas as anti-hyperlipidemic agents.EBI
Bioorg Med Chem 17: 4636-46 (2009)
Dainippon Sumitomo Pharma
Structure-activity relationships of heteroaromatic esters as human rhinovirus 3C protease inhibitors.EBI
Bioorg Med Chem Lett 19: 3632-6 (2009)
Institute of Science and Technology
Nascent structure-activity relationship study of a diastereomeric series of kappa opioid receptor antagonists derived from CJ-15,208.EBI
Bioorg Med Chem Lett 19: 3647-50 (2009)
Adolor
Identification of a PPARdelta agonist with partial agonistic activity on PPARgamma.BDB
Bioorg Med Chem Lett 19: 3550-4 (2009)
Amgen
Structurally simple inhibitors of lanosterol 14alpha-demethylase are efficacious in a rodent model of acute Chagas disease.EBI
J Med Chem 52: 3703-15 (2009)
University of Washington
High-affinity, non-nucleotide-derived competitive antagonists of platelet P2Y12 receptors.EBI
J Med Chem 52: 3784-93 (2009)
University of Bonn
Hybrid compound design to overcome the gatekeeper T338M mutation in cSrc.BDB
J Med Chem 52: 3915-26 (2009)
Chemical Genomics Centre of The Max Planck Society
Inhibition of dynamin mediated endocytosis by the dynoles--synthesis and functional activity of a family of indoles.EBI
J Med Chem 52: 3762-73 (2009)
The University of Newcastle
Discovery of tetrasubstituted imidazolines as potent and selective neuropeptide Y Y5 receptor antagonists: reduced human ether-a-go-go related gene potassium channel binding affinity and potent antiobesity effect.EBI
J Med Chem 52: 3385-96 (2009)
Tsukuba Research Institute
Sesterterpenes as tubulin tyrosine ligase inhibitors. First insight of structure-activity relationships and discovery of new lead.EBI
J Med Chem 52: 3814-28 (2009)
Universita Di Salerno
The structure-based design, synthesis, and biological evaluation of DNA-binding amide linked bisintercalating bisanthrapyrazole anticancer compounds.EBI
Bioorg Med Chem 17: 4575-82 (2009)
University of Manitoba
Hit-to-lead optimization of pyrrolo[1,2-a]quinoxalines as novel cannabinoid type 1 receptor antagonists.EBI
Bioorg Med Chem Lett 19: 3471-5 (2009)
Gedeon Richter
Design and optimization of renin inhibitors: Orally bioavailable alkyl amines.BDB
Bioorg Med Chem Lett 19: 3541-5 (2009)
Vitae Pharmaceuticals
Identification of a disruptor of the MDM2-p53 protein-protein interaction facilitated by high-throughput in silico docking.BDB
Bioorg Med Chem Lett 19: 3756-9 (2009)
H. Lee Moffitt Cancer Center
Identification of 2-aminobenzimidazoles as potent melanin-concentrating hormone 1-receptor (MCH1R) antagonists.BDB
Bioorg Med Chem Lett 19: 3568-72 (2009)
Banyu Pharmaceutical
Compelling P1 substituent affect on metalloprotease binding profile enables the design of a novel cyclohexyl core scaffold with excellent MMP selectivity and HER-2 sheddase inhibition.EBI
Bioorg Med Chem Lett 19: 3525-30 (2009)
Incyte
Non-isotopic dual parameter competition assay suitable for high-throughput screening of histone deacetylases.EBI
Bioorg Med Chem Lett 19: 3651-6 (2009)
University of G£Ttingen
Fenbufen based 3-[5-(substituted aryl)-1,3,4-oxadiazol-2-yl]-1-(biphenyl-4-yl)propan-1-ones as safer antiinflammatory and analgesic agents.EBI
Eur J Med Chem 44: 3798-804 (2009)
Hamdard University
Inhibition of staphyloxanthin virulence factor biosynthesis in Staphylococcus aureus: in vitro, in vivo, and crystallographic results.EBI
J Med Chem 52: 3869-80 (2009)
University of Illinois At Urbana-Champaign
5-hydroxyindole-2-carboxylic acid amides: novel histamine-3 receptor inverse agonists for the treatment of obesity.EBI
J Med Chem 52: 3855-68 (2009)
F. Hoffmann-La Roche
Design, synthesis and primary activity evaluation of L-arginine derivatives as amino-peptidase N/CD13 inhibitors.EBI
Bioorg Med Chem 17: 4666-73 (2009)
Shandong University
N-Substituted-2-alkyl- and 2-arylnorapomorphines: novel, highly active D2 agonists.EBI
Bioorg Med Chem 17: 4756-62 (2009)
University of Tartu
The novel CXCR4 antagonist KRH-3955 is an orally bioavailable and extremely potent inhibitor of human immunodeficiency virus type 1 infection: comparative studies with AMD3100.EBI
Antimicrob Agents Chemother 53: 2940-8 (2009)
National Institute of Infectious Diseases
Synthesis and structure-activity relationships of C-glycosylated oxadiazoles as inhibitors of glycogen phosphorylase.EBI
Bioorg Med Chem 17: 4773-85 (2009)
University of Debrecen
Analysis of binding parameters of HIV-1 integrase inhibitors: correlates of drug inhibition and resistance.EBI
Bioorg Med Chem 17: 4806-18 (2009)
University of Cyprus
Carbonic anhydrase inhibitors. Inhibition and homology modeling studies of the fungal beta-carbonic anhydrase from Candida albicans with sulfonamides.BDB
Bioorg Med Chem 17: 4503-9 (2009)
Universite Degli Studi Di Firenze
Human sialidase inhibitors: design, synthesis, and biological evaluation of 4-acetamido-5-acylamido-2-fluoro benzoic acids.EBI
Bioorg Med Chem 17: 4595-603 (2009)
Gifu University
Discovery and structure-guided drug design of inhibitors of 11beta-hydroxysteroid-dehydrogenase type I based on a spiro-carboxamide scaffold.BDB
Bioorg Med Chem Lett 19: 3682-5 (2009)
Merck Serono
A versatile photoactivatable probe designed to label the diphosphate binding site of farnesyl diphosphate utilizing enzymes.EBI
Bioorg Med Chem 17: 4797-805 (2009)
University of Minnesota
The discovery of the potent aurora inhibitor MK-0457 (VX-680).EBI
Bioorg Med Chem Lett 19: 3586-92 (2009)
Vertex Pharmaceuticals
Exploration of novel thiobarbituric acid-, rhodanine- and thiohydantoin-based HIV-1 integrase inhibitors.EBI
Bioorg Med Chem Lett 19: 3615-8 (2009)
Universit£
In vitro inhibition of human erythrocyte glutathione reductase by some new organic nitrates.EBI
Bioorg Med Chem Lett 19: 3661-3 (2009)
Atat£Rk University
Preparation of L-proline based aeruginosin 298-A analogs: optimization of the P1-moiety.EBI
Bioorg Med Chem Lett 19: 3798-803 (2009)
University of New Orleans
Identification of a novel inhibitor of JAK2 tyrosine kinase by structure-based virtual screening.EBI
Bioorg Med Chem Lett 19: 3598-601 (2009)
Semmelweis University
Serratezomines D and E, new Lycopodium alkaloids from Lycopodium serratum var. serratum.EBI
Bioorg Med Chem Lett 19: 3577-80 (2009)
Hokkaido University
Nocathiacin analogs: Synthesis and antibacterial activity of novel water-soluble amides.EBI
Bioorg Med Chem Lett 19: 3531-5 (2009)
Merck Research Laboratories
Optimization of 5-phenyl-3-pyridinecarbonitriles as PKCtheta inhibitors.EBI
Bioorg Med Chem Lett 19: 3623-6 (2009)
Wyeth Research
Discovery of novel arylpyrazole series as potent and selective opioid receptor-like 1 (ORL1) antagonists.BDB
Bioorg Med Chem Lett 19: 3627-31 (2009)
Banyu Pharmaceutical
Design, synthesis and pharmacological evaluation of new 1-[3-(4-arylpiperazin-1-yl)-2-hydroxy-propyl]-3,3-diphenylpyrrolidin-2-one derivatives with antiarrhythmic, antihypertensive, and alpha-adrenolytic activity.EBI
Eur J Med Chem 44: 3994-4003 (2009)
Jagiellonian University Medical College
Quinazolindione derivatives as potent 5-HT3A receptor antagonists.EBI
Bioorg Med Chem 17: 4793-6 (2009)
Konkuk University
Design and synthesis of 3-alkyl-2-aryl-1,3-thiazinan-4-one derivatives as selective cyclooxygenase (COX-2) inhibitors.EBI
Bioorg Med Chem Lett 19: 3162-5 (2009)
Shahid Beheshti University (M.C)
Novel non-peptide beta-secretase inhibitors derived from structure-based virtual screening and bioassay.EBI
Bioorg Med Chem Lett 19: 3188-92 (2009)
Singapore Polytechnic
Discovery of selective PDE4B inhibitors.EBI
Bioorg Med Chem Lett 19: 3174-6 (2009)
Asahi Kasei Pharma
New potential AChE inhibitor candidates.EBI
Eur J Med Chem 44: 3754-9 (2009)
Universidade Bras£Lia
Fluorinated isatin derivatives. Part 2. New N-substituted 5-pyrrolidinylsulfonyl isatins as potential tools for molecular imaging of caspases in apoptosis.EBI
J Med Chem 52: 3484-95 (2009)
Westfalische Wilhelms-Universitat
Structure-activity relationships comparing N-(6-methylpyridin-yl)-substituted aryl amides to 2-methyl-6-(substituted-arylethynyl)pyridines or 2-methyl-4-(substituted-arylethynyl)thiazoles as novel metabotropic glutamate receptor subtype 5 antagonists.EBI
J Med Chem 52: 3563-75 (2009)
National Institute On Drug Abuse-Intramural Research Program
Synthesis and structure-activity relationship of a novel series of heterocyclic sulfonamide gamma-secretase inhibitors.EBI
Bioorg Med Chem 17: 4708-17 (2009)
Wyeth Research
Glycogen phosphorylase inhibitory effects of 2-oxo-1,2-dihydropyridin-3-yl amide derivatives.BDB
Bioorg Med Chem 17: 4724-33 (2009)
Griffith University
Discovery and SAR of novel mGluR5 non-competitive antagonists not based on an MPEP chemotype.EBI
Bioorg Med Chem Lett 19: 3209-13 (2009)
Vanderbilt University Medical Center
Synthesis and biological evaluation of novel gamma-carboline analogues of Dimebon as potent 5-HT6 receptor antagonists.EBI
Bioorg Med Chem Lett 19: 3183-7 (2009)
Chemical Diversity Research Institute
Discovery of a potent and brain penetrant mGluR5 positive allosteric modulator.EBI
Bioorg Med Chem Lett 19: 3275-8 (2009)
H. Lundbeck
A novel class of H3 antagonists derived from the natural product guided synthesis of unnatural analogs of the marine bromopyrrole alkaloid dispyrin.EBI
Bioorg Med Chem Lett 19: 3204-8 (2009)
Vanderbilt University
A novel photoaffinity ligand for the dopamine transporter based on pyrovalerone.EBI
Bioorg Med Chem 17: 3770-4 (2009)
Duquesne University Mylan School of Pharmacy
The discovery of novel calcium sensing receptor negative allosteric modulators.EBI
Bioorg Med Chem Lett 19: 3328-32 (2009)
Pfizer
Discovery of a potent class I selective ketone histone deacetylase inhibitor with antitumor activity in vivo and optimized pharmacokinetic properties.EBI
J Med Chem 52: 3453-6 (2009)
Irbm/Merck Research Laboratories
Discovery of N-{N-[(3-cyanophenyl)sulfonyl]-4(R)-cyclobutylamino-(L)-prolyl}-4-[(3',5'-dichloroisonicotinoyl) amino]-(L)-phenylalanine (MK-0668), an extremely potent and orally active antagonist of very late antigen-4.EBI
J Med Chem 52: 3449-52 (2009)
Merck Research Laboratories
Design, synthesis, and biological activity of isophthalic acid derivatives targeted to the C1 domain of protein kinase C.EBI
J Med Chem 52: 3969-81 (2009)
University of Helsinki
Discovery of the first highly M5-preferring muscarinic acetylcholine receptor ligand, an M5 positive allosteric modulator derived from a series of 5-trifluoromethoxy N-benzyl isatins.EBI
J Med Chem 52: 3445-8 (2009)
Vanderbilt University Medical Center
Discovery, SAR, and pharmacokinetics of a novel 3-hydroxyquinolin-2(1H)-one series of potent D-amino acid oxidase (DAAO) inhibitors.BDB
J Med Chem 52: 3576-85 (2009)
Pfizer
Discovery of low nanomolar and subnanomolar inhibitors of the mycobacterial beta-carbonic anhydrases Rv1284 and Rv3273.EBI
J Med Chem 52: 4063-7 (2009)
Istanbul University
Biological activity of endomorphin and [Dmt1]endomorphin analogs with six-membered proline surrogates in position 2.EBI
Bioorg Med Chem 17: 3789-94 (2009)
Medical University of Lodz
Pyridones as glucokinase activators: identification of a unique metabolic liability of the 4-sulfonyl-2-pyridone heterocycle.EBI
Bioorg Med Chem Lett 19: 3247-52 (2009)
Pfizer